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ABSTRACT  
  
 
 
AN EXAMINATION OF SPIRITUAL AND RELIGIOUS COPING AND WELL-
BEING AND THEIR IMPACT ON THE HEALTH-RELATED QUALITY OF LIFE 
FOR PATIENTS WITH MECHANICAL CIRCULATORY SUPPORT DEVICES. 
 
 
By Angela S. Hardy-Duncan, M.Div., M.S. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2011 
 
Diane Dodd-McCue, D.B.A, Department of Patient Counseling 
 
 
 Mechanical Circulatory Support (MCS) improves the health-related quality of life 
(HRQOL) for patients with end-stage heart failure (HF) (Friedrich & Bohm, 2007).  
Religious and spiritual practices positively influence health and well-being for cardiac 
patients (Ai, Park, Huang, Rodgers, & Tice, 2007; Blackhall, & Koenig, 1998).  The 
purpose of this study was to examine the impact of spiritual well-being (SWB) and 
religious well-being (RWB) and coping styles and methods (CSM) on the health related 
quality of life (HRQOL) for patients with MCS.    
 This exploratory repeated measures study used Spearmans‘ rho and Wilcoxons‘ 
Signed Rank tests for correlation and comparison analyses. The study population 
included patients with left ventricular assist devices (HMII) and total artificial hearts 
(TAH). Patients were assessed pre and post MCS implant.  Patients reported an increase 
xiv 
 
in the use of faith practices for coping (prayer and meditation), providing evidence for 
spiritual growth after MCS.  SWB, RWB, and CSM, and their corresponding subscales 
were positively related to HRQOL revealing medium to large correlation coefficients and 
variances.   Post MCS, the TAH patients‘ mean scores decreased for SWB and RWB 
(religious comfort) and increased for RWB (religious strain), indicating some spiritual 
distress. The internal locus of control for TAH patients increased with significance.  
HMII patients reported a significant increase in adaptive coping and ―God‖ locus of 
control.   
 The results suggest that early spiritual assessment with MCS patients may 
promote more timely and effective responses to maladaptive and dysfunctional coping. 
Patients who use their faith to cope (in distress or not) may also benefit from an increase 
in emotional and spiritual attention.  Spiritual care providers who are knowledgeable 
about the MCS assessment, surgery, and recovery process could then provide 
interventions that build resilience and mediate improved outcomes through supportive 
and directed counseling.  
 The results of this study inform the future development of interdisciplinary plans 
of spiritual and emotional care for this patient population and for other chronic illness 
populations. Further examination may reveal how SWB, RWB and CSM improve 
HRQOL as well as highlight the unique support needs of HMII and TAH patients.   
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CHAPTER 1: INTRODUCTION 
 
 
  
 There are approximately six million Americans with heart failure (HF), with an 
average of 550,000 more diagnosed each year and one in five dying within a year of 
diagnosis (AHA, 2009h; NHLBI, 2009b).  HF therapy focuses on improving the quality 
of life (QOL) for the patient (Johansson, Dalstrom, & Brostrom, 2006). Mechanical 
circulatory support (MCS) devices, one form of therapy, are implanted into patients who 
are waiting for a heart transplant (HT) but who are at risk of dying while waiting for a 
donor heart (Wray, Hall and Banner, 2007).  MCS devices can improve QOL (Rizzieri, 
Verheijde, Rady, and McGregor, 2008), but little is known about other factors that 
influence QOL as it relates to the health-related quality of life (HRQOL) for patients with 
MCS (Grady, Meyer, Mattea, Dressler, Ormaza, & White-Williams, et al. 2002; Rizzieri, 
Verheijde, Rady, & McGregor, 2008).  
 Although QOL is broad and may measure such constructs as socioeconomic and 
marital status, and life satisfaction, HRQOL as a subset of QOL also measures physical, 
psychological and functional health (Kane, 2006; Ware, 1995; WHO, 1958). In order to 
support an understanding of the current research and conceptual literature used for this 
study, a list of the key terms with definitions is presented in Appendix A.  
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As patients progress through the stages of HF, they may experience anxiety, fear, and 
depression (Burker, Evon, Losielle, Finkel, & Mill, 2005). These emotions become even 
more intense for patients, who are being assessed for a HT or MCS (Wray, Hallas, & 
Banner, 2007), and the way patients cope with HF can significantly impact HRQOL by 
affecting physical symptoms and psychological health (Carels, et al., 2004; Muirhead, et 
al., 1992). Many patients use spirituality or religion as a way to cope with illness and HF 
(Beckelman, Dy, & Becker, 2007; Finch & Sneed, 2003; Mytko & Knight, 1999).   
 Koenig, McCullough, and Larson (2001) report a significant link between 
religion, spirituality, and improved health outcomes. Ai, Park, Huang, Rodgers, and Tice 
(2007),  Ai, Peterson, Tice, Rodgers, Seymour, and Bolling (2006),  Bosworth, 
Steinhauser, Orr, Lindquist, Grambow, and Oddone (2004), and Harris, Dew, and Lee 
(1995) report religious and spiritual coping practices affect health and well-being (WB) 
in HF, cardiac surgery patients, and HT patients. WB, a concept that considers the whole 
person, measures a persons‘ perception about how well life is going for them (Stanford, 
2010).   
 Further research is needed to examine clinical effectiveness, economics, 
resources, costs, patient survival, functional ability, adverse events and HRQOL of 
patients with MCS (Clegg, et al., 2005; Franzen, Saveman, & Blomqvist, 2007; Rizzeri, 
et al., 2008).  Westlake and Dracup (2001) support the need for evidenced-based spiritual 
and religious interventions that improve QOL.  This individual level study examines 
spiritual and religious coping and WB and their impact on the HRQOL for patients with 
MCS. The results from this study may be used in the future to develop emotional and 
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spiritual care interventions that enhance the quality of care (QOC) and improve HRQOL 
outcomes for patients with advanced stage HF, patients with MCS and patients waiting 
for HT.  
Heart Failure 
 HF is one of the most life-threatening and disabling chronic diseases and is the 
only major cardiovascular disorder on the rise (HFSA, 2011). Nearly 300,000 Americans 
die each year from HF, of which 15-25% die while awaiting heart transplantation 
(American Heart Association [AHA], 2009h; Griffin, 2007; Levenson, et al., 2000; 
NHLBI, 2006).  Annually over one million hospitalizations are due to HF contributing to 
an estimated $37.2 billion in associated costs (AHA, 2009h). 
 HF occurs when the heart can no longer pump sufficient amounts of blood needed 
to carry oxygen throughout the body (AHA, 2009h).  Insufficient amounts of oxygen 
decrease the HRQOL for the advanced stage patient with HF as they experience 
symptoms such as difficult and painful breathing, fluid retention, swelling, general 
weakness, and fatigue (AHA, 2007; Beery & McMurray, 1999).  Death can be sudden 
and unexpected (Gottlieb, 2003; Oates, 2004; O‘Brien et al., 1998; Park, 2008). The 
HRQOL for patients with HF is poor.  Therapy is needed to address the disease 
symptoms, survival outcomes, and HRQOL (Johansson, Dalstrom, & Brostrom, 2006). 
 HF therapy includes medical management, surgical repair of heart valves, 
insertion of pacemakers, and cardiac assistance or replacement with MCS devices. 
Although heart transplantation is the treatment of choice; a limited and declining 
availability of donor hearts for transplant creates the need for MCS devices.  MCS 
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devices are implanted into patients who are waiting for a heart transplant, but who are at 
risk of dying while waiting for a donor heart (Wray, Hall, & Banner, 2007).  MCS 
devices are used as bridge therapy until a donor heart becomes available for a transplant.  
MCS devices are also used as a bridge to a heart transplant decision when there are 
factors that might initially prohibit heart transplantation; i.e. as a bridge to recovery when 
patients need temporary circulatory assistance or as destination therapy when a HT is not 
an option (Nair, et al., 2010; Rizzieri, et al., 2008).  HF therapy also includes palliative 
and end-of-life (EOL) preparation and care (Goodlin, 2009; Jessup, Abraham & Casey, 
2009) which may be options at any point along the HF treatment continuum (Goodlin, 
Hauptman, Arnold, Grady, Hershberger, & Kutner, et al., 2004).  
Mechanical Circulatory Support 
 There are several types of MCS devices and this study focuses on spiritual and 
religious coping and WB and its affect on HRQOL with left ventricular assist devices 
(LVAD) or total artificial hearts (TAH). These devices are mechanical pumps that assist 
or replace the heart and help push the blood through the body (AHA, 2009e; VCUPHC, 
2009).  MCS devices alleviate HF disease symptoms and improve patients‘ functional 
capacity and survival (Franzen, Saveman, & Blomqvist, 2007; Rose, Gelijn, Mosowitz, 
Heitjan, Stevenson, & Dembitsky, et al., 2001). HRQOL, which is a predictor of 
survivability (Beery, Baas, Fowler, & Allen, 2002; Faller, Stork, Schowalter, 
Steinbuchel, Wollner, & Ertl, et al., 2007), has multiple domains (physical, functional, 
emotional, psychosocial, spiritual, and cultural) (Kane, 2006; Ware, Kosinski, & Keller, 
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1994; Webster, Cella & Yost, 2003; Westlake, 2002). Further research is needed to 
determine the influence of each HRQOL domain.   
Health-Related Quality of Life 
 Dracup, Walden, Stevenson, and Brecht (1992), Westlake (2002), and Carson, 
Tam, Ghali, Archambault, Taylor, and Cohn, et al. (2009) suggest evaluating HRQOL as 
an outcome of HF therapy.  Grady (2003), Grady et al., (2002, 2003) and Wray, Hallas, 
and Banner (2007) report the significance of HRQOL on the clinical outcomes of MCS 
device patients. Treating HF patients is difficult due to the unpredictable nature of the 
disease (Gibbs et al, 1998; Hanratty et al, 2002; Stewart & McMurray, 2002). The 
uncertainty experienced from the unpredictability increases the psychological effects of 
fear, anxiety, anger, and depression which stems from the patients‘ real or perceived loss 
of personal control (Rhodes & Bowles, 2002).  Patients‘ ability to participate in daily 
physical and social activities becomes limited and they experience feelings of loss and 
grief (Rhodes & Bowles, 2002). HRQOL often deteriorates as HF patients approach the 
EOL and then wait to be placed on a transplant list or receive a MCS device as a 
temporary or permanent solution (Rizzieri, et al., 2008).  As patients progress through the 
stages of HF, their emotions often become more intense as they are evaluated for more 
aggressive therapy such as MCS or HT (Burker, Evon, & Losielle, et al., 2005; Wray, 
Hallas, & Banner, 2007). Rizzieri, et al. (2008), Franzen, et al. (2007) and Clegg et al. 
(2005) emphasize the importance of examining HRQOL and how patients cope with 
MCS.     
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Spiritual Well-Being and Religious Well-Being 
   The healthcare environment recognizes a need for providing patient-centered care 
(care that attends to the ―whole person‖) that addresses the patients‘ beliefs and values 
(Johnson, Roter, Powe, & Cooper, 2004; Peek, 2009; Peek, et al., 2007).  Beliefs and 
values represent personal sources of strength and hope (Gorman, Sultan, & Raines, 
1996). Betancourt, Green, and Carrillo (2002) and Doolen & York (2007) suggest 
improving the quality of healthcare by responding to the varied perspectives, values, and 
behaviors that affect health, WB, and QOL.  A disturbance in the systems that provide 
strength and hope can produce spiritual or existential distress (Gorman, et al., 1996) and a 
patient may use spirituality or religion as one way to cope with his or her illness (Finch & 
Sneed, 2003; Mytko & Knight, 1999; Salyer, Sneed, & Corley, 2001; Sulmasy, 2002). 
Patients often want to find meaning in their illness experience with HF (Murray, Kendal 
& Boyd, 2004). Spiritual well-being (SWB) and religious well-being (RWB) and how 
they affect healthcare outcomes has been explored (Sulmasy, 2002; Villagomeza, 2006), 
but only a few studies address their influence with HF patients (Beckelman, et al., 2007).  
Koenig, McCullough, and Larson (2001) report religious and spiritual coping and WB 
play a significant role in a patients‘ HRQOL, however to date no studies were found that 
report on the impact that spirituality and religion have on the WB or HRQOL of MCS 
patients.  
Background and Significance 
 Because there is no cure for HF, HF therapy focuses on improving the QOL for 
patients (Goodlin, et al., 2004; Hunt, et al., 2005; Johansson, Dalstrom, & Brostrom, 
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2006; Johnson, 2007). MCS improves the HRQOL of patients with end-stage HF (ESHF) 
and can keep them alive until heart transplantation (Friedrich & Bohm, 2007).  
 The number of MCS implants is increasing as the number of HF patients increase 
due to better medical management and longer life for patients with advanced stage HF 
(Stahovich, Chillcott, & Dembitsky, 2007).  MCS improves outcomes for HF symptoms, 
functional capacity, HRQOL and a patient surviving until heart transplantation (Friedrich 
and Bohm, 2007). However, more information is needed about other factors that 
influence outcomes (Westlake, 2002).  Dracup, et al. (1992) and Westlake (2002) suggest 
HRQOL become an essential outcome of HF therapy. Ersek, Kagawa-Singer, Barnes, 
Blackhall, and Koenig (1998), Hu (2007), and King and Hinds (2003) report spirituality, 
religion, and cultural beliefs significantly influence HRQOL. The need for evidence-
based spiritual, religious and culturally sensitive interventions that improve HRQOL 
were also emphasized by (Mayberry, Nicewander, Qin, & Ballard, 2006; Mensah & 
Dunbar, 2006; Westlake & Dracup, 2001). These same interventions may also improve 
HRQOL for patients with MCS devices. 
 The research site, Virginia Commonwealth University Medical Center (VCU), is 
a leading academic medical center offering state-of-the-art care in more than 200 
specialty areas and has a cardiology program that encompasses programs in 
cardiovascular disease, cardiothoracic surgery, electrophysiology, and intervention. 
Specialty areas include HF and heart transplantation.  In 1968 doctors at VCU performed 
the center‘s first HT, making it the second oldest transplant program in the United States.  
VCU is one of a few worldwide heart transplant programs approved to implant the total 
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artificial heart, and continues to pioneer improvements in MCS. The VCU cardiothoracic 
surgery team also implants MCS devices and performs heart transplantation at the 
McGuire Veterans Administration Medical Center in Richmond, Virginia (McGuire).  
Currently, VCU and McGuire implant the Thoratec Heartmate II, Jarvik from Jarvik 
Hearts, and Syncardias‘ Total Artificial Heart.  
 In 2008 VCU and McGuire formed a Circulatory Assist Team (CAT) to improve 
the performance of the MCS device program and received certification from the Joint 
Commission (JCAHO) on hospital accreditation for the Mechanical Circulatory 
Support/Ventricular Assist Device (MCS/VAD) program.  The multi-disciplinary team 
includes cardiothoracic transplant surgeons, cardiologists, nurse transplant coordinators, 
social workers, chaplains, psychologists, dietitians, physical therapists, and pharmacists.  
The goals set by the CAT provided the foundation for this study: improving HRQOL, 
providing patient-focused care, providing patient and family education, using an 
interdisciplinary team approach to care, decreasing the length of stay from the time of 
MCS device implant to discharge, and increasing survival rates.  Research with the VCU 
and McGuire patient population adds to the existing body of research in HF, heart 
transplantation and MCS.  
 The results from this study may inform the future development of 
interdisciplinary plans of care with disease-specific HF interventions and may also help 
to improve the quality of care with MCS patients.  The interdisciplinary plans may be 
used as templates for use with patients diagnosed with other chronic diseases (e.g. 
diabetes, cancer, arthritis).   
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Study Purpose and Objectives 
 The purpose of the study is to examine spiritual well-being (SWB), religious well-
being (RWB) and coping styles and methods (CSM) and their influence on the HRQOL 
for patients with MCS.  The study objectives are: 
 To summarize the MCS patient sample population using descriptive statistics.  
 To determine if there is a positive relationship between the SWB and HRQOL for 
patients with MCS. 
 
 To determine if there is a positive relationship between the RWB and HRQOL for 
patients with MCS. 
 
 To determine if there is a positive relationship between the CSM and HRQOL for   
patients with MCS. 
 
 To determine if there is a positive relationship between the CSM and SWB for 
patients with MCS. 
 
 To determine if there is a positive relationship between the CSM and RWB for 
patients with MCS. 
 
 To determine if the SWB increases over time (2 intervals – pre and post MCS). 
 
 To determine if the RWB increases over time (2 intervals – pre and post MCS). 
 
 To determine if the CSM increases over time (2 intervals –  pre and post MCS). 
 
 To determine if the HRQOL increases over time (2 intervals – pre and post MCS). 
 
Conceptual Model for Study 
 The conceptual model for this study examines spiritual and religious coping and 
WB and their influence on the relationship between a MCS intervention and HRQOL 
(See Figure 1). It is based upon the works of Boland (2000), Gall, Charbonneau, Clarke, 
Grant, Joseph, & Shouldice (2005) and Utsey, Bolden, and Williams (2007), who  
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CONSTRUCTS 
    
      
  
 
 
 
 
 
 
 
Variables 
   
   MCS Variables (1)                            Coping Variables ( 3) 
   TAH       Coping Style Religious/Other 
   HMII      Locus of Control 
        Social/Family Support    
              Support/Confidante 
       Faith traditions, rituals, practices 
       Faith community and visitations 
 
   Well-Being Variables (2)                   HRQOL Variables (4) 
   Meaning/Peace     Physical 
   Role of Faith in Illness    Functional 
   Relational/Connectedness     Emotional 
   Religious Comfort   Spiritual Outcomes 
   Religious Strain    Patient Satisfaction    
                       # of survival days 
 
       For HMII and TAH Freedom Driver 
       # of days from MCS to discharge 
       # of readmission days 
       # of inpatient days overall 
       # of readmission times 
 
 
 
        
Figure 1: MCS Quality of Life, Coping and Well-Being Conceptual Framework   
The constructs and variables in a modified Bacharach (1989) framework.   
WB 
SWB 
RWB 
HRQOL 
 
Coping  
MCS 
Type 
Variable 
3 
Variable 
2 Variable 
4 
Variable 
1 
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suggest coping behaviors and resources in the form of spirituality, religiosity, and culture 
help to manage stressful situations. This conceptual model also builds upon the cognitive 
model of stress and coping of Lazarus and Folkman (1984), Folkman (1997, 2008), and 
Moos and Holahans‘ Coping Model (2007). HRQOL variables are based on models by 
Wilson and Cleary (1995), Majani, Pierogon, and Giardini (1999) and Kane, 2006. 
 Previous research has demonstrated that MCS improves the HRQOL of HF 
patients (Clegg, et al., 2005) and has identified spirituality and religion as mediators 
between coping and QOL (Utsey, Bolden, & Williams, 2007).  The spiritual, religious, 
and coping variables examined in this study are listed in Table 1.  HRQOL outcomes 
variables are in Table 2 and descriptive variables are listed in Table 3. Variable 
definitions and survey measurement and instruments are listed in Appendix B, C, D and 
E. 
 This study will use IBM SPSS Statistics 19 (IBM SPSS 19) and Excel 2007 for 
statistical testing.  Descriptive testing will be used to summarize the patient sample 
population.  Correlation analyses will be used to determine correlations between SWB, 
RWB and CSM and HRQOL.  Comparative analyses will be used to determine if SWB, 
RWB, CSM, and HRQOL change over time.   
Chapter Summary 
 HF is a disabling chronic disease and makes patient care planning difficult 
(Freedland and Carney, 2000).  HF therapy with MCS can keep patients alive  
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until heart transplantation (Friedrich  & Bohm, 2007) or prolong life as a destination 
therapy (Rizzieri, et. al., 2008).  MCS improves outcomes for HF symptoms, functional 
Table 1:  Well-Being and Coping Variables   
Well-Being Variables (WB) 
Spiritual Well-Being (SWB) and Religious Well-Being (RWB) 
     Spiritual Well-Being Overall (SWB) 
     Sense of meaning and peace (SWB-MP) 
     Role of faith in illness (SWB-ROF) 
     Relational (forgiveness, connectedness, appreciation) (SWB-RLC) 
     Religious Well-Being Overall (RWB) 
     Religious Comfort (RWB-RC) 
     Religious Strain/Distress (RWB-RS) 
 
Coping Style and Method Variables (CSM) 
Coping 
     Coping (BCOPE –EF emotion focused, BCOPE – PF problem focused, BCOPE -DF  
     dysfunctional focus) 
     Religious Coping (BRCope-AD adaptive, BRCope-M maladaptive) 
     Locus of Control(LOC-I internal, LOC-E external, LOC-G God) 
     Faith tradition 
     Faith community membership 
     Faith rituals and practices 
     Faith visitation (from chaplains, outside clergy/faith leaders, community of faith) 
     Having a confidante (someone to confide in) 
     Social/Family Relationship Status (SF) 
 
 
Table 2:  Health-Related Quality of Life Outcome Variables. 
Health-Related Quality of Life Variables (HRQOL) 
Physical Status (HRQOL-P) 
Functional Status (HRQOL-F) 
Emotional Status (HRQOL-E) 
Spirituality Outcomes - enhanced coping, faith/courage, hope, belief system, connection 
with higher power, connection with relationships, sense of self, sense of meaning, sense 
of vocation, reconciliation with self, situational reinterpretation, advance directives 
completed, patient spiritual and emotional condition unchanged after spiritual assessment 
during chaplain visit 
Patient treatment satisfaction (PTS-E, PTS-I, PTS-CC, PTS-TQ, PTS-DM, PTS-Nurses,  
PTS-Trust, PTS-R, PTS-CA, PTS-OE) 
Number of survival days post MCS implant (MCS-SD) 
Number of days till discharge home post MCS implant (MCS-DD)  
Number of readmissions post MCS implant (MCS-RD) 
Number of inpatient days post MCS implant (MCS-ID) 
Number of readmission times post MCS implant (MCS-RT) 
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Table 3:  Descriptive Variables  
 
Descriptive Variables 
MCS Device Type 
Heart Transplant  Y/N and # of Days post MCS Device 
Palliative Care Y/N 
Length of illness prior to MCS implant 
HF Etiology 
Distance lived from hospital 
Number of hospital admissions in previous 6 months 
Number of hospital inpatient days in previous 6 months 
Race/Ethnicity 
Age 
Gender 
Marital Status 
Having an Advance Directive  
Education Level 
Socioeconomic Level Income Level 
Socioeconomic Level Occupation 
 
 
capacity, HRQOL and a patient‘s survivability to heart transplantation (Friedrich and 
Bohm, 2007), but more information is needed about other factors that influence HRQOL 
outcomes (Westlake, 2002).   
 Dracup, et al., (1992) and Westlake (2002) recommend HRQOL be an essential 
outcome of HF therapy.  Previous studies report the significance of faith and spirituality, 
their influence on HRQOL, and their role in helping patients cope with ESHF (Ersek, et 
al., 1998; Hu, 2007; King et al., 2003; Koenig, McCullough, & Larson, 2001). This study 
will examine SWB, RWB and CSM and their impact on the HRQOL for patients with 
MCS.   
Organization of the Study 
 The remaining chapters are organized as follows.  Chapter 2 contains a review of 
the literature and includes background on HF and HT, spiritual and religious coping, and 
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well-being and HRQOL.  Chapter 3 builds upon the previously stated research objectives 
and includes the research questions, study hypotheses, research methods, instrumentation 
and measurement, and statistical analyses used in this study.  Chapter 4 presents the study 
results and includes the descriptions of the patient sample, the results of the correlation 
analyses (Spearmans‘ Correlation Analysis) and the comparative analyses (Wilcoxons‘ 
Rank-Signed Test). Chapter 5 offers study conclusions and summarizes the studys‘ 
strengths and limitations. Also provided in Chapter 5 are recommendations for future 
research.   A bibliography and appendices conclude the study. 
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CHAPTER 2:  LITERATURE REVIEW 
 
 
  
 This chapter will review the literature for HF, HT and MCS.  Most often 
frameworks and models for healthcare address the disease from a pathophysiological 
model (Larson & Lubkin, 2009, p. 4).  This study will focus on the patients‘ experience 
with the illness which includes the symptoms and suffering and will review the literature 
on WB, CSM and HRQOL.   
 The conceptual framework for this study (See Figure1) posits SWB, RWB and 
coping as mediators (Boland, 2000; Gall, Charbonneau, & Clarke, 2005; Utsey et al., 
2007) between MCS device implantation and HRQOL.  The conceptual framework is 
derived from the cognitive model of stress and coping of Folkman (1997, 2008), Lazarus 
and Folkman (1984), and Moos and Holahan (2007). Also used to shape the study 
framework is a Spiritual Framework of Coping by Gall et al. (2005) and a model that 
posits culture specific coping and spiritual WB as predictors of QOL (Boland, 2000; 
Utsey et al., 2007).  HRQOL variables are based on models by Kane (2006), Majani et al. 
(1999) and Wilson and Cleary (1995).  
Heart Failure 
 The number of HF deaths per year has doubled in 30 years (HFSA, 2009) and the 
rate of new diagnoses is expected to triple over the next 30 years (Masoudi, Havranek, & 
16 
 
 
 
Krumholz, 2002).  The cost of caring for HF patients is currently $38 billion per year and 
continues to escalate due to expenditures on clinic and home care visits, frequent and 
prolonged hospital stays, and medications and laboratory tests (AHA, 2009h; Copeland, 
et al., 2004; Hunt, et al., 2005; O‘Connell & Bristow, 1993; Starling, 1998).  Improving 
HF symptoms and QOL is the focus of medical and surgical treatment (Goodlin, 
Hauptman, & Arnold., et al., 2004; Hunt, Abraham, & Chin, et al., 2005; Johansson, 
Dalstrom, & Brostrom, 2006).  HT or MCS is the last treatment option when all other 
medical or surgical treatments have failed (NHLBI, 2010a; 2010c).  
 A normal heart, which is a little larger than a fist, has two upper (atria) and two 
lower (ventricles) chambers. Oxygen rich blood travels from the left atrium to the left 
ventricle where it is pumped to the rest of the body.  The right atrium takes the blood 
depleted of oxygen and sends it to the right ventricle and then to the lungs where it 
becomes re-oxygenated (AHA, 2009h).  HF is diagnosed when the heart can no longer 
pump efficiently to produce the body‘s needed requirements for blood and oxygen.  
 HF can be experienced at any age, but it is more common in persons over the age 
of 65 (AHA, 2009a).  Causes of HF may be coronary artery disease, previous myocardial 
infarctions, hypertension, abnormal heart valves, heart muscle disease (cardiomyopathy, 
myocarditis), congenital heart disease, severe lung disease, diabetes, severe anemia, 
hyperthyroidism, and abnormal heart rhythms (arrhythmia, dysrhythmia) (AHA, 2009a). 
 Many patients with HF are unaware that they have it until many years after its 
onset, because the heart will try to compensate by enlarging, developing more muscle 
mass, or pumping faster (AHA, 2009h).  Another way that the heart tries to compensate is 
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by narrowing the blood vessels and sending blood to more vital organs and away from 
less important organs and tissues. As HF progresses, patients experience symptoms such 
as fatigue and dyspnea (shortness of breath).  Congestive heart failure (CHF) happens 
when the blood returning to the heart backs up and causes congestion to the body tissues 
(AHA, 2009h).  Symptoms include swelling (edema) in the legs and ankles as well as 
other parts of the body.  Dyspnea is also experienced when fluid collects in the lungs 
possibly leading to respiratory distress and the kidneys are impacted when they cannot 
dispose of sodium and water and body tissues swell (edema) (AHA, 2010g). 
HF may affect the left side, right side, or both sides of the heart.   
 Other distressing symptoms experienced with HF are sudden weight gain (e.g. 3 
or more pounds in one day or 5 or more pounds in one week), dyspnea at rest, pain in the 
legs, ankles and abdomen, trouble sleeping, frequent and dry cough, loss of appetite and 
fatigue, palpitations, angina (pain) with less than ordinary activity or at rest (AHA, 
2009c; HFSA, 2010).  Co-morbidities such as diabetes, hypertension, chronic obstructive 
pulmonary disease (COPD) and stroke exacerbate HF symptoms (Berry & McMurray, 
1999).  
 Insufficient amounts of oxygen decrease the QOL for HF patients as they 
experience symptoms such as difficult and painful breathing, fluid retention, swelling, 
general weakness, and fatigue (AHA, 2009c; Beery & McMurray, 1999).  Death is often 
sudden and unexpected (Gottlieb, 2003; Oates, 2004; O'Brien, Welsh & Dunn, 1998; 
Park, 2008).  There is no cure for HF and the QOL for the advanced stage HF patient is 
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poor therefore therapy that addresses the disease symptoms, survival outcomes and 
HRQOL becomes crucial (Johansson, Dalstrom, & Brostrom, 2006). 
Heart Failure Therapy 
 Healthcare providers use the recommended New York Heart Association 
(NYHA) HF Classification (HFSA, 2010) and/or the American College of Cardiology 
(ACC) and American Heart Association (AHA) Guidelines for the Evaluation and 
Management of Chronic Heart Failure in the Adult (Hunt, Abraham & Chin, et al., 2005) 
to determine the classification or stage of HF and the best course of HF therapy. The 
NYHA Classification and the ACC and AHA Guidelines relate to symptoms, daily 
activities and QOL (NYHA, 2010).  Advanced and end-stage HF (ESHF) or Class IV is 
determined by the healthcare provider when a patient experiences a marked limitation of 
physical activity and is comfortable only at rest (Stevenson & Rose, 2008).   
 Treatment of HF usually involves management of symptoms and includes 
lifestyle changes, medication, and/or surgery (AHA, 2009f) (See Figure 2). 
Recommended lifestyle changes include smoking cessation, losing weight, avoiding 
alcohol, avoiding or limiting caffeine, eating a healthy diet (e.g., a diet low in saturated 
fat, cholesterol, and sodium), exercise, stress management, and blood pressure 
monitoring.  Treatment may also include palliative care.    
Medication Management 
 HF patients require multiple medications (AHA, 2010f).  Medications used in the 
treatment of HF symptoms include ace (angiotensin-converting enzyme) inhibitors, 
vasodilators, digitalis preparations, beta blockers, blood thinners, angiotensin II receptor  
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Figure 2:  Pathway for Heart Failure (HF) Management. 
BTD (bridge to decision), BTR (bridge to recovery), BTT (bridge to transplant), DT 
(destination therapy), EOL (end-of-life care), HF (heart failure), HT (heart transplant), 
PC (palliative/comfort care), TAH (total artificial heart), VAD (ventricular assist device).   
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blockers (ARBs), potassium, and cholesterol-lowering drugs (AHA, 2010e).  Ace-
inhibitors slow the progression of HF and expand blood vessels, lower blood pressure, 
and decrease the workload on the heart.  If patients are unable to tolerate ACE inhibitors, 
they may be prescribed vasodilators which cause the walls of the blood vessels to relax 
and allow blood to flow more freely.  
 Digitalis preparations increase heart contractions and can slow irregular 
heartbeats.  Beta blockers reduce the heart rate and decrease the amount of oxygen that  
circulates through the body and are sometimes used with other HF medications.  Blood 
thinners reduce the risk for developing blood clots.  ARBs block the effects of 
angiotensin II, lower the blood pressure and improve the circulation to the heart.   
Angiotensin II is a chemical which causes the small blood vessels to constrict and raise 
the blood pressure. Diuretics decrease the swelling in the body tissue by causing the 
kidneys to remove sodium and water from the blood stream and converting the excess 
fluid to urine. The result is a decreased amount of fluid needing to be pumped from the 
body and reducing the workload on the heart. Diuretics also remove potassium through 
the urine.  Since potassium controls the heart rhythm, patients that take diuretics need 
potassium supplements or foods that contain potassium to replace what they lose (AHA, 
2010e).  Cholesteral-lowering drugs decrease the LDL (low density lipoprotein) (bad 
cholesterol), raise the HDL (high density lipoprotein)(good cholesterol) and lower 
triglyceride levels.  
 HF medications sometimes produce side effects (AHA, 2010e) including  
persistent cough, weakness or dizziness, skin rashes, altered sense of taste, high or low 
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potassium levels, nausea, vomiting, and headaches.  Patients may also experience fatigue, 
low blood pressure, and poor kidney function, heart palpitations, fast or skipped  
heartbeats, nasal congestion and flushing, loss of appetite, worsening asthma symptoms, 
unusual bleeding such as, nosebleeds, bleeding in the gums or easy bruising and ankle 
swelling 
Surgical Interventions 
Surgery and other medical procedures may be used to treat HF. Surgery is used 
when lifestyle changes and medications can no longer treat the symptoms (AHA, 2009e) 
and may include surgical repair or replacement of heart valves, pacemaker placement, 
percutaneous coronary intervention (PCI or angioplasty), coronary artery bypass 
(CABG), defibrillator implantation (AHA, 2009e), HT and MCS.   
Valve repair and replacement surgery are performed when the heart valves that 
regulate the blood flow become defective or diseased and cause extra strain on the heart.   
The bad valves are either repaired or removed and replaced with a biological or 
mechanical valve.   
 PCI or angioplasty is performed when the coronary arteries restrict the blood 
supply to the heart muscle.  A small catheter or tube with a deflated balloon on the end is 
pushed through the diseased artery to open it.  The balloon is inflated and removed after 
opening the arteries.   
 Coronary artery bypass (CABG) is a procedure that reroutes the blood supply 
around arteries that become blocked. The surgeon removes healthy blood vessels from 
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other parts of the body and then attaches them to the heart to allow the blood to flow 
around the blockage.   
 Defibrillators can prevent sudden death from cardiac arrest when patients 
experience irregular heartbeats that are too fast or too slow.  The defibrillator is placed 
near the heart, in a pouch, underneath the patients‘ skin and uses electrical pulses to 
either pace or shock the heart back into a normal rhythm (AHA, 2010b, NHLBI, 2010c). 
Heart Transplantation 
 A HT may be an option when lifestyle changes, medications and no other 
surgeries are effective (NHLBI, 2010a).  The damaged heart is replaced with another 
heart taken from a donor.  The patient must first be placed on a transplant waiting list.  
Waiting for a donor heart may take several months and if the patient begins to decline, 
MCS devices such as an LVAD or TAH may be implanted to keep the patient alive until 
a donor heart becomes available (Gray & Selzman, 2006; Nair, Kormos, & Teuteberg et 
al, 2010; Rizzieri, et. al., 2008; Vural, 2008). 
 Mortality for patients that are on HT waiting lists is approximately 30% per year 
(Vural, 2008).  The need for MCS is increased due to an increase in the number of 
patients listed for transplant and the need for a way to bridge patients to transplantation 
who might not survive otherwise (Ferrazzi, Triggiani, & Simon, et al., 2009).  
Mechanical Circulatory Support 
 MCS devices are mechanical pumps that assist or replace the heart and help push 
the blood through the body (AHA, 2009e; VCUPHC, 2009).  MCS devices alleviate HF 
disease symptoms and improve a patients‘ functional capacity and survival as well as the  
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HRQOL (Franzen, Saveman, & Blomqvist, 2007; Friedrich & Bohm, 2007; Rose et al., 
2001). There are various types of MCS devices.  This study will measure spiritual and 
religious WB and CSM and HRQOL for patients with the LVAD, a left-sided support 
system (Heartmate II/HMII) from Thoratec or the total artificial heart, a left and right 
sided support system (TAH) from Syncardia. 
 An LVAD may be used as a bridge to HT, a bridge until the heart recovers or as 
destination therapy when HT is not an option (Vural, 2008). According to AHA (2010a), 
approximately 100,000 patients with advanced or ESHF may benefit from a MCS device. 
The LVAD is attached to the native hearts‘ left ventricle, the main pumping chamber, and 
the aorta, the main artery of the heart to carry oxygenated blood to the rest of the body 
(Thoratec, 2011).  An external driveline connects the LVAD to a small ―wearable 
system‖ that includes a controller and external batteries that may be worn by the patient 
over or underneath his or her clothing (Thoratec, 2011). The LVAD is approximately 3 
inches in size and weighs approximately 10 ounces.  The batteries may last up to 14 
hours before needing a recharge.   
 The majority of patients with LVADs report feeling more energetic, less fatigued. 
Many are able to return to work or other activities, but have to adjust their bathing habits.  
Water immersion, showers and swimming are not options for patients who have an 
LVAD.    
  TAHs are mechanical hearts used as a bridge to HT for patients who are dying 
from biventricular failure (right and left side heart failure). The diseased heart is removed 
and the 70cc mechanical heart is implanted (CardioWest, 2010).  The patient with the 
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total artificial heart is tethered to a 418 pound power supply ―Big Blue‖ and must remain 
in the hospital until a donor heart is received.  Some patients may be eligible to enroll in a 
clinical study for a Freedom portable driver that weighs 13.5 pounds.  The portable driver 
allows the patients to go home and to wait for the donor heart as opposed to remaining in 
the hospital. 
Palliative Care 
 Palliative care, which is pain and symptom management care, and EOL care are 
considerations at every stage of a HF treatment plan (Goodlin, 2009; Goodlin, Hauptman, 
& Arnold et al., 2004), but becomes more crucial when HT or MCS are not options 
(Jessup, Abraham & Casey, 2009).  Palliative care aims to provide a ―holistic approach‖ 
to improve the quality of life for the patient with a life limiting and threatening illness 
(Goodlin, 2009; McGoldrick, 1999; WHO, 2002).  Patients experience individual and 
family burden throughout the course of HF therapy and experience physical, psychosocial 
and spiritual distress.  Multidisciplinary healthcare teams can provide integrated and 
comprehensive HF interventions that eliminate suffering (Goodlin, 2009).  Psychosocial 
and spiritual distress may be addressed through an ongoing assessment of quality of life, 
providing supportive communication, inclusion of the patient and family in the treatment 
planning, addressing patient and family treatment preferences, addressing emotional and 
spiritual needs, support of coping with dying, and bereavement follow-up care with 
family and friends. 
 
 
25 
 
 
 
Health-Related Quality of Life 
 Quality of life (QOL) is the degree of WB felt by an individual (Finch & Sneed, 
2003; WHO, 1948) and is a recommended outcome for patients with incurable chronic 
illness (Burckhardt & Anderson, 2003; Johansson, Dahlstrom, & Brostrom, 2006). QOL 
is the patients‘ perception of his or her position in life in the context of culture, the value 
system in which he or she lives, and in relation to his or her goals, expectations, 
standards, and concerns (WHO, 1998; Utsey, Chae, Brown, & Kelly, 2002, p. 369). 
 HRQOL is QOL as it pertains to an individuals‘ health status (Guyatt, Feeny, & 
Patrick, 1993) and is determined by a patients‘ perception of his or her own health status 
(Heo, Moser, & Riegel, et al., 2005; Keepstra et al., 2008).  ―Health,‖ as defined by 
WHO (1948, 2002) is ―a complete state of physical and mental WB and not merely the 
absence of disease or infirmity‖ (WHO, 1948). Several studies have linked HRQOL with 
patient mortality (Berry & McMurray, 1999; Keepstra et al., 2008).  
 HF affects patients‘ health status in multiple HRQOL domains (e.g., physical, 
work, family and social issues, sexual intimacy and future orientation) (Webster, Cella, & 
Yost, 2003).  Several HRQOL models for study have been proposed.  Majani, Pierogon, 
and Giardini (1999) suggest including subjective domains (e.g., illness perception, 
symptomatology, and satisfaction) in addition to objective domains (e.g., physical, 
psychological, cognitive, social and work) when measuring HRQOL because subjective 
indicators correlate with a sense of WB and are better barometers of QOL.  
 Kane (2006) presents another model of health with eight domains. They are 
physical, social, emotional, sexual, cognitive, pain/discomfort, vitality and overall WB.  
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One other proposed model by Wilson and Cleary (1995) uses biologic/physiologic, 
symptom, functional, health perception, individual patient characteristics, and 
environmental outcomes to determine HRQOL.     
Heart Failure and Quality of Life 
 Lifestyle changes, medical management, and surgical therapy delay the 
progression of HF disease and allow patients to live longer, but a HF patient experiences 
greater limitations and a decrease in his or her HRQOL as compared to other diseases 
(Beery & McMurray, 1999).   Poor HRQOL is a predictor of death (Beckelman, Dy, & 
Becker, et. al., 2007; Beery & McMurray, 1999; Konstam, et al., 1996; O‘Loughlin, 
Murphy, & Conlon, 2008) and a patients‘ tolerance and coping for living with HF 
symptoms is dependent on the patients‘ perception of his or her health status (Heo, 
Moser, & Riegel, et al., 2005).  HRQOL with respect to HF is determined by limitations 
and impairments and encompasses multiple domains (Westlake, Dracup, & Creaser, et 
al., 2002).  Historically, the traditional measures of HF HRQOL were exercise capacity, 
recurrent hospitalization, left ventricular ejection fraction (EF) and death (Berry & 
McMurray, 1999; CONSENSUS, 1987; Ghali et al., 1992; Jafri et al., 1986), but HRQOL 
also includes other variables (e.g., functional, symptom, biological and physiologic, 
psychological, social and economic, demographic and health perception)(Bosworth, 
Steinhauser, & Orr, et al., 2004; Heo, Moser, & Reigel, et al., 2005).   
 Physical HRQOL is impacted by fatigue, dyspnea, swelling and loss of muscle 
bulk (Beery & McMurray, 1999).  Psychosocial functioning is effected by a decrease in 
appetite and sexual activity and a limited ability to work. Patients also experience a loss 
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of autonomy due to increased hospital admissions and prolonged lengths of stay (Berry & 
McMurray, 1999; Johansson, Dahlstrom, & Brostrom, 2006).  Psychological impairments 
such as depression, anxiety, uncertainty, and anger often accompany the physical 
problems and increase the mortality risk (Beckelman, Dy, & Becker, et al.,2007;  
Gottlieb, Khatta, & Friedmann, et al., 2004; Havranek, Ware, & Lowes, et al, 1999; 
Rozzini et al., 2002).  Chronic health problems also impair and limit a patient‘s ability to 
participate in daily activities (Lehman, 1995 as cited in Shi & Singh) and limit access to 
the community, resulting in decreased overall WB.  Controlling or reducing stress 
becomes essential for improving HRQOL (Heo, Doering, & Widener, et al., 2008).  
Mechanical Circulatory Support and Quality of Life 
 HRQOL deteriorates as HF patients approach advanced or ESHF and then wait to 
be placed on a HT list or receive MCS as a temporary or destination solution (Rizzieri, 
Verheijde, Rady, & McGregor, 2008).  Patients may also experience emotions such as 
anxiety, fear, depression and grief from the HF experience (Burker, Evon, & Losielle, et 
al., 2005; Leeuwen, Tiesinga, Jochemasen, & Post, 2007) and these emotions intensify 
during the evaluation process for HT or MCS (Haugh & Salyer, 2007; Wray, Hallas, & 
Banner, 2007). The goal of MCS implantation is to improve HRQOL (Copeland, Smith, 
& Arabia et al., 2004; Gray & Selzman, 2006; Rizzieri, et al., 2008).  Patients‘ perceive 
HRQOL with MCS to be better than treatment with medical therapy alone (Moskowitz, 
Weinberg, & Oz, et al., 1997) and patient satisfaction results are high (Grady, Meyer, & 
Mattea, 2002). Although good HRQOL is important to an overall successful MCS 
placement (Grady, Meyer, & Dressler, 2004) ethical challenges do exist.   
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 The challenges with MCS implantation are the adverse events such as pump 
failure, infection, clotting, neurological complications, and death (Lietz & Miller, 2007).  
Hernandez et al. (2008) report mortality rates between 48 and 53 percent at one year post 
implant with an LVAD implant and suggest finding a method for patient selection that 
reduces mortality.  Although MCS devices may extend life, advance planning and end of 
life (EOL) care may be necessary (Rizzieri, et al., 2008) Additional challenges are related 
to finances and caregiver burden (Lietz & Miller, 2007).      
Coping With Heart Failure 
 Healthcare systems and providers focus on managing and curing disease and may 
not always attend to the psychological, social, and emotional needs of patients (Larsen & 
Hummel, 2009). Treating HF patients is difficult due to the unpredictable nature of the 
disease (Gibbs et al., 1998; Hanratty et al., 2002; Stewart & McMurray, 2002) and patient 
management of HF may benefit from identifying and providing resources and support 
that assists with emotionally adjusting to the illness (Klein, Turvey, & Pies, 2007).  The 
uncertainty experienced from the unpredictable illness trajectory increases stress for the 
patient which increases the psychological effects of fear, anxiety, anger, depression and 
grief when patients experience real or perceived loss of personal control (Leeuwen et al., 
2007; Johnson, Afari, & Zautra, 2009; Oates, 2004; Rhodes & Bowles, 2002).  Patients‘ 
ability to participate in daily, physical, and social activities becomes limited, which also 
leads to feelings of loss and grief (Oates, 2004; Rhodes &Bowles, 2002).  A patient who 
adapts and copes poorly to his or her illness may become noncompliant, overly 
dependent, experience loss of self-esteem and/or depression (Gorman et al., 1996).  This 
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may result in the patients using denial as a way to protect themselves psychologically and 
not acknowledge the illness.  They may also use anger as a way to attempt to control the 
illness and associated fear (Gorman et al. 1996). How patients cope with illness affects 
the health outcomes (Finch & Sneed, 2003; Mytko & Knight, 1999) and is influenced by 
the patients‘ personality traits, past experiences, culture and values (Larson & Hummel, 
2009).  On the other hand a patient may adjust the way he or she copes with the 
progression of HF in a positive manner leading them to a spiritual quest, meaning-making 
(finding a sense of meaning, purpose or value around the illness) and/or  discovering and 
using other resources that affect the physical, mental and spiritual aspects of life 
(Pargament, 1997). 
 Patients‘ perceptions and beliefs about illness shape HRQOL (Johnson, Elbert-
Avila, & Tulsky, 2005; Miklancie, 2007; Schneider, et al., 2001) impacts clinical 
outcomes for MCS patients (Grady, 2003; Grady, Meyer, & Mattea, et al., 2002, 2003; 
Wray, Hallas, & Banner, 2007). Reducing or eliminating the stressors that respectively 
impact HRQOL may not always be possible, as a result understanding how patients cope 
is important.  Maladaptive coping strategies negatively affect HRQOL, thus the increase 
in the significance of encouraging and supporting patients to use positive coping 
strategies (Klein, Turvey, & Pies, 2007; Moser & Worster, 2000).   
 Suggested positive coping strategies include actively participating in treatment 
planning (Folkman & Greer, 2000), finding support in communities of faith (Koenig, 
McCullough & Larson, 2001, p. 222), talking with clergy or trusted family and friends 
and other forms of support such as counseling or support groups (AHA, 2010d; Larson & 
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Hummel, 2009. p. 76; Moos & Holahan, 2007).  Reducing stress with relaxation and 
breathing exercises can reduce stress as well as learning how to accept things that cannot 
be changed (Klein, Turvey, & Pies, 2007; AHA, 2010d). Lifestyle changes such as 
avoiding smoking and drinking, exercising, reducing work times, and controlling or 
avoiding stressful situations are also ways to reduce stress (AHA, 2010d). 
Coping Adjustment/Adaptation and Resilience 
Coping 
 Coping, adjustment, and resilience contribute to HRQOL outcomes (Austenfield 
& Stanton, 2004; Smith, Lumley, & Longo, 2002; Polk, 1997).  Coping is defined as the 
―cognitive and behavioral efforts to manage external and internal demands that are 
appraised as taxing or exceeding the resources of the individual‖ (Folkman & Lazarus, 
1991, p. 210; Radnitz & Tiersky, 2007). Coping strategies contribute to an 
adaptation/adjustment construct by mediating stressful life events (Larsen & Hummel, 
2009).  
Adjustment/Adaptation 
 Adaptation is the response to a change in the environment that allows an organism 
to become more suitably adapted to change (Sharpe & Curran, 2006, p. 1154 ; Larson & 
Hummel, 2009).  The attributes of adjustment are multidimensional, dynamic, unique, 
heterogeneous, and have both positive and negative indicators (Stanton & Revenson, 
2007).  Adaptation, which is sometimes used interchangeably with adjustment (Larsen & 
Hummell, 2009; Stanton & Revenson, 2007), is operationalized as having ―good quality 
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of life, well-being, vitality, positive affect, life satisfaction, and global self-esteem‖ 
(Sharpe & Curran, 2006; Larson & Hummel, 2009, p. 68).   
 Adaptation to illness is effected by personality traits, past experiences and disease 
and treatment variables, and is mediated by cognitive strategies (Larson & Hummel, 
2009; Lazarus & Folkman, 1984). Adjustment spans several dimensions (interpersonal, 
cognitive, emotional, and behavioral) and is holistic and interrelated in nature (Larsen & 
Hummel, 2009; Stanton & Revenson, 2007; Stanton, Collins, & Sworowski, 2001).  
Positive or negative responses in one domain can influence and determine a response in 
another.  For example, positive responses might be reflected in a positive morale 
(Folkman, Moskowitz, Ozer, & Park, 1997) or negative changes in patients‘ values 
systems (Sprangers & Swartz, 2000) and negative responses might cause psychological 
distress and dysfunction and disruption in relationships.  
 Responses to changes in a disease process are dynamic and may not always be 
related to the physical changes in the disease (Larson & Hummel, 2009; Stanton & 
Revenson, 2007).  For example, response to the disease may be triggered by other areas 
of a patients‘ life such as family or workplace.  The patients‘ responses are influenced by 
age, gender, ethnicity, and social status (Stanton & Revenson, 2007) and other individual 
unique qualities that contribute to the heterogeneous responses (Larson & Hummel, 
2009).  Adaptation by individuals over a continuum of time builds resilience (Luthar, 
1991; Masten & Coatsworth, 1998; Resnick, 2000; Rutter, 1993; Tusaie & Dyer, 2004; 
Tusaie, Puskar, & Sereika, 2007; Werner & Smith, 1992).  
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Resilience 
 Polk (1997) and Luthar, Cicchetti, & Becker (2000) posit resilience as a dynamic 
process which causes persons to adapt and attain competent functioning despite chronic 
stress and deleterious events including prolonged exposure to trauma. Resilience is the 
ability to adapt and restore equilibrium (Beardslee, 1989).  Resilience provides an ability 
to reach a good outcome even when there are threats to the ability to adapt (Jenkins, 
2005; Masten, 2001) and is composed of self-confidence, curiosity, self-discipline, self-
esteem, and control over the environment (Beardslee, 1989). All individuals possess 
some level of resilience (Hauser, 1999; Luthar, 1991; Masten & Coatsworth, 1998; 
Resnick, 2000; Rutter, 1993; Tusaie & Dyer, 2004; Tusaie, Puskar, & Sereika, 2007; 
Werner & Smith,1992).  Resilience is shaped by cognitive reframing, problem-solving 
abilities, optimism, a sense of meaning, a cohesive narrative about the stressor, high 
intelligence level, reading skills, resourcefulness in seeking social support, positive 
parental attachments, survival from negative life events, and a history of competence or 
successes (Chang, 2001; Geanellos, 2005; Rutter,1993; Scheir & Carver, 1987; Tusaie & 
Dyer, 2007; Werner & Smith, 1992). 
Coping and Adjustment Models 
 Various models exist for examining strategies for adjustment and coping. The 
concepts used for this study will be drawn from six models that combine the disease 
process and the illness experience (Larson & Lubkin, 2009, p. 4, p. 29; Martz & Livneh, 
2007, p. 4). Relevant to this study are the Medicine Model, Haans‘ Model of Coping, the 
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Biopsychosocial Model, Lazarus & Folkmans‘ Cognitive-Phenomenological Theory of 
Stress, the Livneh & Antonak Model, and the Moos & Holahan Framework. 
Medical Model 
 The Medical Model is used to explain the nature of health and illness. 
Pathophysiology, pharmacoptherapy and technology are used in the diagnosis and 
intervention of illness (Larsen & Hummel, 2009, p. 70).  The Medical Model alone is 
limited, creating a need to include non-medical health-related variables in order to 
provide a more comprehensive framework for assessing chronic illness and disease.  
Haan Model of Coping 
 The Haan Model of Coping (1968, 1977, 1993) is a model of ego processes that 
includes coping, defense and fragmentation.  Haan defines coping as ―an attempt to 
overcome difficulties by reaching out and within for resources to come to terms with 
difficulties‖ (Haan, 1993, p. 260).  Defense is a method of adaptation or self-protection 
that involves ―unyielding fortification‖ (Haan, 1993, p. 260) and fragmentation is a form 
of adaptive ―failure.‖  Coping behavior with illness involves active problem-solving such 
as seeking support.  Defensive behavior may be rigid and inflexible, and may involve 
denying the illness diagnosis and not seeking support.  Fragmented behavior is ritualistic 
and automated and may cause withdrawal or non-communication (Haan, 1977; Radnitz & 
Tiersky, 2007, pp. 29-37).  
The Biopsychosocial Model 
 The Biopsychosocial Model (Engel, 1977) attends to both biological and 
psychosocial stressors.  Psychosocial factors influence health outcomes directly or 
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indirectly.  Direct influence might be due to patients‘ beliefs or values about illness or 
treatment that prevent care.  An example of indirect influence is when physical factors 
influence psychological or emotional factors that ultimately impact health outcomes 
(Stewart, Ross, & Hartley, 2004).   
Lazarus and Folkman Cognitive-Phenomenological Theory of Stress  
 Lazarus and Folkmans‘ Cognitive-Phenomenological Theory of Stress (Lazarus & 
Folkman,1984; Folkman & Lazarus,1991; Folkman, 1997; Folkman, 2008) defines 
coping as a person-environment, transactional variable, a dynamic and contextual process 
(Folkman, Lazarus, & Dunkel-Schetter, et al., 1986; Radnitz & Tiersky, 2007).  The 
cognitive strategies of primary appraisal (emotion-focus) involve an initial assessment 
that determines the significance of the event or experience and are influenced by 
background, experiences, culture, ethnicity, and personality and affect the type of 
emotions experienced (Folkman, Lazarus, Gruen, & Delongis, 1986; Larson & Hummel, 
2009).  Secondary appraisal (problem-focus) addresses the management of the event or 
experience and is determined by the physical and social environment (Stewart, Ross, & 
Hartley, 2004; Larson & Hummel, 2009). Folkmans‘ revised model (Folkman, 2007, 
2008) introduces meaning-focused coping and positive emotions that restore coping 
resources and motivate problem-focused coping over time (See Figure 3).  
 Coping styles such as emotion-focused and problem-focused coping impact the 
relationship between the event or experience and the health outcome (Major, McCoy, 
Kaiser, & Quinton. 2003; Park & Folkman, 1997).  Emotions are ―complex organized 
psychophysiological reactions, consisting of cognitive appraisals, action impulses, and  
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Figure 3: Revised Stress and Coping Model (adapted from Folkman, 1997)  
Source:  Folkman, S. (2008). The case for positive emotions in the stress process.  Anxiety, Stress, & 
Coping, 21(1), 3-14, p.6  
 
patterned somatic reactions‖ (Folkman & Lazarus, 1991, p. 209; Radnitz & Tiersky,  
2007).   Appraisal is an evaluative judgment about the personal significance of an event 
(Lazarus, 1995; Radnitz and Tiersky, 2007).  
Livneh and Antonak Model  
 The Livneh and Antonak Model (1997) describe the adaptation process as 
dynamic, non-linear, multidimensional and distinct from outcomes of adaptation (Livneh 
& Antonak, 1997). Livneh and Antonak describe four groups of variables that influence 
patients‘ adaptation to chronic illness.  The four groups are disability and illness-related 
(condition, terminal, non-terminal); sociodemographic (gender, age, ethnicity); individual 
differences of personality (coping strategies, locus of control, personal meaning of 
condition); and social and physical environment (social support, stigma).  
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Moos and Holahan Framework  
 The Moos and Holahans Framework (2007) (See Figure 4) suggests that the 
process of cognitive appraisal determines the type of adaptive tasks and necessary coping 
skills for health-related outcomes. Cognitive appraisal is the process of evaluating the 
event or experience as a challenge or a threat, a harm or loss, and the degree of 
significance. Cognitive appraisal is influenced by: 1) personal resources, intellectual 
ability, ego, self-confidence, religion, prior health-related coping experiences, 
demographic characteristics (age, gender, ethnicity, culture and level of education), 
personality, locus of control, optimism and autonomy,  2) health-related factors such as 
type of onset, disease progression, chronicity, symptom location, prognosis and 
disability, disease and treatment factors and 3) social and physical context  which are the 
relationships between the individuals and the disease, family members and caregivers, 
social network and other forms of support.   
 Cognitive appraisal will determine the type of adaptive tasks needed.  Adaptive 
tasks are symptom management, treatment, and emotions, forming relationships with 
healthcare providers, maintaining a positive self-image, relating to family members and 
friends, and preparing for an uncertain future (Moss & Holahan, 2007, pp.112-114;  
Larsen and Hummel, 2009). Cognitive appraisal and the type of adaptive tasks will 
determine the choice of coping skills needed.  Coping skills are logical analysis and  
search for meaning, positive reappraisal, seeking of guidance and support, problem-
solving action, cognitive avoidance or denial, acceptance and resignation, seeking  
alternative rewards and emotional discharge.  Health-related outcomes are appraisals of 
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Figure 4: Conceptual Model of the Determinants of Health-Related Outcomes of Chronic Illness and 
Disability 
Source: Moos, R.H. & Holahan, C.J. (2007). Adaptive tasks and methods of coping with illness and 
disability. In E. Martz & H. Livneh (Eds.). Coping with chronic illness and disability (pp.107-128, p 110). 
New York: Springer.  
 
WB, satisfaction in various life domains, high experience of positive affect, and optimal 
behavior and functional status (Larsen and Hummel, 2009, pp. 72-79).   
 Positive adaptive coping strategies, thoughts, and behaviors have been associated 
with improved WB and better health outcomes in medically ill populations (Carels, 2004; 
Carver et al., 1993; Holahan, Holahan, Moos, & Brennan,1995 as cited in Klein, Turvey 
& Pies, 2007, p, 23; Chesney, Neilands, & Chambers, et al., 2006; Folkman, Lazarus, 
Gruen, & Delongis,1986, p. 572).  Healthcare teams that support and encourage positive 
coping strategies may improve the WB and HRQOL for patients with HF and MCS. 
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Well-Being 
 Well-being (WB), rooted in moral philosophy, utilitarianism, and ethics 
(Stanford, 2010), is the state of being happy, healthy, or prosperous and is synonymous 
with welfare and comfort (MW, 2010).  WB has both positive and negative connotations 
(Koenig, 2001; Stanford, 2010) and exists on a continuum from severe depression and 
hopelessness to genuine happiness (Koenig, 2001).  Some components of WB are 
physiological, psychological, mental/cognitive functional, emotional, spiritual, religious, 
cultural, social, and economic (Folkman, Lazarus, & Dunkel-Schetter, et al., 1986; Gall, 
Charbonneau, & Clarke, 2005; Hill & Pargament, 2007; Martz, Livneh, & Priebe, et al., 
2005; NIDCR, 2010; Pesta, McDaniel, & Bertsch, et al., 2010).  This study focus is 
spiritual well-being (SWB) and religious well-being (RWB).  The SWB variables are 
meaning and peace, role of faith in illness and relational connectedness.  The RWB 
variables are religious comfort and religious strain/distress. 
Spiritual and Religious Coping and Well-Being 
 Illness affects a patient‘s emotional and spiritual health, in addition to his or her 
physical health (NHLBI PIO, 2004). Spirituality, religion, and culture are considered 
personal resources that contribute to coping, WB and HRQOL (Brown, 2008; Daaleman, 
Perera, & Studenski, 2004; Larsen & Hummel, 2009; Samuel-Hodge, Watkins, Rowell, 
et al., 2008).  Coping theories that include psychology, spirituality, religion, and culture 
provide a framework for understanding transition and growth, loss, grief, attachment, 
resilience, hardiness, meaning, peace, reconciliation, hope, optimism, core values and 
beliefs, rituals and forgiveness (Belavich & Pargament, 2002; Boland, 2000; Folkman & 
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Lazarus, 1984; Gall, Charbonneau, & Clarke, 2005; Major, McCoy, & Kaiser, et al., 
2003; Sperry & Shafranske, 2005; Utsey, Bolden, & Williams, 2007).  The concepts for 
this study are derived from a model that measures SWB as a mediator between the 
relationship of cultural coping and HRQOL (Boland, 2000; Gall, Charbonneau, & Clarke, 
2005; McNulty, Livneh, & Wilson, 2004; Utsey, Bolden, & Williams, 2007). 
  In 1971, a White House Conference on Aging provided the foundation for the 
recognition of spirituality as an accepted sociological concept (Moberg, 1971).  Moberg 
defines spirituality  ―as pertaining to man's inner resources, especially his or her ultimate 
concerns, the basic value around which all other values are focused, the central 
philosophy of life which guides a person's conduct and the supernatural and nonmaterial 
dimensions of human nature.  Moberg states that all men (of humanity) are "spiritual," 
even if they have no use for religious institutions and practice no personal pieties 
(Moberg, 1971, p.3).   
 Galek, Flannelly, Vane, & Flannelly (2005) and Puchalski (2007) state the 
definition of spirituality is broad, but Pargament (1999, p. 12) describes it as ―how people 
think, feel, act, or interrelate in the effort to find, conserve and transform the sacred in 
life.‖  Spirituality consists of cognitive, emotional, and behavioral components that 
contribute to defining the way a patient experiences life (Byrne, 2007; Watson, 2005).   
The World Health Organization [WHOQOL Group, 1998] stressed the significance of 
individual spirituality and the importance in measuring SWB and the opposite of SWB, 
spiritual distress (Exline,Yali,& Sanderson, 2000; Gall & Grant, 2005; Pargament, 
Koenig, & Tarakeshwar, et al., 2001; Sulmasy, 2002; WHOQOL Group, 1998).  
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 SWB ―includes an awareness of and ability to draw on inner resources and 
strengths thus facilitating an ability to commit to and sustain practice of certain 
behaviors" (Boland, 2000, p. 21).  Components of SWB are overall positive affect and 
low negative affect with life, and work satisfaction, alienation from the world, self, and 
others (Pargament, 1997; Park & Folkman, 1997; Gall, Charbonneau, & Clarke, 2005, p. 
90; Exline, Yali, & Sanderson, 2000; Rowald, 2009).  A patients‘ SWB is affected by his 
or her own spiritual history, current biopsychosocial state, religious coping style, spiritual 
interventions and practices (Sulmasy, 2002).  
 Spiritual Distress on the other hand may occur when stressors or life events such 
as crisis or loss threaten a patients‘ belief system and impact his or her biologic, 
psychologic, sociocultural and spiritual aspects of life (Gorman, et al., 1996).  The cause 
of the stress, crisis or loss may involve employment, a significant other, position or status 
or major illness (Gorman, et. al., 1996) and it is the value of the loss that impacts the 
individual.  
 Religion is ―a search for significance in ways related to the sacred‖ (Pargament, 
1997, p. 32) and may be exhibited as membership in organized religion, practice of 
sacraments and rituals, and obedience to creeds and doctrines (Shafranske & Sperry, 
2005).  Words that are used interchangeably with religion are religiosity and 
religiousness.  All three refer to the numerous aspects of religious activity, dedication, 
and beliefs. 
 Religious distress has similarities to spiritual distress, but is related to the beliefs 
about a higher power or ―God‖ and the rituals and practices associated with the organized 
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religion.  Individuals may refrain from his or her normal religious practices and activities 
or withdraw from interacting with religious leaders, friends and associations with the 
religious institutions (Gorman, et. al., 1996).  A patient may verbalize he or she does not 
find comfort or relief in former religious or spiritual practices.    
 Spirituality and religion often overlap and are used interchangeably (Villagomeza, 
2006) when describing one‘s relationship to and experience of the transcendent or the 
unseen.  Sometimes, the emphasis is on the individual or personal faith journey (Gallup, 
2000, 2003). Both spirituality and religion guide the way an individual understands his or 
her life, search for meaning, seek peace, see the divine, and rely on a transcendent 
presence for support during troubled times, like illness and death (Highfield & Cason, 
1983 Hungelmann et al., 1985; Jenkins & Pargament, 1995; Gall & Grant, 2005; 
Muldoon & King, 1995).  
Spiritual and Religious Coping Strategies and Practices 
 Previous studies demonstrate positive spiritual and religious coping strategies and 
WB are associated with better health outcomes and HRQOL (Daaleman, Perera, & 
Sudenski, 2004; Koenig, 2001; Pargament, 1997; WHOQOL, 1995; Sulmasy, 2002). 
Spirituality correlates positively with a higher HRQOL and negatively with depression 
and mortality (Del Giglio, et al., 2006) and may become more important to patients 
during the illness experience and as they approach death (Pulchalski, 2004; Sulmasy, 
2002 as cited in Park, 2008).   
 Tepper, Rogers, Coleman, & Maloney (2001) found certain religious beliefs and 
practices reduce stress, symptom severity and the number of hospitalizations. The use of 
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religious and spiritual coping resources preserves self-esteem, boosts confidence, guides 
meaning and purpose, gives emotional comfort and instills hope (Gall & Grant, 2005, p. 
516; Jenkins, & Pargament, 1995; Johnson & Spilka, 1991; Levin, 1994;).  Religion and 
spirituality influence the attitudes and behaviors of individuals experiencing illness and 
assists in the adjustment process (Dull & Skokan, 1995; Rokeach, 1960; Gall & Grant, 
2005)     
 Patients may experience increased spirituality and religiosity and consider 
transcendence and meaning during crisis and feelings of threat when faced with the 
unknown (Bosworth et al., 2004; Fitchett et al., 2004 Koenig, 2002; Murray, Kendall, & 
Boyd, et al., 2004; Pargament, 1997; Puchalski, 2004; Sulmasy, 2002; Williams, 2006).  
Pargament (1997), Hamrick & Diefenback  (2006) and Koenig (1998) report that patients 
desire a deeper faith and closer relationship to ―God‖ following stressful and traumatic 
events. SWB facilitates religious and spiritual coping (Utsey, et al., 2007).   
 Religious and spiritual coping is defined as the "use of cognitive or behavioral 
techniques, in the face of stressful life events, that arise out of one's religion or 
spirituality" (Tix & Frazier, 1998, p. 411). Religious or spiritual coping strategies guide 
an individual as he or she attempts to understand a stressful situation through the use of 
his or her religious belief system (Gall, Charbonneau, Clarke, et al., 2005).  Tix and 
Frazier (1998, p. 411) identify prayer, confession of sins, and seeking comfort and 
strength from ―God‖ as ways that patients cope with illness.  Acceptance, positive 
reframing, receiving protection and blessing are also ways that patients adjust to illness 
(Brodsky, 2000; Carver, Pozo, & Harris, 1993).  Tix & Frazier (1998, p. 412) posit the 
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―use of religious coping exerts beneficial effects through three general pathways: a 
framework of beliefs that may facilitate cognitive restructuring of the meaning of the 
event, the social support of the religious community, and a sense of control over the 
stressful episode.‖ Religion and spirituality can have both positive and negative effects 
(Koenig, McCullough, & Larson, 2001) and are important to consider when providing 
support to patients who use religion and spirituality as a coping resource.    
 Gall, Kristjansson, & Carbonneau (2009), Greenway, Phelan, Turnbull, & Milne 
(2007), Koenig (2001) and Levin (2001) report positive images of ―God,‖ sacred texts, 
hymns and prayer may provide comfort peace and joy and may lead to lower levels of 
patient distress during the illness experience, while negative images of ―God‖ may induce 
stress and distress.  Spiritual struggle and religious discontent may lead to psychological 
distress and lower life satisfaction (Gall, Charbonneau, & Clark, et al., 2005). Brown 
(2008) and Harrison, Koenig, & Hays (2001) report patients may view the illness 
experience as an opportunity for growth or as punishment from ―God‖.  Supportive 
networks and alliances may prevent social isolation and provide a sense of belonging and 
provide an opportunity to work through the distress (Koenig, 1997; Holland, Kash, & 
Passik, et al.,1998; Koenig, McCullough, & Larson, 2001). 
Spiritual and Religious Coping and Intervention Models 
 This study will use The Spiritual Framework of Coping (SFC) (See Figure 5) to 
guide the selection and classification of variables measured. The Spiritual Framework of 
Coping is a ―rationale-theoretical framework‖ by Gall, Charbonneau, & Clark et al., 2005  
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Figure 5: The Spiritual Framework of Coping.    
Source: Gall, T.L., Charbonneau, C., Clarke, N.H., Grant, K., Joseph, A. & Shouldice, L. (2005). 
Understanding the nature and role of spirituality in relation to coping and health: A conceptual framework. 
Canadian Psychology/Psychologie Canadienne, 46(2), 88-104, p.89. 
 
that proposes the spiritual constructs used in the coping process as well as a schema to 
explain the function of these constructs.  Gall et al. (2005) admit that validation of this  
framework is needed.  The SFC is an adaptation/application of a transactional model and 
is dynamic, relational, phenomenological and process-oriented (Gall et al., 2005).  
Similar to the stress and coping models in Lazarus & Folkman (1984) and Folkman 
(1997, 2008), spirituality can function at the level of person factors, primary and 
secondary appraisals, coping behavior, coping resources, and meaning-making (Gall et 
al., 2005) and contribute to individual WB (Pargament et al., 1990 and Gall, 2003., Gall, 
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2005). Viktor Frankl, a psychiatrist and concentration camp survivor describes a human 
need to find a sense of meaning, purpose and value in life and how a sense of meaning in 
a persons‘ life impacts his or her WB, peace and connectedness with others (Frankl, 
1959, 1992). 
 Spiritual person-factors are individual beliefs which provide the lens for 
interpretation, comprehension, and reaction to events as well as guide the meaning-
making process (Dull & Skokan, 1995; Gall, et al., 2005).  Spiritual appraisals and 
spiritual coping behaviors are mediating agents that guide the coping as well as the 
response to the stressor (problem-focus) and the associated emotions (emotion-focus).  
Spiritual resources are the connections such as nature, others, and the ―transcendent 
other.‖ The attempt to make sense of the stress begins at this point of spiritual appraisal 
which results in the meaning-making phase.  Meaning-making is the process of cognitive 
appraisal and is often associated with spirituality and religion (Ameling & Povilonis, 
2001; Gall et al., 2005).  Meaning-making is important to the process of coping, 
adaptation, and WB (Emmons, 1999; Gall, et al., 2005)    
 Religion and positive religious and spiritual coping practices have been 
demonstrated to improve health and WB in HF, cardiac surgery patients, and HT patients 
(Ai, Park, & Huang et al., 2007; Ai, Peterson, & Tice et al., 2006; Bosworth, Steinhauser, 
& Orr et al., 2004; Harris, Dew, & Lee, 1995).  The uncertainty of the illness trajectory in 
HF, HT and MCS patients provides opportunities for spiritual care interventions that 
support positive coping including education and counseling (Gall, Charbonneau, & 
Clarke, 2005; Gall & Grant, 2005; Koenig, McCullough, & Larson, 2001; Oates, 2004).  
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Interventions that address the spiritual needs of patients may enhance recovery from 
illness (Mueller, Plevak, & Rummans, 2001).  
 Sulmasy (2002) recommends using a biopsychosocial spiritual framework for 
patient care (See Figure 6) that contributes to patient HRQOL through collaboration from 
multiple disciplines (physicians, nursing, pastoral care, social work, psychology, dietary, 
physical and occupational therapy).  Multidisciplinary care for patients and families is 
critical for the quality of care. (Conner et al., 2002; Puchalski et al., 2006; Sulmasy, 
2002).  Disease-specific spiritual pathways/guidelines that use outcome-based care help 
to direct any spiritual interventions (Shi and Singh, 2004; Duncan, 2007) (Appendix F). 
  
 
      
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: A Biopsychosocial-Spiritual Model of the Care of Dying Persons (Adaptation) 
Source: Sulmasy, D.P. (2002).  A biopsychosocial-spiritual model for the care of patients at the EOL. The 
Gerontologist, (42), 24-33. (See Appendix F for an example of a HF spiritual care guideline)  
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Williams (2006) suggests the search for answers around meaning, value and 
relationship, suffering and death prompts patients to perform spiritual tasks.  Williams 
(2006) conceptualizes this process as including spiritual despair (alienation and struggle),  
SWB (connection and self-actualization), and spiritual work (forgiveness and self-
exploration).  Williams (2006) proposes using these three concepts as a framework when 
addressing spiritual concerns of patients.  Koenig (2002) adds, making peace with ―God‖ 
and asking, receiving, and giving forgiveness are also spiritual tasks during illness and 
death.  Spiritual tasks provide opportunities for patients to consider transcendence, 
meaning (Murray et al., 2004; Bosworth et al., 2004), and spiritual struggle (Fitchett et 
al., 2004). Westlake & Dracup (2001) describe a three-step process that patients might 
use to cope with ESHF: development of regret over past behaviors and lifestyles, the 
search for meaning with the experience of HF, and the search for hope for the future 
while reclaiming optimism.  Parks et al. (2008) maintain that meaning in life relates to 
both mental and physical components of HRQOL, which increases through states of 
acceptance and religious coping over time in the context of HF.  Assessments that 
address HF patients‘ spirituality can assist patients with coping during the process of 
adjustment and decision-making and may contribute to a positive SWB and a more 
transparent relationship between the patient and clinician.  An open patient and 
healthcare provider relationship can reduce the risk of clinician underestimation of QOL 
impairment (Fisch, Titzer, and Kristeller, 2003). 
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Spiritual and Religious Coping and Well-Being with Heart Failure and Mechanical 
Circulatory Support 
 
 Prior research demonstrates that the way in which a patient copes with his or her 
illness affects HRQOL and many patients use spirituality or religion as a way to cope 
(Finch & Sneed, 2003; Mytko & Knight, 1999).  It also shows that a patients‘ perception 
and beliefs about his or her illness shape HRQOL and influences his or her cultural 
experience (Johnson, Elbert-Avila, & Tulsky, 2005: Miklancie, 2007).  Grady (2003), 
Grady et al., (2002, 2003) and Wray, Hallas, & Banner (2007) all report the significance 
of HRQOL on the clinical outcomes of MCS device patients.   
 A patient with a MCS device will experience physical, functional and emotional 
changes and can benefit from support that assists with his or her adaptation and coping 
with the MCS device.  Fear, anxiety and depression around illness, death, burden to 
family, sense of isolation and the fact that someone has to die in order for the patient to 
receive a HT impacts adaptation and coping and may produce hopelessness and 
helplessness that could potentially result in denial, over dependence, regression, 
noncompliance and lack of interest in health maintaining behaviors, new medical regimes 
and medications.  Poor adaptation and coping could also result in poor judgment and 
decision-making, misinterpretation of education and information, exacerbation of 
symptoms, failure to progress or improve, increased financial stressors and family and 
social conflict (Gorman et. al., 1996).   
 Harris, Dew & Lee et al. (1995) report that religiosity and religious practices 
predict improved health and general WB in HT patients.  However, to date no studies 
examine the impact of WB on the HRQOL of a patient with MCS. Prior studies 
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demonstrated that SWB and RWB influence healthcare outcomes (Sulmasy, 2002; 
Villagomeza, 2006), but few studies address their influence with HF patients (Bekelman 
et al., 2007). The healthcare environment is moving towards more patient-centered and 
patient-directed care models that respect and include the patients‘ beliefs and values 
(Johnson et al., 2004; McCauley, Bixby, & Naylor, 2006; Peek et al., 2008).  Betancourt, 
Green and Carrillo et al. (2002) and Doolen and York (2007) recommend responding to 
the varied perspectives, values, and behaviors that effect health, WB and QOL in order to 
improve the quality of healthcare in healthcare systems that serve multi-faith, multi-
cultural and multi-ethnic patient populations. VCU is an urban medical center with a 
varied referral network and that encompasses an ethnically, culturally, and 
socioeconomically diverse patient population.   
 Although spirituality and religion have a positive influence on health outcomes, 
the mechanism is not completely understood.  Boland (2000) suggests that spirituality 
indirectly affects or mediates health outcomes through the process of coping.  Utsey, 
Bolden, & Williams (2007) examined the culture specific factors that affect QOL and 
revealed SWB partially mediated the effects of culture-specific coping on QOL(See 
Figure 7).           
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Figure 7: Conceptual Framework for Spiritual Well-Being 
Source: Utsey, S.O., Bolden, M.A., Williams, O., Lee, A., Lanier, Y., & Newsome, C. (2007). Spiritual 
well-being as a mediator of the relation between culture-specific coping and quality of life in a community 
sample of African-Americans. Journal of Cross-Cultural Psychology. 38, 123-136, p. 125. 
 
 
Spiritual, religious and cultural resources impact WB and contribute to health outcomes 
(Potts, 1996; Boland, 2000; Simoni, Martone, & Kerwin, 2002; Wilson & Miles, 2001; 
Utsey, 2007).  In order to support positive coping with HF and HF therapy particularly 
with patients that have MCS, it may be helpful to provide patient-centered health care 
that focuses on the variables that support WB. This study will measure SWB (meaning 
and peace, role of faith in the illness, relational/connectedness) and RWB religious 
comfort, religious strain/distress).  
 HRQOL variables include physical, functional, emotional and spiritual outcomes 
(enhanced coping, faith and courage, hope, belief system, connection with higher power, 
connection with relationships, sense of self, sense of meaning, sense of vocation, 
reconciliation with self, situational reinterpretation, advance directives completed, patient 
Spiritual 
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Culture 
Specific 
Coping 
Quality of 
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spiritual and emotional condition unchanged after chaplain visit). HRQOL also includes 
patient satisfaction with treatment, number of survival days after MCS implant, number 
of days to discharge home post MCS, number of readmissions post MCS, number of 
inpatient days post MCS. Discharge and readmission data is for LVADs and Freedom 
Drivers. Other patient-related variables of interest include social and family well-being 
and support, type of MCS implant, race/ethnicity, age, gender, marital status, living status 
(not alone/alone), advance directive status, level of education, faith denomination and 
faith community membership.  WB may be influenced by locus of control, faith rituals 
and practices, faith visitation from faith community or  chaplains, faith outcomes 
(enhanced-coping, faith/courage, hope, belief system, connection with higher power, 
connection with relationships, sense of self, sense of meaning, sense of vocation; 
reconciliation of self, situational reinterpretation, advance directives completion, spiritual  
status after spiritual intervention), having a confidante, illness length, illness severity/HF 
class, HF etiology, distance lived from hospital, number of readmissions and number of 
inpatient days.   
Chapter Summary 
 The literature supports the significance of SWB, RWB, CSM and their influence 
on HRQOL and also supports the need for further study of the HF and MCS patient 
population. This study responds to the call for research that examines the spiritual and 
religious factors that influence positive health outcomes and provides an opportunity to 
study the distinct MCS and HT patient population at VCU and McGuire.   
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 The remaining chapters are organized as follows.  Chapter 3 will outline the 
research methods, measurement, and statistical analyses used in this study.  Chapter 3 
will also discuss the rationale for using nonparametric testing. Chapter 4 will present the 
study results and discuss the influence of SWB, RWB and CSM on the HRQOL of 
patients with MCS. The sample descriptive statistics, the results of the Spearman Rho 
Correlations and the Wilcoxon Signed Rank Sum Tests will be presented. 
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CHAPTER 3: METHODOLOGY 
 
 
 
 This chapter describes the research design and procedures used for this study.  
Included are the: study objectives, research questions and corresponding hypotheses, 
research design, population and sample description, sample size and sampling 
procedures, data collection, instrumentation, data analysis, and study limitations.  The 
purpose of the study is to examine spiritual well-being (SWB), religious well-being 
(RWB), coping style and method (CSM) and their impact on the health-related quality of 
life (HRQOL) for patients with mechanical circulatory support (MCS). This is a 
preliminary study with many variables for possible use in a future study capable of 
building a predictive outcomes model.  
The study objectives are: 
 To summarize the MCS patient sample population using descriptive statistics.  
 
 To determine if there is a positive relationship between the SWB and HRQOL  
for patients with MCS. 
 
 To determine if there is a positive relationship between the RWB and HRQOL for 
patients with MCS. 
 
 To determine if there is a positive relationship between the CSM and HRQOL for 
patients with MCS.  
 
 To determine if there is a positive relationship between the CSM and SWB for 
patients with MCS. 
 
 To determine if there is positive relationship between the CSM and RWB for 
patients with MCS. 
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 To determine if the SWB of patients with MCS increases over time (2 intervals – 
pre and post MCS). 
 
 To determine if the RWB of patients with MCS increase over time (2 intervals – 
pre and post MCS). 
 
 To determine if the CSM of patients increases over time (2- intervals pre and post 
MCS intervention). 
 
 To determine if the HRQOL of patients increase over time (2 intervals – pre and 
post MCS). 
 
Research Questions and Corresponding Research Hypotheses 
The following research questions, corresponding research hypotheses, and  conceptual 
model will guide this study. 
Research Questions 
1. Is there a positive relationship between the SWB and HRQOL for patients with 
MCS?  
 
2. Is there a positive relationship between the RWB and HRQOL for patients with 
MCS? 
 
3. Is there a positive relationship between CSM and HRQOL for patients with MCS?  
 
4. Is there a positive relationship between the CSM and SWB for patients with 
MCS? 
 
5. Is there a positive relationship between CSM and RWB for patients with MCS? 
 
6. Does the SWB for patients with MCS increase over time from pre to post MCS 
device intervention? 
 
7. Does the RWB for patients with MCS increase over time from pre to post MCS 
device intervention? 
 
8. Does the CSM for patients with MCS increase over time from pre to post MCS 
device intervention? 
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9. Does the HRQOL for patients with MCS increase over time from pre to post MCS 
device intervention? 
 
Hypotheses 
 
 Multiple hypotheses are associated with each of the research questions (See Table 
4).  Detailed hypotheses grids are presented in Appendices G, H, I, J, K and L.  As 
already stated in Chapter One, the definitions for the variables used in this study are 
displayed in Appendices B, C, D and E.     
 
Table 4:  Study Research Questions and Corresponding Hypothesis  
 
Question 1: Is there a positive relationship between the SWB and HRQOL for patients with MCS? 
 
Hypothesis 1 (See Appendix G for a detailed hypotheses grid) 
a. There will be a positive relationship between SWB overall and HRQOL for patients  with MCS. 
b. There will be a positive relationship between meaning and peace (MP) and HRQOL for patients with 
MCS.  
c. There will be a positive relationship between role of faith (ROF) and HRQOL for patients with MCS. 
d. There will be a positive relationship between relational connectedness (RLC) and HRQOL for patients 
with MCS. 
Question 2: Is there a positive relationship between the RWB and HRQOL for patients with 
MCS? 
 
Hypothesis 2 (See Appendix G for a detailed hypotheses grid) 
 
a. There will be a positive relationship between RWB overall and HRQOL for patients with MCS. 
  
b. There will be a positive relationship between religious comfort (RC) and HRQOL for patients with 
MCS. 
 
c. There will be a negative relationship between religious strain and distress (RS) and HRQOL for 
patients with MCS. 
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Table 4: continued 
 
Question 3: Is there a positive relationship between the CSM and HRQOL for patients with MCS? 
 
Hypothesis 3 (See Appendix H for a detailed hypotheses grid) 
 
a. There will be a positive relationship between BCOPE-EF and HRQOL for patients with MCS.  
 
b. There will be a positive relationship between BCOPE-PF and HRQOL for patients with MCS. 
  
c. There will be a negative relationship between BCOPE-DF and HRQOL for patients with MCS. 
 
d. There will be a positive relationship between BRCope-AD and HRQOL for patients with MCS. 
  
e. There will be a negative relationship between BRCope-M and HRQOL for patients with MCS.  
 
f. There will be a positive relationship between LOC-I and HRQOL for patients with MCS.  
 
g. There will be a negative relationship between LOC-E and HRQOL for patients with MCS.  
 
h. There will be a positive relationship between LOC-G and HRQOL for patients with MCS.  
 
i. There will be a positive relationship between SF and HRQOL for patients with MCS. 
 
Question 4: Is there a positive relationship between CSM and SWB for patients with MCS? 
 
Hypothesis 4 (See Appendix I for a detailed hypotheses grid) 
 
a. There will be a positive relationship between BCOPE-EF and SWB for patients with MCS.  
 
b. There will be a positive relationship between BCOPE-PF and SWB for patients with MCS. 
  
c. There will be a negative relationship between BCOPE-DF and SWB for patients with MCS. 
  
d. There will be a positive relationship between BRCope-AD and SWB for patients with MCS. 
  
e. There will be a negative relationship between BRCope-M and SWB for patients with MCS.  
 
f. There will be a positive relationship between LOC-I and SWB for patients with MCS.  
 
g. There will be a negative relationship between LOC-E and SWB for patients with MCS.  
 
h. There will be a positive relationship between LOC-G and SWB for patients with MCS.  
 
i. There will be a positive relationship between SF and SWB for patients with MCS.  
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Table 4: continued 
 
Question 5: Is there a positive relationship between CSM and RWB for patients with MCS? 
 
Hypothesis 5:  (See Appendix I for a detailed hypotheses grid) 
 
a. There will be a positive relationship between BCOPE-EF and RWB for patients with MCS.  
 
b. There will be a positive relationship between BCOPE-PF and RWB for patients with MCS. 
  
c. There will be a negative relationship between BCOPE-DF and RWB for patients with MCS. 
  
d. There will be a positive relationship between BRCope-AD and RWB for patients with MCS. 
  
e. There will be a negative relationship between BRCope-M and RWB for patients with MCS.  
 
f. There will be a positive relationship between LOC-I and RWB for patients with MCS.  
 
g. There will be a negative relationship between LOC-E and RWB for patients with MCS.  
 
h. There will be a positive relationship between LOC-G and RWB for patients with MCS.  
 
i. There will be a positive relationship between SF and RWB for patients with MCS.    
 
Question 6: Does the SWB for patients with MCS increase over time from pre to post MCS device 
intervention? 
 
Hypothesis 6  (See Appendix J for a detailed hypotheses grid) 
 
a. The SWB for patients with MCS will increase over time (SWB1 and SWB2)  
 
b. The MP for patients with MCS will increase over time (MP1 and MP2). 
 
c. The ROF for patients with MCS will increase over time (ROF1 and ROF2). 
 
d. The RLC for patients with MCS will increase over time (RLC1 and RLC2). 
 
Question 7: Does the RWB for patients with MCS increase over time from pre to post MCS device 
intervention? 
 
Hypothesis 7 (See Appendix J for a detailed hypotheses grid) 
 
a. The RWB for patients with MCS increase over time (RWB1 and RWB2). 
 
b. The RC for patients with MCS will increase over time (RC1 and RC2). 
 
c. The RS for patients with MCS will increase over time (RS1 and RS2). 
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Table 4: continued 
 
Question 8: Does the CSM for patients with MCS increase over time from pre to post MCS device 
intervention? 
 
Hypothesis 8 (See Appendix K for a detailed hypotheses grid) 
 
a. The BCOPE-EF for patients with MCS will increase over time (BCOPE-EF1 and BCOPE-EF2).   
 
b. The BCOPE-PF for patients with MCS will increase over time (BCOPE-PF1 and BCOPE-PF2).  
  
c. The BCOPE-DF for patients with MCS will increase over time (BCOPE-DF1 and BCOPE-DF2).  
 
d. The BRCope-AD for patients with MCS will increase over time (BRCope-AD1 and BRCope-AD2).  
 
e. The BRCope-M for patients with MCS will increase over time (BRCope-M1 and BRCope-M2). 
 
f. The LOC-I for patients with MCS will increase over time (LOC-I1 and LOC-I2).  
 
g. The LOC-E for patients with MCS will increase over time (LOC-E1 and LOC-E2). 
 
h. The LOC-G for patients with MCS will increase over time (LOC-G1 and LOC-G2).  
 
i. The SF for patients with MCS will increase over time (SF1 and SF2). 
 
Question 9: Does the HRQOL for patients with MCS increase over time from pre to post MCS 
device intervention? 
 
Hypothesis 9  (See Appendix L for a detailed hypotheses grid) 
 
a. The HRQOL-Physical (P) health status for patients with MCS will increase over time (HRQOL-P1 
and HRQOL-P2). 
 
b. The HRQOL-Functional (F) health status for patients with MCS will increase over time (HRQOL-F1 
and HRQOL-F2). 
 
c. The HRQOL-Emotional (E) health status for patients with MCS will increase over time (HRQOL-E1 
and HRQOL-E2). 
 
 
Research Design 
 
 This individual level study is a non-experimental, exploratory, repeated measures 
design that will examine the relationship between SWB, RWB and CSM and their 
influence on the HRQOL for patients with MCS.  SF (social support), faith community 
support, faith denomination and tradition and rituals and practices will also be  
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examined.  Initial demographic information and chart extraction for historical data will 
be recorded and pre and post-testing measures for SWB (meaning and peace, role of 
faith in illness, relational connectedness), RWB (religious comfort, religious strain and 
distress), CSM (coping, religious coping, locus of control, social and family health) and 
HRQOL (physical health, functional health, emotional health) will be taken at 2 
intervals (within a range of 30 days prior to implant to approximately 2 weeks post 
transplant and around 45-90 days after implant). Spiritual outcomes, PTS patient 
treatment satisfaction, number of survival days MCS-SD, number of days from MCS 
implant to discharge MCS-DD, number of readmission days post discharge MCS-RD,  
number of inpatient days post MCS MCS-ID and number of times readmitted post 
discharge MCS-RT will also be explored (See Table 5). 
Population 
 The target population for this study is end-stage heart failure patients (ESHF) with 
MCS devices, more specifically Heartmate IIs (HMII) and Total Artificial Hearts (TAH). 
A non-random purposive sample will be measured from two different medical centers, 
Virginia Commonwealth University Medical Center (VCU), an urban university medical 
center in Richmond, Va. and the McGuire Veterans Administration Medical Center 
(McGuire), a regional referral center for MCS and HT also in Richmond, Virginia.  The 
cardiac surgery team is comprised of members from VCU and McGuire and implants  
MCS devices and performs HT at both locations.  VCU implants the Thoratec Heartmate 
II (HMII) and the Syncardia Total Artificial Heart (TAH).  McGuire implants the HMII.   
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Table 5:  Research Design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Jarvik from Jarvik Heart, another left-ventricular assist device (LVAD), is also 
implanted, but is not the focus of this study due to a very small number of implants. The 
patients included in the study will be implanted with either the HMII or the TAH. 
Patients are evaluated and approved for MCS by the combined VCU and McGuire 
HF and HT service. The interdisciplinary team includes cardiologists, cardiac surgeons, 
nurse practitioners, psychologists, chaplains, social workers, nutritionists, pharmacists, 
Research Design for MCS Patients 
O1 e-r X a b O2 e-x 
      O = WB Coping and HRQOL 
WB (e) Spiritual (f) Religious 
 
CSM (g) coping style other (h) coping style religious 
(i) locus of control (j) faith denomination and tradition 
(k) community of faith membership (l) rituals and practices 
(m) faith community visitation (n) social and family support 
(o) having a confidante 
 
HRQOL (p) Physical health status (q) Functional health status 
(r) Emotional health status (s) Spiritual Outcomes 
(t) Patient Treatment Satisfaction (u) # of Survival Days 
(v) # of days to discharge home post MCS 
(w) # of readmissions post MCS 
(x) # of inpatient days overall post MCS 
 
     X = MCS device implant 
 
a=Heartmate II (LVAD) 
b=TAH (Artificial Heart) 
 
Other types of patient care recorded but not the focus of this study 
c=HT (Heart Transplant) 
d=PC (Palliative Care) 
 
Time intervals 
1= prior to implant (within 30 days) and post 2 weeks 
2= between 45-90 days 
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physical therapists and occupational therapists. Other disciplines participate as needed 
and may include palliative care professionals, ethicists, infectious disease professionals 
and biomedical engineers. Patients are referred to VCU from outpatient HF clinics at 
VCU and from outside community hospitals and clinics. Patients are referred to McGuire 
from within the Veterans Administration (VA) healthcare system.   
Sample Size, Sampling and Recruitment Methods 
 The sample for this study will be small. In behavioral science, small sample sizes 
are common (Mundry & Fischer, 1998).  Related studies with MCS and HRQOL have 
used various sample sizes. Mueller, Swetz and Freeman et al. (2010) case studied 14 
patients who withdrew MCS support.  Two other QOL studies with MCS were conducted 
by Dew, Kormos and Winowich, et al., 2001 and Grady, Meyer and Dressler et al., 2003 
with samples sizes of 63 and 40, respectively. VCU implanted 13 TAHs in 2009 and 21 
in 2010.  VCU and McGuire implanted 21 HM IIs in 2009 and 36 in 2010.  As of April 
2011, VCU implanted 3 TAHs and both VCU and McGuire implanted 13 HMIIs. 
 Small samples run the risk of not having adequate power to detect a true 
relationship or difference when analyzing samples. Power (1— β) is the probability of 
rejecting a false null hypothesis and is used to determine sample size. A power analysis is 
used to reduce the risk of Type II errors (Polit and Beck, 2008).  Type II errors are 
created by accepting the null hypothesis when it is false causing the researcher to  
overlook significant results (Polit and Beck, 2008).  A power analysis is comprised of 
four components, power, ―α‖ (significance criterion), sample size, effect size (estimate of 
relationship strength between the independent and dependent variable) and power. The 
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significance criterion is the probability of getting Type I errors.  Type I errors are created 
by rejecting the null hypothesis when it is true (Polit and Beck, 2008). The effect size can 
be estimated from previous studies or based on an expectation of a small, medium or 
large effect (Polit & Beck, 2011).  Significant relationships can be detected from small 
samples when the effects of that relationship are strong (Polit & Beck, 2011). Sample size 
estimates for this study were taken from the ―Approximate Sample Size Table on page 
425 (Polit & Beck, 2011):   
α= .05, 1— β = .80, effect size =.80, N = 10 
The power analysis is supported with similar recommendations and studies (Mueller, 
Swetz and Freeman et al. 2010; Mundry & Fischer, 1998).  However, multiple research 
questions, correlations and comparisons of multiple variables on such a small data sample 
increase the risk for Type I errors. The primary researcher will conduct the study to 
collect preliminary research data for a future multivariate study with a larger sample size.   
 Nonparametric testing is appropriate for this study due to the ordinal level of 
measurement, small sample size and unknown shape of the population distribution 
(Beaumont, 2010; Field, 2005).  Siegel and Castellan (1998) recommend a sample size 
range from 15 to 25 participants for the nonparametric tests (Spearman Rho and 
Wilcoxon Signed Rank Sum Test) used in this study. The primary researcher will 
oversample knowing patients may be lost through attrition.   
 After Institutional Review Board (IRB) approval, a purposive sample of 15-25 
patients will be recruited by the primary researcher.  Patients already approved for MCS 
will be recruited from the outpatient HF clinic and from the inpatient cardiology or 
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cardiac surgery units.  The patients who are approved for MCS have no serious 
psychosocial deficits or medical co-morbidities as determined by the multidisciplinary 
team which includes the psychologist and social worker. Patients with serious 
psychosocial deficits do not fit the criteria for acceptance into the MCS program due to 
the level of functioning and support needed to successfully live with the MCS device.  
Medical co-morbidities such as cancer or other organ failure may interfere with the 
patients‘ survival.  
Patients will be invited to participate in the study after being informed they are a 
candidate for a MCS device or if they have recently received a device. Written consent 
will be obtained from each patient after they agree to participate in the study.  The first 
set of survey forms will be given prior to receiving the MCS device or soon after. The 
patients will be able to complete the surveys over several days and will be given the 
option to complete the forms with the assistance of a chaplain.  The second set of survey 
forms will be given to the patients after receiving the MCS implant.  
Instrumentation and Measurement 
 Assessments will be made using self-report surveys, chart extraction, and patient 
interviews.  Individual items on each survey will be analyzed separately and then 
analyzed by scale.  Overall composite scores will be created for SWB and RWB.  The 
variables and associated survey instruments used in this study will be presented by 
concept (descriptive, WB, CSM, HRQOL). Instrumentation, scales and measurements for 
descriptive variables are presented in Table 6, WB variables are presented in Table 7, 
CSM variables in Table 8 and HRQOL variables are presented in Table 9.  The survey  
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Table 6:  Instrumentation and Measurement for Descriptive Variables 
 
Variable Instrument/Scale/Measurement  Data Type 
Gender Chart 0=male, 1=female Dichotomous 
Age Chart Age in years Continuous 
Race/Ethnicity Chart 0=African American, 1=Asian American 
2=White American, 4=Hispanic 
5=Native American, 6= Other 
Categorical 
Marital Status Chart 0=(S)ingle, 1=(M)arried, 2=(S)eparated 
3=(D)ivorced, 4=(W)idowed, 5=(ISR)in 
significant relationship, 6=(NISR)not in significant 
relationship 
Categorical 
Educational Level Intake Form 0=less than high school, 1=high 
school graduate, 2=GED, 3=vocational/technical 
4=some college, 5=college, 6=graduate  
7=graduate/professional degree 
Categorical 
Income Level Intake Form 0=0-25,000, 1=26,000-50,000 
2=51,000-75,000, 3=76,000-100,000, 4=over 
100,000 
Categorical 
Hospital Distance Intake Form # of miles lived from hospital Continuous 
Length of Illness Intake Form # of months since diagnosed with HF Continuous 
HF Etiology HF/HT Data Manager 0=ischemic, 1=non 
ischemic 3=idiopathic, 4=hypertension, 
5=valvular, 6=alcoholic, 7=postpartum, 8=other 
Categorical 
# of hospital admissions 
in 6 mos 
Intake Form # of times admitted to the hospital in 
6 mos. prior to MCS implant 
Continuous 
# of inpatient days in 6 
mos 
Intake Form # of inpatient days in 6 mos. prior to 
MCS implant 
Continuous 
Insurance Payor Chart 0=no insurance/fin code, 1=private pay 
2=commercial, 3=medicare, 4=Medicaid 5=other 
Categorical 
MCS Type Chart 0=HMII, 1=TAH Dichotomous 
MCS Actual HF/HT Data Manager 1=BTR, 2=BTD, 3=BTT, 
4=DT 
Categorical 
Advance Directive Intake Form 0=N, 1=Y Dichotomous 
 
Table 7: Instrumentation and Measurement for Well-Being Variables 
 
Variable Instrument/Scale/Measurement Data Type 
SWB Survey Facit-sp  SWB Ordinal/Continuous 
Meaning/Peace MP Survey Facit - sp  MP score Ordinal/Continuous  
Role of Faith Illness ROF Survey Facit – sp  ROF score Ordinal/Continuous 
Relational/Connectedness Survey Facit –sp RLC score Ordinal/Continuous 
RWB Survey Exline & Rose, 2005 Overall  Ordinal/Continuous 
Religious Comfort RC Survey Exline & Rose, 2005 RC score Ordinal/Continuous 
Religious Strain/Distress RS Survey Exline & Rose, 2005 RS score Ordinal/Continuous 
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Table 8:  Instrumentation and Measurement for Coping Variables  
 
Variable Instrument/Scale/Measurement Data Type 
Coping Style EF Survey BCope Emotion-focused score Ordinal/Continuous 
Coping Style PF Survey BCope Problem-focused score Ordinal/Continuous 
Coping Style DF Survey BCope Dysfunctional score Ordinal/Continuous 
Religious Coping – AD 
adaptive 
Survey BRCope AD score Ordinal/Continuous 
Religious Coping – M 
maladaptive 
Survey BRCope M score Ordinal/Continuous 
Locus of Control/E Survey LOC External Control Score Ordinal/Continuous 
Locus of Control/I Survey LOC Internal Control Score Ordinal/Continuous 
Locus of Control/G Survey LOC God Control Score Ordinal/Continuous 
Faith Tradition/FT Intake Form 0=None, 1=Baptist, 2=Methodist, 
3=Episcopal, 4=Presbyterian, 5=Catholic, 6= 
Pentacostal/Apostolic/Charismatic, 7=Non-
Denomonational 8=Other/Specify 
Categorical 
Faith Community 
/FC 
Intake Form 0=No, 1=Y (Do you belong to a faith 
community?) 
Dichotomous 
Faith Rituals and 
Practice/FRP 
Intake Form 1=communion, 2=prayer, 
3=meditation, 
4=sacred text, 5=community worship,  
6=fasting, 7=anointing, 8=other_________ 
Categorical 
Faith  Visitations 1/FV1 Intake Form 0=N, 1=Y (Do you receive visitations 
from  
Chaplain/Clergy/community of faith?) 
Dichotomous 
Faith Visitations 2/FV2 Intake Form How often? ___ 
Wk/mo/yr ______ 
Continuous 
Faith Visitations 3 FV/3 Intake Form 0=N, 1=Y (Would you prefer more 
visits?) 
Dichotomous 
Faith Visitations 4/FV4 Intake Form 1=helps me cope, 2-increases faith and 
courage, 3=gives me hope, 4=helps my belief 
system, 5=helps me connect with my higher power, 
6=helps me connect with my relationships, 7=helps 
me understand myself, 8=helps me find meaning, 
9=gives me sense of purpose/calling/vocation, 
10=helps me find peace and forgiveness with 
myself, 11=helps me reinterpret my situation, 
12=helped me to complete my advance directives, 
13=does not help me (How does a visit from  
chaplain/clergy/community of faith help?) 
Categorical 
Social/Family SF Survey Facit -SF Social Family support score Ordinal/Continuous 
Confidante CF Intake Form 0=N, 1=Y (Do you have someone to 
confide in?) 
Dichotomous 
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Table 9:  Instrumentation and Measurement for HRQOL Variables 
 
Variable Instrument/Scale /Measurement Data Type 
Physical Survey Fact-GP Physical health score Ordinal/Continuous 
Functional Survey Fact-GF Functional health score Ordinal/Continuous 
Emotional Survey Fact-GE Emotional health score Ordinal/Continuous 
Spiritual Outcomes Intake Form and Final Interview 1=helps me cope, 
2-increases faith and courage, 3=gives me hope, 
4=helps my belief system, 5=helps me connect 
with my higher power, 6=helps me connect with 
my relationships, 7=helps me understand myself, 
8=helps me find meaning, 9=gives me sense of 
purpose/calling/vocation, 10=helps me find peace 
and forgiveness with myself, 11=helps me 
reinterpret my situation, 12=helped me to 
complete my advance directives, 13=does not help 
me (How does a visit from 
chaplain/clergy/community of faith help?) 
Categorical 
Patient Satisfaction Survey Facit-PTS score Patient treatment 
satisfaction (PTS-E, PTS-I, PTS-CC, PTS-TQ, 
PTS-DM, PTS-Nurses, PTS-Trust, PTS-R, PTS-
CA, PTS-OE) 
Ordinal/Continuous 
Survival Days Post MCS 
implant   
HF/HT Data Manager # of Survival days up to 90 Continuous 
Number of days to 
Discharge Home post 
MCS implant(LVAD)  
HF/HT Data Manager # of days to discharge after 
LVAD implant to 90 days 
Continuous 
Number of Readmissions 
post MCS implant 
(LVAD)  
HF/HT Data Manager # of readmissions after 
initial discharge to 90 days for LVAD 
Continuous 
Total Inpatient Days post 
MCS implant (LVAD) 
HF/HT Data Manager # of inpatient days after 
LVAD implant to 90 days 
Continuous 
 
 
instrument descriptions are presented with the variable descriptions that were mentioned 
in Chapter One (Appendices B, C, D and E). 
Data Collection Measurement and Analysis 
Data Collection Procedure 
 An initial semi-structured patient interview guided by the Joint Commission basic 
spiritual assessment (Appendix M) will be conducted by the primary researcher for 
patients who consent to participate in the study. After the interview, the primary 
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researcher or graduate level chaplain resident will give the first of two survey packets to 
the patients. The first survey packet will be given prior to MCS implant and include 
surveys and forms for the first observation (See Table 5). Included in the first survey 
packet will be the Initial Intake Form and the following surveys: Facit-sp (MP meaning 
and peace, ROF role of faith in illness, RLC relational connectedness), Exline  et al., 
2000 (RC religious comfort and RS strain/distress), Brief Cope (BCOPE-EF emotion 
focus, BCOPE-PF problem focus, BCOPE-DF dysfunctional focus), Brief RCope 
(BRCope-AD adaptive, BRCope-M maladaptive), Locus of Control (LOC-I internal, 
LOC-E external, LOC-G God), SF social and family support status and HRQOL 
(HRQOL-P physical, HRQOL-F functional and HRQOL-E emotional health status) (See 
Appendices M, N, O, P, Q, R and S). The second survey packet will include the 
previously mentioned surveys with the addition of the Facit-PTS (patients‘ satisfaction 
with treatment) and the Final Interview Form (See Appendices T and U).  The initial 
interview and intake form will collect information about faith denomination and tradition, 
community of faith membership, rituals and practices and faith community visitation 
prior to MCS device implant. The final interview will collect spiritual outcomes data. 
Demographic data will be extracted from the hospital information system by the primary 
researcher.  MCS outcomes data (MCS-DD discharge days, MCS-RD readmissions days, 
MCS-ID inpatient days and MCS-RT readmission times) will be provided by the HF/HT 
data manager. 
 The survey packets collected will be identified by a survey number to protect the 
identity of the patient.  Patients will place completed surveys in number coded envelopes 
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and return them to the primary researcher or graduate level chaplain resident.  All surveys 
will be stored in a locked file cabinet within a secure area and separate from the signed 
consent forms and other identified data. Data collection sheets (Appendix X, Y and Z) 
will be used to keep track of the identifier and survey data collected.  Survey and 
interview data will be entered by a graduate level chaplain resident and the primary 
researcher into Excel 2007 and IBM SPSS 19. Spiritual assessments by the hospital 
chaplains, which are within the usual scope of hospital practice (purpose for consultation, 
assessment, intervention and action, progress and outcomes, continuing care plan) will be 
ongoing and recorded into the hospital information system.    
Data Cleaning and Preparation 
 Data will be periodically reviewed and examined for errors to insure integrity and 
consistency in collection, survey and intervention methods.  Data will then be entered 
into Excel 2007 and IBM SPSS 19.  Data cleaning with IBM SPSS 19 will be used for a 
missing value analysis.  The data set will be small enough to check for missing values 
results by visually looking at all data fields.  Clarification and corrections will be made as 
needed. Open ended conversations will be conducted with patients, families by the 
chaplain resident and the primary researcher for study feedback.   
  Facit –sp 23 items # 4 and # 8 will be reverse scored before adding the SWB 
composite score.  The religious strain/distress scale will be reverse scored and then added 
to the religious comfort score for a RWB composite score.  The Facit HRQOL-GP for 
physical health status and the Facit HRQOL-GE for emotional health status will also be 
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reverse scored because high scores represent poor health status rather than a positive 
health status.  Composite scores will be created for each survey subscale. 
Data Analysis and Statistical Technique 
 The primary researcher will interpret the data results with the assistance of the 
VCU statistical consulting service, statistical manuals, online resources, previous studies 
and the dissertation committee statistical expert.   
 Univariate analyses (SPSS FREQUENCIES, DESCRIPTIVES, EXPLORE, 
CROSSTABS) will be performed on all variables to assess distributions, assumptions and 
outliers using descriptive statistics, frequency histograms and bar charts, normal p-p plots 
and detrended normal p-plots. Data will be screened for normality by assessing skewness 
and kurtosis.  Bivariate analyses using non-parametric tests (Spearmans‘ Rho 
Correlations and Wilcoxon Signed Rank Sum Tests) will be used to test the relationships 
(correlation) between SWB and HRQOL, RWB and HRQOL, CSM and HRQOL, CSM 
and SWB and CSM and SWB and also used to test any changes pre and post MCS device 
implant (comparative)(SWB, RWB, CSM, HRQOL). Assuming the sampling distribution 
is not normal, non parametric tests are less restrictive about parameter and distribution 
assumptions and are more robust for analyzing ordinal data (ranking based on relative 
standing to each other in an attribute) (Field, 2005; Polit and Beck, 2008). 
Types of Analyses 
 Descriptive Analysis:  Descriptive statistics summarize and synthesize the data 
characteristics (Polit & Beck, 2008) and will be used to describe the MCS patient sample 
in a clear and concise manner.  IBM SPSS 19 (FREQUENCIES, DESCRIPTIVES, 
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EXPLORE, CROSSTABS, WILCOXON RANK SUM TESTS) and Excel 2007 will be 
used to summarize the descriptive variables in Table 6. 
 Correlational Analysis:  Correlation is the interrelationship or association 
between two variables. The measurement scales most often used are interval, but not 
always and yield a coefficient correlation that ranges from -1.00 (negative correlation) to 
+ 1.00 (positive correlation). 0.00 represents no correlation (Polit and Beck, 2008).     
 The Spearmans‘ Rho Correlation test (Spearman, 1904, 1910) will be used to 
create the correlation index (Spearmans‘ rho ρ or rs).  Spearmans‘ ―ρ‖ indicates the 
magnitude of the relationship between two variables measured on an ordinal scale. 
Relationship does not indicate cause and effect.  It is common in psychosocial research 
for the correlation coefficient ―ρ‖ to be in the .20 - .40 range ( Polit & Beck, 2008). 
Correlation coefficients will be calculated at two intervals (within 30 days prior to MCS 
implant – 14 days post MCS implant and around 45 days – 90 days post MCS implant) 
for the following constructs: SWB and HRQOL, RWB and HRQOL, CSM and HRQOL, 
CSM and SWB, and CSM and RWB.  The correlation coefficient (rs) will be squared to 
determine the proportion of variance ―r2‖(shared or explained variance) in one variable 
that is related to the other variable (Warner, 2008)  (See Table 10). The correlation 
coefficient and variance describe the effect size (strength/magnitude of the bivariate 
relationship) as well as the influence each variable has on the other one.    
  
 
 
71 
 
 
 
Table 10:  Correlation Coefficient and Variance  
 rs r
2 
Large >.50 >.25 
Medium about .30 about .09 
Small < .10   <.01 
 
The SWB variables are MP, ROF and RLC and the RWB are RC and RS (See 
Table 7 and Appendix C).  The CSM variables are BCOPE-EF, BCOPE-PF, BCOPE-DF, 
BRCope-AD, BRCope-M, LOC-I, LOC-E, LOC-G and SF (See Table 8 and Appendix 
D.) 
Faith tradition and denomination, faith community membership, faith rituals and 
practices, faith community visitation (clergy, community of faith officials, chaplains) and 
the existence of a confidante (person to confide in) will be examined to assist in the 
interpretation of the study results (See Table 8 and Appendix D).  The HRQOL variables 
are HRQOL-P, HRQOL-F and HRQOL-E, MCS-SD, MCS-DD, MCS-ID, MCS-RT, 
PTS-E, PTS-I, PTS-CC, PTS-TQ, PTS-DM, PTS-Nurses, PTS-Trust, PTS-R, PTS-CA 
and PTS-OE (See Table 9 and Appendix E). Spiritual outcomes (enhanced-coping, faith 
and courage, hope, belief system, connection with higher power, connection with 
relationships, sense of self, sense of meaning, sense of vocation; reconciliation with self, 
situational reinterpretation, advance directives completed, unchanged because the 
chaplain visit did not produce a difference in the patients‘ emotional or spiritual status 
will be examined to also assist in the interpretation of the study results (Table 9 and 
Appendix E). 
72 
 
 
 
 Comparative Analysis: A comparative analyses compares two or more groups of 
subjects on a dependent variable. The groups can be independent (two or more samples in 
which the subjects are not related) or dependent (two or more samples in which the 
subjects are paired or related in some way). 
 The Wilcoxon Signed Rank Sum Test (Wilcoxon, 1945) will be used to rank the 
differences from ordinal data taken from subjects at 2 intervals (within 30 days prior to 
MCS implant – 14 days post MCS implant and around 45 days – 90 days post MCS 
implant).  The variables measured will be SWB1 and SWB2, RWB1 and RWB2, CSM1 
and CSM2 and HRQOL1 and HRQOL2. A positive or negative rank will be given for 
each pairing and is dependent upon whether the second interval data point is higher or 
lower than the first interval data point.  The mean of the positive and the mean of the 
negative ranks, the Z statistic and the p value will be calculated to determine if there are 
any significant changes between interval 1 and 2.  The null hypothesis is ―there is no 
change‖ from interval 1 to interval 2. IBM SPSS 19 (with the exact test option) will be 
used for the Wilcoxon signed-rank test. 
Study Assumptions and Limitations 
Threats to Internal Validity 
 Internal validity infers that the independent variable and not other confounding 
variables are responsible for the observed effects (Polit and Beck, 2008).  One threat to 
internal validity is the lack of randomization in this non-experimental purposive design.  
Patients cannot be given a MCS device at random and it may be unethical to withhold a 
MCS device from a patient if they meet the HT or MCS implant criteria. Also, pastoral 
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care from chaplains will be provided within the normal scope of practice for VCU and 
McGuire and will not be controlled for this study.  The lack of randomization and 
experiment decreases the ability to infer causal relationships due to unexplained effects 
from confounding variables (Polit & Beck, 2008). An attempt to control this will be to 
use a repeated measures design with the same subjects and semi-structured patient 
interviews to help clarify study results.  
 Selection bias could be a potential threat since patients have to consent for MCS.  
Unequal proportions of patients electing to receive MCS may infer incorrect assumptions 
about the definition of QOL with MCS.  Some patients may even decline the offer of 
MCS to wait for a heart transplant (HT) or choose palliative care and eventually hospice.  
Not included in this study are patients with end-stage of heart failure (ESHF) who are not 
eligible for HT or MCS. A future study might compare the MCS patient group with those 
patients who decide not to receive the device or are unable to. 
 Another limitation to this study is the construct validity.  Construct validity is ―the 
validity of inferences from observed persons, settings and interventions in a study to the 
constructs that these instances might represent; with an instrument, the degree to which it 
measures the construct under investigation‖ (Polit and Beck, 2008).  Latent variables 
such as SWB and RWB are abstract and not directly measured, but inferred from other 
observed variables. An attempt to control for construct validity involved using previously 
defined constructs that were measured using previously validated instruments (Brady, 
Peterman and Fitchett, et al., 1999; Cella, Tulsky and Gray, et al., 1993; Gall, T.L., 
Charbonneau, C., Clarke, N.H., Grant, K., Joseph, A. & Shouldice, L. (2005). 
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 Another threat to internal validity is measurement.  Latent variables must be 
inferred by using a priori knowledge and clear definitions.  SWB and RWB are subjective 
variables and sometimes nebulous in nature and definition.  Defining their meaning by 
using the most frequent definitions is an attempt to decrease any confusion about what is 
being tested and then testing multiple similar variables on the same construct allows for 
cross-validation.    
 Internal validity may be threatened by the placebo effects from spiritual and 
religious care visits to potentially bias the self-report survey results. Patients who use 
spirituality or religion may also exhibit some spiritual growth as they struggle with 
emotions during the MCS process.  This growth may influence the maturation process 
and may make it more difficult to separate which factors caused the growth.  Attempts 
will be made to visit patients on a regular basis to determine if other significant life 
events are influencing HRQOL.  Survey results will be compared to the spiritual 
assessments entered into the hospital information system for further clarification. The 
subjective nature of the self-report surveys may be biased due to the Hawthorne effect 
(respondents desiring to please the researchers).  Failure to complete surveys and trouble 
recalling information may also be factors to consider when interpreting results (Polit and 
Beck, 2008). Still, other factors that may not be captured are the history threats or those 
events that can happen simultaneously with the MCS intervention.  The chaplains 
assigned to the cardiology units will meet with study participants routinely to monitor the 
existence of other significant life events that may occur simultaneously with the MCS 
implant.  
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 The nature of the repeated measures design may produce exposure and testing 
effects since patients will have seen some of the survey questions more than once and 
may be sensitized to a particular topic.  Patients may also remember how to answer the 
survey in a way that affects positive results.  Repeated measures designs are also 
threatened by the patient‘s mortality or through attrition.  Patients may not be able to 
complete the self-report surveys because they become ―too sick‖ or ―too overwhelmed‖ 
with the MCS or study process.  A small sample size along with the use of nonparametric 
statistical analysis may decrease the power of the study, but the significance of the study 
results with a plan to continue adding subjects can potentially lead to a more robust future 
study.   
Threats to External Validity 
 Threats to external validity will be the generalizability of this study in non-urban, 
non-teaching, non-government hospitals.  This study used two sites with different referral 
systems for the MCS device.  Site one is an urban teaching hospital and receives referrals 
from the inpatient populations and from community physicians.  Site two is a Veterans 
Administration hospital and receives referrals from all over the United States.  Future 
studies with a larger sample size may provide additional information by comparing the 
two sites and then expanding to other sites with a more diverse age, gender, racial, ethnic 
and socioeconomic population.  
Threats Statistical Validity 
 Small samples sizes with repeated measures on multiple and similar variables 
increase the risk of producing Type I errors.  The chance for increasing or inflating  the 
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Type 1 error rate by using a family of tests on the same data is known as the ―family wise 
error rate‖ (Field, 2005).  
Family wise error rate = 1 — (.95)n   
where ―n‖ is the number of tests.  One way to control the risk of producing Type 1 errors 
is to lower the p-level of significance (α alpha).  The Bonferroni correction procedure 
controls the ―family wise error rate‖ by dividing the alpha level with the number of tests 
performed.  This generates a lower critical ―p- value‖ to compare to the test ―p-value‖ 
and decreases the chance for falsely rejecting the null. The Bonferroni correction 
procedure is only one method (Cole, 2011; Hochberg, 1988 ) to control Type I errors and 
is a very conservative one because it calculates the significance level so low that only a 
few tests may reveal statistical significance (Warner, 2008).  As this is a preliminary 
study, the Bonferonni correction procedure will not be used. Ward (2008) and Westen 
and Rosenthal (2003) state it is common practice in exploratory and non-experimental 
studies for researchers to test many variables, but recommend making a decision prior to 
the study about which variables will be paired together, in addition to making predictions 
about the test outcomes. The primary researcher attempts to control the study variables by 
making predictions about the direction of the correlational relationships between SWB 
and HRQOL, RWB and HRQOL, CSM and HRQOL, CSM and SWB and CSM and 
RWB and the comparative relationships of SWB, RWB,CSM and HRQOL pre and post 
MCS implant.        
 Reducing the rate for Type I errors can also increase the chance for Type II errors.  
In order to reduce the chance for Type II errors, a priori knowledge is used in addition to 
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using the most robust statistical tests available to calculate the test statistics and ―p-
values.‖   Nonparametric tests are more prone to Type II errors than parametric tests. 
IBM SPSS 19 with the module for ―exact tests‖ will be used to calculate the test statistic 
and ‗p-value. An exact algorithm as opposed to an asymptotic one will be used.  
Asymptotic approximations are more appropriate for larger sample sizes.  Mundry & 
Fischer (1997) discussed how the incorrect use asymptotic algorithms with small sample 
data produces false positive results when there are none (Siegel & Castellan, 1988).   
 Providing support to the increasing MCS patient population dictates a need for 
evidenced-based support therefore the ―p – level‖ will remain at .05 and the study results 
will be interpreted recognizing the potential for Type I and Type II errors.  Post hoc 
analyses will be used to determine the future use of current study variables or other 
variables of interest for this patient population.    
Chapter Summary 
 An assortment of self-report instruments will be used to collect data in addition to 
an initial and final semi-structured patient interview for demographic data and medical 
history.  The hospital information system and HF and HT charts and database will be also 
used. After data is collected, descriptive statistical tools will be used to explore the 
patient population. The Spearman Rho Correlation will be used to test relationships 
between constructs and The Wilcoxon Signed Rank Sum test will be used to compare 
data at 2 intervals.  Results of the study will be presented in Chapter 4 and Chapter 5 will 
discuss the results in view of the proposed conceptual model and current literature.  
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Recommendations for practical application of the results and future research will also be 
explored.  
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CHAPTER 4: RESULTS 
 
 
  
 This chapter summarizes the statistical analyses performed on the SWB, RWB, 
CSM and HRQOL variables. The purpose of this non-experimental exploratory repeated 
measures study was to examine SWB, RWB and CSM and their impact on the HRQOL 
for patients with MCS.  The sample demographics are presented from the descriptive 
analyses options in SPSS 19 (Frequencies, Descriptives, Crosstabs and Wilcoxons‘ Rank 
Sum Tests).  Results from the Spearmans‘ Correlation analyses of SWB, RWB, CSM and 
HRQOL and Wilcoxons‘ Signed Rank comparative analyses of those same variables are 
also presented.    
Patient Sample 
 Twenty six patients were approached for this study. The primary researcher 
excluded patients who were not feeling well enough to participate because of statements 
such as ―I‘m ―too tired‖ or ―too weak‖ Other patients not asked were those who appeared 
to be overwhelmed (as determined by the primary researcher and graduate level chaplain 
resident) from the patients‘ comments about the HT and MCS evaluation process. 
Overwhelmed meant the patients appeared to be unable to focus during initial and follow-
up conversations.  Twenty-five patients of a possible 57 patients implanted with MCS 
devices in 2010 and through the first quarter of 2011 were asked to participate (44% of 
VCU/McGuire of the 2010 population).  Nineteen patients agreed to participate in the 
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study (76 % response rate).  One patient died after receiving a HM II and was not able to 
complete the surveys or interviews.  Eighteen patients completed the interviews and 
surveys for a 72% completion rate.  
Data Preparation 
 Data was collected and entered into Excel 2007 and SPSS 19.  Data was checked 
for missing items and accuracy and variable abbreviations were assigned for consistency 
and reporting (See Table 11).  All variables were initially assessed for distribution using 
ANALYZE, DESCRIPTIVE STATISTICS, EXPLORE AND PLOTS in SPSS 19.  
Initial analyses supported the prediction that the data would not fit any of the assumptions 
used for parametric testing (normal distribution, outliers, interval or ratio level data), but 
did show patterns of relationship as presumed and supported further analyses using 
nonparametric tests as planned for correlation and comparison. 
Descriptive Statistics 
 The ANALYZE, DESCRIPTIVE STATISTICS, FREQUENCIES and 
DESCRIPTIVES options in SPSS 19 were used to summarize the demographic data (See 
Table 12). Most of the patients were from the VCU patient population.  Sixteen patients 
(88.9%) were from VCU and two patients were from McGuire (11.1%) for a total sample 
size of 18.  Since all of the patients survived the 90 day period, MCS-SD was excluded. 
 All of the devices were implanted at VCU with one half of the study participants 
living less than 75 miles from VCU (50%, n=9).  The sample population was mostly male 
(72.2%, n=13).  African Americans represented 50 % (n=9) of the patient population,  
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Table 11:  Variable Abbreviations 
Well-Being Variables 
 
SWB1 and 2: spiritual well-being overall                                                           
MP1 and 2: meaning/peace subscale 
ROF1 and 2: role of faith subscale 
RLC1 and 2: relational/connectedness 
subscale 
RWB1 and 2: religious comfort/strain 
RC1 and 2: religious comfort subscale 
RS1 and 2: religious strain subscale 
 
Coping Mechanism (CM)Variables 
 
BCope EF1 and EF2: emotion-focused 
subscale 
BCope PF1 and PF2: problem-focused 
subscale 
BCope DF1 and 2: dysfunctional coping 
subscale 
BRCope AD1 and 2: adaptive subscale 
BRCOPE M1 and 2: mal-adaptive subscale 
LOC I1 and 2: internal-focused subscale 
LOC E1 and 2: external-focused subscale 
LOC G1 and 2: God-focused subscale 
SF1 and 2:  social family status  
 
 
1= pre MCS device implant 
2= post MCS device implant 
Health-Related Quality of Life  
 
HRQOL P1 and 2: physical status                                                            
HRQOL F1 and 2: functional status 
HRQOL E1 and 2: emotional status 
PTS  E: patient treatment satisfaction with 
doctors explanation 
PTS I: interpersonal relations with doctors 
PTS CC:  comprehensive care 
PTS TQ:  technical quality  
PTS DM: decision-making 
PTS Nurses: nursing care and relations  
PTS Trust: trust in the treatment team 
PTS R: recommend to others 
PTS CA: choose again  
PTS OE: overall experience 
MCS DD: discharge days post MCS 
MCS RD: readmissions post MCS 
 MCS ID: inpatient days with readmissions 
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Table 12:  Demographic Characteristics: Full Sample and by Device Type  
                                                                n (%) 
Characteristics                             Full Sample            Heartmate II                   TAH                   Both  
                                                            N=18                          n=7                           n=10                     n=1 
MCS Device Type     
       Heartmate II 7(38.9) 7 -- -- 
       Total Artificial Heart     10(55.6) -- 10 -- 
       Both 1(5.5) -- -- 1 
Freedom Driver     
       Freedom Driver 7(70.0) -- 6 1 
Age (years)     
     Mean  49.9 53.86 48 42 
     Range 32 25 29 0 
     Standard Deviation 
  9.5 8.75 9.8 0 
        30-39 
3(16.7) 1(14.3) 2(20) 0 
        40-49 
5(27.8) 1(14.3) 3(30) 1(100) 
        50-59 
7(38.9) 3(42.9) 4(40) 0 
        60-69 
3(16.7) 2(28.6) 1(10) 0 
Gender     
        Male 
13(72.2) 5 (71.4) 8(80)  
        Female 
5(27.8) 2(28.6) 2(20) 1(100) 
Race/Ethnicity     
       African American 9(50.0) 3(42.9) 5(50) 1(100) 
       White American 8(44.4) 3(42.9) 5(50)  
       Hispanic 1(5.6) 1(14.3)   
Marital Status     
       Single 1(5.6) 1(14.3) 0 0 
       Married 13(72.2) 3(42.9) 9(90.0) 1(100) 
       Divorced 3(16.7) 3(42.9) 0 0 
       Significant Other 1(5.6) 0 1(10)  
Educational Level     
       High School  4(22.2) 2(28.6) 1(10) 1(100) 
       GED 2(11.1) 1(14.3) 1(10) 0 
       Some college 4(22.2) 1(14.3) 3(30) 0 
       College 5(27.8) 2(28.6) 3(30) 0 
       Graduate School 3(16.7) 1(14.3) 2(20) 0 
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Table 12: continued 
 
Income Level     
        0-25,000 7(38.9) 4(57.1) 2(20) 1(100) 
        25,000-50,000 4(22.2) 1(14.3) 3(30) 0 
        51,000-75,000 5(27.8) 2(28.6) 3(30) 0 
        over 100,000 2(11.1) 0 2(20) 0 
Primary Insurance Payor     
       Commercial 9(50.0) 3(42.9) 5(50) 1(100) 
       Medicare 5(27.8) 4(57.1) 1(10) 0 
       Veterans 2(11.1) 0 2(20) 0 
       Tricare/Champus 1(5.6) 0 1(10) 0 
       Medicare &    
       Medicaid 
1(5.6) 0 1(10) 0 
Distance lived from 
hospital 
    
   Mean (miles)   96.6 39.3 140.4 60 
   Range 486 136 480 0 
   Standard Deviation 135.4 49.5 167.8 0 
       0-25 miles 8(44.4) 5(71.4) 3(30) 0 
       51-75 miles 1(5.6) 0 1(10) 0 
       76-100 miles 2(11.1) 1(14.3) 0 1(100) 
       101 over 7(38.9) 1(14.3) 6(60) 0 
Hospital Location     
        VCU 16(88.9) 7(100) 8(80) 1(100) 
        McGuire 2(11.1) 0 2(20) 0 
HF Etiology     
        Ischemic 1(5.6) 1(14.3)) 0  
        Non-Ischemic 16(88.9) 6(85.7) 9(90) 1(100) 
        Rejection 1(5.6) 0 1(10) 0 
Illness Length (HF)     
Mean (months) 91.7 156.7 52 24 
Range 356 324 216 0 
Standard Deviation 98.2 113 64.5 0 
       13-24 mos 2(11.1) 0 2(20) 0 
       25-36 mos 3(16.7) 0 2(20) 1(100) 
       37-48 mos 2(11.1) 1(14.3) 1(10) 0 
       49 over 11(61.1) 6(85.7) 5(50) 0 
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Table 12: continued 
 
Admissions 
6 months pre MCS  
    
Mean (# of admissions) 3.39 2.71 3 12 
Range 12 6 5 0 
Standard Deviation 2.77 1.79 1.89 0 
        0-5 1(5.6) 1(14.3) 0 0 
        6-10 14(77.8) 5(71.4) 9(90) 0 
        11-15 2(11.1) 1(14.3) 1(10) 0 
        Over 16 1(5.6) 0 0 1(100) 
Hospital Days 
6 months pre MCS  
    
Mean (days) 55.33 22.9 76.6 70 
Range 150 45 130 0 
Standard Deviation 40.4 19.8 38.4 0 
        0 days 1(5.6) 1(14.3) 0 0 
        1-30 days 3(16.7) 2(28.6) 1(10) 0 
        31-60 days 8(44.4) 4(57.1) 4(40) 0 
        61-90 days 2(11.1) 0 1(10) 1(100) 
        91 over  4(22.2) 0 4(40) 0 
Discharge Days 90 days 
post MCS (MCS-DD) 
    
Mean (days) 92.33 45.7 128.7 94 
Range 227 86 210 0 
Standard Deviation 61.5 28.5 59.3 0 
        0-30 days 2(11.1) 2(28.6) 0 0 
        31-60 days 5(27.8) 4(57.1) 1(10) 0 
        61-90 2(11.1) 0 2(20) 0 
        91 over 9(50.0) 1(14.3) 7(70) 1(100) 
Readmissions Days  post 
MCS (MCS-RD) 
    
Mean (days) 8.1 9.4 3.5 41 
Range 41 38 18 0 
Standard Deviation 12.8 13.6 6.7 0 
        0 days 10(55.6) 3(42.9) 7(70) 0 
        1-3 days 1(5.6) 0 1(10) 0 
        4-6 days 1(5.6) 1(14.3) 0 0 
        7 over 6(33.3) 3(42.9) 2(20) 1(100) 
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Table 12: continued 
 
Admissions Times  post 
MCS (MCS-RT) 
    
Mean (days) .72 .86 .4 3 
Range 3 2 2 0 
Standard Deviation 1.02 .9 .84 0 
        0 days 11(61.1) 3(42.9) 8(80) 0 
        1-3 days 7(38.9) 4(57.1) 2(20) 1(100) 
        4-6 days 0 0 0 0 
        7 over 0 0 0 0 
Inpatient Days 90 days 
post MCS (MCS-ID) 
(Overlaps with 
readmissions included) 
    
Mean (days) 100.4 53.7 132.2 135 
Range 223 120 196 0 
Standard Deviation 61.3 41.5 56.4 0 
        1-30 days 2(11.1) 2(28.6) 0 0 
        31-60 days 4(22.2) 3(42.9) 1(10) 0 
        61-90 days 3(16.7) 1(14.3) 2(20) 0 
        91 over 9(50.) 1(14.3) 7(70) 1(100) 
Living Will     
          No  7(39.9) 2(28.6) 5(50) 0 
 
White Americans made up 44.8% (n=8) and 5.6% (n=1) reported being Hispanic. The 
patient sample was married (72.2%, n=13) and had some college or a higher level of 
education 69.7% (n=12). Most household incomes were at $50,000 and below (61.1%, 
n=11) with 38.9% (n=7) at $25,000 or below. Fifty percent (n=9) of the patient sample 
had commercial insurance as the primary payer for medical services.    
 Medical charts revealed the participants HF etiology was non-ischemic (88.9%, 
n=16).  More TAHs were implanted (61.1%, n=11) and 7 of the TAH implants were 
converted to Freedom Drivers.  Study participants reported an average length of illness  
from HF diagnosis to MCS implant of 91.17 months for all devices (156.7 HMII, 52 
TAH and 24 for the patient with both the HMII and TAH) and were admitted to the 
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hospital an average of 3.39 times for all devices (2.7 HMII, 3 TAH and 12 for the patient 
with both the HMII and TAH). 
 The average number of inpatient days prior to implant was 53.3 days (22.9 HMII, 
76.6 TAH and 70.0 for the patient with both the HMII and TAH).  Patients were 
discharged from the hospital an average of 92.3 days for all devices (45.7 HMII, 128.7 
TAH and 135 for the patient with both the HMII and TAH) with an average of 8.1 
readmission days (9.4 HMII, 3.5 TAH and 41 for the patient with both the HMII and 
TAH).  The average number of inpatient days including readmissions post MCS implant 
was 100.4 for all devices (53.7 HMII, 132.2, TAH and 135 for the patient with both the 
HMII and TAH). The average number of times readmitted was .72 for all devices (.86 
HMII, .40 TAH, and 3 for the patient with both devices).  
Faith background and the use of faith resources (See Table 13 and 14) can be used 
by healthcare providers to determine how patients cope with illness.  The study sample 
was mostly Protestant (72.3%, n=13) and reported membership in an organized 
community of faith (77.8%, n=14).  The majority of patients received visits from a 
member of their community of faith (e.g. clergy, religious leader, community of faith 
official or member) or a hospital chaplain between one and four times weekly.  All 
patients reported visitations from their faith community or hospital chaplains helped them 
to cope with their illness and 77.8% (n=14) reported more visits would be helpful for 
coping with the illness.  Seven (39%) patients reported attendance to their community of 
faith was low or non-existent due to poor health prior to the MCS implant. Three (17%)  
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Table 13:  Faith Rituals and Practice: Full Sample and By Device Type 
                                                         n (%) 
Characteristics                                   Full Sample             HMII                      TAH                      Both  
                                                                  N=18                      n=7                       n=10                       n=1  
Faith Tradition     
Baptist 7(38.9) 3(42.9) 3(30) 1(100) 
Methodist 2(11.1) 1(14.3) 1(10) 0 
Episcopal 1(5.6) 0 1(10) 0 
Catholic 1(5.6) 0 1(10) 0 
Pentecostal/Charismatic 1(5.6) 1(14.3) 0 0 
Non-Denominational  2(11.1) 1(14.3) 1(10) 0 
Other (Christian, Spiritual, 
Open-Minded) 
4(22.2) 1(14.3) 3(30) 0 
Faith Community Membership      
 Yes 14(77.8) 7(100) 6(60) 1(100) 
  No 4(22.2) 0 4(40) 0 
 Faith Visitation     
Yes 18(100.0) 7 (100) 10(100) 1(100) 
No 0 0 0 0 
Faith Visitation 
Frequency (weekly) 
    
Mean (# of visits) 1.4 1 1.7 1 
Range 3 0 3 0 
Standard Deviation .98 0 1.25 0 
0 0 0 0 0 
1-3 16(88.9) 7(100) 8(80) 1(100) 
>4  2(11.1) 0 2(20) 0 
Do Visits Help     
Yes 18(100.0) 7(100) 10(100) 1(100) 
No 0 0 0 0 
Desire more visits     
 
Yes 
14(77.8) 6(85.7) 7(70) 1(100) 
No 4(22.2) 1(14.3) 3(30) 0 
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Table 14:  Faith Practices: Initial Intake Form  
Faith Practices N=18 
Communion 
11 
Prayer 14 
Meditation 8 
Sacred Text Reading 5 
Community Worship 8 
Fasting 5 
Anointing 6 
Other  
     Tarot Cards 
     Bible Study 
     Corporate Praise and Worship 
     Private Worship 
4 
 
patients reported a loss of faith or faith practices over a lifetime. Two (11%) patients 
reported a desire to return to a faith community after discharge from hospital.  
The initial and final interview questions (Table 15) along with the notes made in 
the hospital information system revealed patients experienced an increase in faith and 
courage, belief system, connection with relationships, understanding of self, meaning,  
sense of purpose and a reinterpretation of their life situation.  One patient commented that 
life was made worse with the MCS device. Patients attributed their increase in faith 
practices to visits from the faith community and hospital chaplains.  Prayer and 
meditation was most often used and patients reported these two practices helped them 
cope with their illness. Patients reported becoming closer to family members and others 
important to them and talked about helping others when they were discharged from the 
hospital.  The majority of patients reported that they were fearful of the future and had 
thought about dying.    
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Table 15:  Faith and Coping: Initial Intake and Final Interview Form 
Initial and Final Interview                    
Pre   Post   
1.   Helps me cope better 9 11 
2.   Increases my faith and courage 7 8 
3.   Gives me hope 10 10 
4.   Helps my belief system 5 7 
5.   Helps me connect with my higher power 5 5 
6.   Helps me connect with my relationships  7 10 
7.   Helped me understand myself better 3 6 
8.   Helps me find meaning in my life 1 4 
9.   Gives me a sense of purpose/calling/vocation 2 6 
10. Helps me find peace and forgiveness with myself 4 4 
11. Helps me reinterpret my life situation 6 7 
12. Does not help 0 1 
Comments from interviews and hospital information system  
I think I moved too fast before, now I want to slow down and heal.   
I want to get better first so I don‘t have to come back.  I know God is with me.  I just keep 
praying. (HMII, TAH, FD) 
I keep praying, but sometimes I think God is testing me. (HMII) 
It‘s a hassle because I can‘t shower or swim, but I‘m glad I‘m alive.  My heart is pumping.  I 
trust God and I‘m going to live my life. (HMII) 
I‘m still sick sometimes.  I just read and pray. (HMII) 
I now understand the importance of submission and surrender and the importance of my 
relationship with God and other people. (TAH) 
This sucks.  I‘m hoping for the best, but I‘m afraid if I go home I won‘t get a heart. (TAH, 
FD) 
My faith is stronger now. (TAH) 
I just want a heart.  My mother and her church pray for me. (TAH, FD) 
My life is ―out there‖ and I‘m not promised another day.  So I‘m going to trust God and go 
home and live my life. (TAH, FD) 
I was struggling because I didn‘t understand why God would let this happen to me. I believe 
God had me arrested for a season so I‘m listening to his voice for my next assignment. (TAH) 
I just want to go home.  I think I can heal better there with my family.  I worry about them. 
(HMII)  
I worry about my family and I‘m afraid.  I write poetry. (HMII) 
I‘m writing a book about this experience so I can help others. (TAH) 
I afraid and I don‘t want to die.  I‘m anxious about the surgery.  I pray and read my bible. 
(HMII) 
I didn‘t realize how much other people love me.  My spouse is a saint (TAH) 
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Hypothesis Testing and Results 
 After the preliminary descriptive review each hypothesis was tested.  This section 
presents each hypothesis with significant results. Significant results do not imply 
causation for there are various reasons for correlation.  In bivariate (X, Y) correlations, X 
may be the cause of Y or Y may be the cause of X.  There also might be other unknown 
variables that either mediate or confound the correlation.  It is important to keep in mind 
the familywise error rate therefore interpretation of results will be conservative.   
 It is also important to note that the following significant results had medium to 
large correlation coefficients and variances.  Hypothesis that did not produce 
correlational evidence will not be reported.   
Correlation Analyses 
Hypothesis 1(See Appendix G for Hypotheses Grid) 
a. There will be a positive relationship between SWB and HRQOL for patients with    
     MCS. 
 
b. There will be a positive relationship between MP and HRQOL for patients with MCS. 
 
c. There will be a positive relationship between ROF and HRQOL for patients with MCS. 
 
d. There will be a positive relationship between relational connectedness RLC and  
    HRQOL for patients with MCS. 
 
Hypothesis 1 was tested using a Spearman‘s Correlation Analysis to compute the 
correlation coefficients (rs) and (r
2
) for SWB and HRQOL.  The variables tested were 
SWB1, MP1, ROF1, RLC1, HRQOL P1, HRQOL F1, HRQOL E1, SWB2, MP2, ROF2, 
RLC2, HRQOL P2, HRQOL F2, HRQOL E2, PTS E, PTS I, PTS CC, PTS TQ, PTS 
DM, PTS Nurses, PTS Trust, PTS R, PTS CA, PTS OE, MCS DD, MCS RD, MCS ID, 
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and MCS RT.  The correlation coefficients and variances are presented in Table 16, 17, 
18, 19 and 20.   
Table 16:  Correlation Coefficients and Variances for SWB and HRQOL 
                                                  rs             p value   r 
2
 
    
SWB1 and HRQOL E1  .565 .007**  .32 
SWB2 and HRQOL E2  .547 .009**  .30 
SWB2 and PTS CC  .425 .039*  .18 
MP1 and HRQOL P1  .613 .003**  .38 
MP1 and HRQOL E1  .523 .013*  .27 
MP2 and HRQOL F2  .476 .023*  .23 
MP2 and HRQOL E2  .706 .001**  .50 
MP2 and MCS ID  .412 .045*  .17 
ROF1 and HRQOL E1  .482 .022*  .23 
ROF2 and HRQOL F2  .413 .044*  .17 
ROF2 and HRQOL E2  .403 .049*  .16 
ROF2 and PTS CC  .574 .006**  .33 
ROF2 and PTS CA   .437 .035*  .19 
RLC1 and HRQOL E1  .482 .021*  .23 
 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
 
Table 17:  Spearmans‘ Correlations: SWB1 and HRQOL1 
 SWB1 MP1 ROF1 RLC1 HRQOL P1 
HRQOL 
F1 
HRQOL 
E1 
 SWB1 Correlation Coefficient 1.000 .804** .648** .955** .346 .136 .565** 
Sig. (1-tailed) . .000 .002 .000 .079 .295 .007 
MP1 Correlation Coefficient .804** 1.000 .198 .642** .613** .329 .523* 
Sig. (1-tailed) .000 . .215 .002 .003 .091 .013 
ROF1 Correlation Coefficient .648** .198 1.000 .699** .146 -.030 .482* 
Sig. (1-tailed) .002 .215 . .001 .282 .453 .022 
RLC1 Correlation Coefficient .955** .642** .699** 1.000 .169 -.040 .482* 
Sig. (1-tailed) .000 .002 .001 . .251 .438 .021 
HRQOL P1 Correlation Coefficient .346 .613** .146 .169 1.000 .484* .732** 
Sig. (1-tailed) .079 .003 .282 .251 . .021 .000 
HRQOL F1 Correlation Coefficient .136 .329 -.030 -.040 .484* 1.000 .400* 
Sig. (1-tailed) .295 .091 .453 .438 .021 . .050 
HRQOL E1 Correlation Coefficient .565** .523* .482* .482* .732** .400* 1.000 
Sig. (1-tailed) .007 .013 .022 .021 .000 .050 . 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
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Table 18:  Spearmans‘ Correlations: SWB2 and HRQOL2  
 
Table 19: Spearmans‘ Correlations: SWB2 and MCS 
 SWB2 MP2 ROF2 RLC2 
MCS 
DD 
MCS 
RD 
MCS 
ID MCS RT 
 SWB2 Correlation Coefficient 1.000 .594** .845** .778** -.024 .332 .054 .399 
Sig. (1-tailed) . .005 .000 .000 .463 .089 .415 .051 
MP2 Correlation Coefficient .594** 1.000 .310 .379 .318 -.118 .412* -.091 
Sig. (1-tailed) .005 . .106 .061 .100 .320 .045 .360 
ROF2 Correlation Coefficient .845** .310 1.000 .545** -.277 .332 -.224 .332 
Sig. (1-tailed) .000 .106 . .010 .133 .089 .186 .089 
RLC2 Correlation Coefficient .778** .379 .545** 1.000 .209 .273 .243 .354 
Sig. (1-tailed) .000 .061 .010 . .203 .137 .166 .075 
MCS DD Correlation Coefficient -.024 .318 -.277 .209 1.000 -.264 .966** -.190 
Sig. (1-tailed) .463 .100 .133 .203 . .145 .000 .225 
MCS RD Correlation Coefficient .332 -.118 .332 .273 -.264 1.000 -.116 .872** 
Sig. (1-tailed) .089 .320 .089 .137 .145 . .323 .000 
MCS ID Correlation Coefficient .054 .412* -.224 .243 .966** -.116 1.000 -.072 
Sig. (1-tailed) .415 .045 .186 .166 .000 .323 . .389 
**. Correlation is significant at the 0.01 level (1-tailed).    *. Correlation is significant at the 0.05 level (1-tailed). 
 
 SWB2 MP2 ROF2 RLC2 
HRQOL 
P2 
HRQOL 
F2 
HRQOL 
E2 
 SWB2 Correlation Coefficient 1.000 .594** .845** .778** .084 .377 .547** 
Sig. (1-tailed) . .005 .000 .000 .370 .062 .009 
MP2 Correlation Coefficient .594** 1.000 .310 .379 .324 .476* .706** 
Sig. (1-tailed) .005 . .106 .061 .095 .023 .001 
ROF2 Correlation Coefficient .845** .310 1.000 .545** .116 .413* .403* 
Sig. (1-tailed) .000 .106 . .010 .323 .044 .049 
RLC2 Correlation Coefficient .778** .379 .545** 1.000 .001 .259 .173 
Sig. (1-tailed) .000 .061 .010 . .499 .150 .246 
HRQOL P2 Correlation Coefficient .084 .324 .116 .001 1.000 .418* .469* 
Sig. (1-tailed) .370 .095 .323 .499 . .042 .025 
HRQOL F2 Correlation Coefficient .377 .476* .413* .259 .418* 1.000 .282 
Sig. (1-tailed) .062 .023 .044 .150 .042 . .129 
HRQOL E2 Correlation Coefficient .547** .706** .403* .173 .469* .282 1.000 
Sig. (1-tailed) .009 .001 .049 .246 .025 .129 . 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
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Table 20:  Spearmans‘ Correlations: SWB and PTS 
 
 SWB2 MP2 ROF2 RLC2 PTS E PTS I 
PTS 
CC 
PTS 
TQ 
PTS 
DM 
PTS 
Nurses 
PTS 
Trust PTS R 
PTS 
CA 
PTS 
OE 
 SWB2 Correlation Coefficient 1.000 .594
**
 .845
**
 .778
**
 .001 .061 .425
*
 -.152 .244 -.158 .144 .117 .205 -.152 
Sig. (1-tailed) . .005 .000 .000 .498 .406 .039 .274 .165 .265 .284 .321 .207 .274 
MP2 Correlation Coefficient .594
**
 1.000 .310 .379 .162 -.168 .165 -.263 .118 -.347 .273 -.047 -.069 -.263 
Sig. (1-tailed) .005 . .106 .061 .260 .252 .256 .146 .320 .079 .137 .426 .393 .146 
ROF2 Correlation Coefficient .845
**
 .310 1.000 .545
**
 .143 .309 .574
**
 .057 .318 -.095 .286 .275 .437
*
 .057 
Sig. (1-tailed) .000 .106 . .010 .286 .106 .006 .412 .099 .353 .125 .135 .035 .412 
RLC2 Correlation Coefficient .778
**
 .379 .545
**
 1.000 -.058 -.094 .370 -.116 .032 .046 -.098 .164 .188 -.116 
Sig. (1-tailed) .000 .061 .010 . .409 .355 .065 .324 .451 .429 .349 .257 .227 .324 
PTS E Correlation Coefficient .001 .162 .143 -.058 1.000 .296 .433
*
 .478
*
 .028 -.089 .664
**
 .454
*
 .195 .478
*
 
Sig. (1-tailed) .498 .260 .286 .409 . .116 .036 .023 .456 .363 .001 .029 .219 .023 
PTS I Correlation Coefficient .061 -.168 .309 -.094 .296 1.000 .252 .791
**
 .274 -.198 .648
**
 .612
**
 .367 .396 
Sig. (1-tailed) .406 .252 .106 .355 .116 . .157 .000 .135 .215 .002 .003 .067 .052 
PTS CC Correlation Coefficient .425
*
 .165 .574
**
 .370 .433
*
 .252 1.000 .245 .113 -.051 .417
*
 .404
*
 .381 .245 
Sig. (1-tailed) .039 .256 .006 .065 .036 .157 . .164 .328 .420 .043 .048 .059 .164 
PTS TQ Correlation Coefficient -.152 -.263 .057 -.116 .478
*
 .791
**
 .245 1.000 .163 -.157 .517
*
 .728
**
 .468
*
 .500
*
 
Sig. (1-tailed) .274 .146 .412 .324 .023 .000 .164 . .259 .267 .014 .000 .025 .017 
PTS DM Correlation Coefficient .244 .118 .318 .032 .028 .274 .113 .163 1.000 .031 .017 .362 .568
**
 .163 
Sig. (1-tailed) .165 .320 .099 .451 .456 .135 .328 .259 . .451 .474 .070 .007 .259 
PTS Nurses Correlation Coefficient -.158 -.347 -.095 .046 -.089 -.198 -.051 -.157 .031 1.000 -.307 -.108 .289 .338 
Sig. (1-tailed) .265 .079 .353 .429 .363 .215 .420 .267 .451 . .107 .335 .123 .085 
PTS Trust Correlation Coefficient .144 .273 .286 -.098 .664
**
 .648
**
 .417
*
 .517
*
 .017 -.307 1.000 .474
*
 .224 .249 
Sig. (1-tailed) .284 .137 .125 .349 .001 .002 .043 .014 .474 .107 . .023 .186 .159 
PTS R Correlation Coefficient .117 -.047 .275 .164 .454
*
 .612
**
 .404
*
 .728
**
 .362 -.108 .474
*
 1.000 .686
**
 .728
**
 
Sig. (1-tailed) .321 .426 .135 .257 .029 .003 .048 .000 .070 .335 .023 . .001 .000 
PTS CA Correlation Coefficient .205 -.069 .437
*
 .188 .195 .367 .381 .468
*
 .568
**
 .289 .224 .686
**
 1.000 .468
*
 
Sig. (1-tailed) .207 .393 .035 .227 .219 .067 .059 .025 .007 .123 .186 .001 . .025 
PTS OE Correlation Coefficient -.152 -.263 .057 -.116 .478
*
 .396 .245 .500
*
 .163 .338 .249 .728
**
 .468
*
 1.000 
Sig. (1-tailed) .274 .146 .412 .324 .023 .052 .164 .017 .259 .085 .159 .000 .025 . 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
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SWB included the three subscales MP, ROF and RLC.  The MP scale statements 
were ―I feel peaceful,‖ ―I have a reason for living,‖ ―I have a sense of meaning and 
purpose in my life,‖ ―my life has been productive,‖ ―I feel a sense of harmony with 
myself,‖ ―I am able to reach down deep into myself for comfort‖ and ―my life has been 
productive.‖  The ROF  statements were ―I find comfort in my faith or spiritual beliefs,‖ 
―I find strength in my faith or spiritual beliefs,‖ ―my illness has strengthened my faith or 
spiritual beliefs,‖ and ―whatever happens with my illness, things will be okay.‖ The RLC 
statements were ―I feel connected to a  higher power or God,‖ ―I feel connected to other 
people‖ ―I feel loved,‖ ―I feel love for others,‖ I am able to forgive others for any harm 
they have caused me,‖ I am able to feel forgiven for any harm I have caused,‖ 
―throughout the course of my day, I feel a sense of thankfulness for my life,‖ ―throughout 
the course of my day, I feel a sense of thankfulness for what others bring to my life,‖ ―I 
feel hopeful,‖  ―I feel a  sense of appreciation for the beauty of nature,‖ and ―I feel 
compassion for others, in the difficulties they are facing.‖ HRQOL E (emotional QOL)  
statements were reverse scored and translated to ―I don‘t feel sad,‖ ―I don‘t feel nervous,‖ 
―I don‘t worry about dying,‖ ―I don‘t worry that my condition will get worse,‖ and ―I am 
not losing hope in the fight against my illness.‖ HRQOL P (physical QOL) statements 
were reverse scored and were translated to ―I don‘t have lack of energy,‖ ―I don‘t have 
pain,‖ ―I don‘t have nausea,‖ ―I am not bothered by the side effects of treatment,‖ ―I 
don‘t feel ill,‖ ―I am not forced to spend time in bed,‖ and ―I do not have trouble meeting  
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the needs of my family because of my physical condition.‖ The  HRQOL F statements 
were ―I am able to work,‖ ―my work (including work at home) is fulfilling,‖ ―I am able to 
enjoy life,‖ ―I have accepted my illness,‖ ―I am sleeping well,‖ ―I am content with the 
quality of my life, ‖ and ―I am able to enjoy the things in my life that I do for fun.‖ 
Positive associations were found between SWB and HRQOL E pre and post MCS 
device implant and showed patients found comfort in their overall spiritual beliefs while 
feeling hopeful about their emotional QOL.  Positive associations were found between 
MP and HRQOL E pre and post MCS and showed patients who found meaning and 
peace during their illness experience also had a positive emotional QOL. A positive 
association was found between MP and HRQOL P pre MCS and reflected patients who 
found meaning and peace also had a higher physical QOL. A positive association was 
also found between MP and HRQOL F post implant.  Patients reported ―feeling better‖ 
and ―able to move around‖ without getting tired.  One patient stated ―I feel fine and if it 
wasn‘t for the noise this device makes I wouldn‘t know I was sick.‖  One other patient 
remarked ―I feel better now since  I have the device.‖ Patients reported enjoying life and 
being content in spite of having MCS.  Although patients said they felt better, they 
admitted it was difficult to remain in the hospital because they did not feel sick.   
A positive association was found between MP and MCS ID post MCS implant.  
An association between meaning and peace and an increase in the number of inpatient 
days appears to be related to chance and could be due to complications for medical 
reasons or the patients finding security and comfort from being in the hospital inpatient 
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setting.  Important to note is the variance which had a medium effect on the two variables 
and warrants further study. 
 A positive association was found between ROF and HRQOL E pre and post MCS 
and reflected the positive effects that the patients‘ role of faith had on their emotional 
QOL.  One patient commented that faith had been used to cope with stressors in the past 
and would be used again to cope with the MCS device and future HT surgery. One other 
patient said ―my life is out there (meaning outside of the hospital) and if I have two days 
or two years, I‘m going to live it to the best of my ability.‖ It appears that the patients 
who used their faith with previous stressors also planned to use their faith throughout the 
MCS course of treatment. ROF correlated with HRQOL F post MCS. Patients who felt 
satisfied with the way they were coping and strengthened by their faith were also able to 
find acceptance with the MCS device. 
 A positive association was found between SWB and ROF and between PTS CC 
and ROF and also between ROF and PTS CA post MCS.  The patient satisfaction scores 
for comprehensive care reflected the patient‘s perception of their treatment care, 
accessibility to staff and openness during conversations about their illness and treatment. 
Questions on the PTS CC were  ―did the doctor(s) understand your needs,‖ ―did the 
treatment staff work together towards the same goal,‖ ―were you able to talk to the 
doctor(s) when you needed to,‖ ―did the treatment staff discuss how your health and 
treatment might affect your work (including housework),‖ ―did the treatment staff discuss 
how your health and treatment might affect your normal activities,‖ ―did the treatment 
staff discuss how your health and treatment might affect your personal relationships‖ and 
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―did the treatment staff discuss how your health and treatment might affect you 
emotionally?‖  Questions on the PTS CA were ―would you choose this 
hospital/clinic/office again?‖  Initial and final interviews with patients revealed their 
impressions about the treatment team and trust in ―God.‖ Patients reported they trusted 
what the doctors said, but believed ―God‖ was going to ―have the last word‖.  Patients 
also reported that ―God‖ works through the doctors.  Most of the patients appeared to 
cope better when they could say ―whatever happens with my illness, things will be okay‖.   
  An increase in the reported use of faith practices and faith and coping (Table 14 
and Table 15) provides evidence of spiritual growth from pre to post MCS device 
implant.  Patients were able to express their concerns about dying and the continuing 
welfare of their family. When given the opportunity, some patients reported they found 
comfort in expressing their fears. Goal setting in collaboration with the treatment team 
and family members also appeared to help patients by providing structure for them to 
complete concrete tasks. 
Hypotheses 2 (See Appendix G for a detailed hypotheses grid) 
a. There will be a positive relationship between RWB and HRQOL for patients with 
MCS. 
  
b. There will be a positive relationship between religious comfort (RC) and HRQOL for 
patients with MCS. 
 
c. There will be a negative relationship between religious strain and distress (RS) and 
HRQOL for patients with MCS. 
 
 Hypothesis 2 was tested using a Spearman‘s Correlation Analysis to compute the 
correlation coefficient (rs) and (r
2
) for RWB and HRQOL.  The variables tested were 
RWB1, RC1, RS1, HRQOL P1, HRQOL F1, HRQOL E1, RWB2, RC2, RS2,  
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HRQOL P2, HRQOL F2, HRQOL E2, PTS E, PTS I, PTS CC, PTS TQ, PTS DM, PTS 
Nurses, PTS Trust, PTS R, PTS CA, PTS OE, MCS DD, MCS RD, MCS ID and MCS 
RT.  The correlation coefficients and variances are presented in Table 21, 22, 23, 24, and 
25.  
Table 21: Correlation Coefficients and Variance for RWB and HRQOL                                 
 
                                                                                            rs                  p value        r
2
 
RWB1 and HRQOL E1  .652 .002**      .43 
RWB2 and MCS RD  .667 .001**       .44 
RWB2 and MCS RT  .472 .024*  .22 
RWB2 and PTS CC  .415 .044*  .17 
RWB2 and PTS DM  .559 .008**        .31 
RWB2 and PTS CA  .546 .009*  .30 
RC1 and HRQOL E1  .528 .012*    .28 
RC2 and HRQOL E2   -.498 .018*       .25 
RC2 and MCS DD  -.487      .020*  .24 
RC2 and MCS ID  -.446 .032*    .20 
RS1 and HRQOL P1  -.556      .008**      .31 
RS1and HRQOL E1  -.607 .004**       .37 
RS2 and MCS RD  -.451 .030*  .20 
RS2 and PTS CC   -.417 .042*  .17 
RS2 and PTS R   -.401 .050*      .16 
RS2 and PTS CA   -.533 .011*  .28 
RS2 and PTS OE   -.454 .029*      .21 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
 
Table 22: Spearmans‘ Correlations: RWB1 and HRQOL1 
 
 RWB1 RC1 RS1 HRQOL P1 HRQOL F1 HRQOL E1 
 RWB1 Correlation Coefficient 1.000 .793** -.790** .370 .156 .652** 
Sig. (1-tailed) . .000 .000 .066 .268 .002 
RC1 Correlation Coefficient .793** 1.000 -.331 .266 .107 .528* 
Sig. (1-tailed) .000 . .090 .143 .336 .012 
RS1 Correlation Coefficient -.790** -.331 1.000 -.556** -.165 -.607** 
Sig. (1-tailed) .000 .090 . .008 .257 .004 
HRQOL 
P1 
Correlation Coefficient .370 .266 -.556** 1.000 .484* .732** 
Sig. (1-tailed) .066 .143 .008 . .021 .000 
HRQOL 
F1 
Correlation Coefficient .156 .107 -.165 .484* 1.000 .400* 
Sig. (1-tailed) .268 .336 .257 .021 . .050 
HRQOL 
E1 
Correlation Coefficient .652** .528* -.607** .732** .400* 1.000 
Sig. (1-tailed) .002 .012 .004 .000 .050 . 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
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Table 23:  Spearmans‘ Correlations: RWB2 and HRQOL2 
 
 RWB2 RC2 RS2 HRQOL P2 HRQOL F2 HRQOL E2 
 RWB2 Correlation Coefficient 1.000 -.047 -.761** -.370 .175 .165 
Sig. (1-tailed) . .426 .000 .065 .243 .257 
RC2 Correlation Coefficient -.047 1.000 -.024 -.026 .195 -.498* 
Sig. (1-tailed) .426 . .463 .460 .219 .018 
RS2 Correlation Coefficient -.761** -.024 1.000 .259 -.069 -.174 
Sig. (1-tailed) .000 .463 . .150 .392 .244 
HRQOL 
P2 
Correlation Coefficient -.370 -.026 .259 1.000 .418* .469* 
Sig. (1-tailed) .065 .460 .150 . .042 .025 
HRQOL 
F2 
Correlation Coefficient .175 .195 -.069 .418* 1.000 .282 
Sig. (1-tailed) .243 .219 .392 .042 . .129 
HRQOL 
E2 
Correlation Coefficient .165 -.498* -.174 .469* .282 1.000 
Sig. (1-tailed) .257 .018 .244 .025 .129 . 
**. Correlation is significant at the 0.01 level (1-tailed).  *. Correlation is significant at the 0.05 level (1-tailed). 
 
 
Table 24: Spearmans‘ Correlations: RWB2 AND MCS 
 
 RWB2 RC2 RS2 MCS DD MCS RD MCS ID MCS RT 
 RWB2 Correlation Coefficient 1.000 -.047 -.761** .030 .667** .160 .472* 
Sig. (1-tailed) . .426 .000 .453 .001 .263 .024 
RC2 Correlation Coefficient -.047 1.000 -.024 -.487* .143 -.446* .021 
Sig. (1-tailed) .426 . .463 .020 .286 .032 .466 
RS2 Correlation Coefficient -.761** -.024 1.000 -.027 -.451* -.118 -.206 
Sig. (1-tailed) .000 .463 . .458 .030 .321 .206 
MCS DD Correlation Coefficient .030 -.487* -.027 1.000 -.264 .966** -.190 
Sig. (1-tailed) .453 .020 .458 . .145 .000 .225 
MCS RD Correlation Coefficient .667** .143 -.451* -.264 1.000 -.116 .872** 
Sig. (1-tailed) .001 .286 .030 .145 . .323 .000 
MCS ID Correlation Coefficient .160 -.446* -.118 .966** -.116 1.000 -.072 
Sig. (1-tailed) .263 .032 .321 .000 .323 . .389 
MCS RT Correlation Coefficient .472* .021 -.206 -.190 .872** -.072 1.000 
Sig. (1-tailed) .024 .466 .206 .225 .000 .389 . 
**. Correlation is significant at the 0.01 level (1-tailed).  *. Correlation is significant at the 0.05 level (1-tailed). 
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Table 25:  Spearmans‘ Correlations: RWB2 and PTS 
 
 RWB2 RC2 RS2 PTS E PTS I PTS CC PTS TQ 
PTS 
DM PTS Nurses 
PTS 
Trust PTS R 
PTS 
CA 
PTS 
OE 
 RWB2 Correlation Coefficient 1.000 -.047 -.761
**
 .103 .224 .415
*
 .048 .559
**
 .273 .189 .398 .546
**
 .322 
Sig. (1-tailed) . .426 .000 .342 .185 .044 .425 .008 .136 .227 .051 .009 .096 
RC2 Correlation Coefficient -.047 1.000 -.024 .394 .216 .194 .171 -.106 .185 .200 .117 -.120 .236 
Sig. (1-tailed) .426 . .463 .053 .195 .220 .249 .338 .232 .213 .321 .318 .173 
RS2 Correlation Coefficient -.761
**
 -.024 1.000 -.181 -.074 -.417
*
 -.130 -.363 -.363 -.114 -.401
*
 -.533
*
 -.454
*
 
Sig. (1-tailed) .000 .463 . .236 .386 .042 .304 .070 .070 .326 .050 .011 .029 
PTS E Correlation Coefficient .103 .394 -.181 1.000 .296 .433
*
 .478
*
 .028 -.089 .664
**
 .454
*
 .195 .478
*
 
Sig. (1-tailed) .342 .053 .236 . .116 .036 .023 .456 .363 .001 .029 .219 .023 
PTS I Correlation Coefficient .224 .216 -.074 .296 1.000 .252 .791
**
 .274 -.198 .648
**
 .612
**
 .367 .396 
Sig. (1-tailed) .185 .195 .386 .116 . .157 .000 .135 .215 .002 .003 .067 .052 
PTS CC Correlation Coefficient .415
*
 .194 -.417
*
 .433
*
 .252 1.000 .245 .113 -.051 .417
*
 .404
*
 .381 .245 
Sig. (1-tailed) .044 .220 .042 .036 .157 . .164 .328 .420 .043 .048 .059 .164 
PTS TQ Correlation Coefficient .048 .171 -.130 .478
*
 .791
**
 .245 1.000 .163 -.157 .517
*
 .728
**
 .468
*
 .500
*
 
Sig. (1-tailed) .425 .249 .304 .023 .000 .164 . .259 .267 .014 .000 .025 .017 
PTS DM Correlation Coefficient .559
**
 -.106 -.363 .028 .274 .113 .163 1.000 .031 .017 .362 .568
**
 .163 
Sig. (1-tailed) .008 .338 .070 .456 .135 .328 .259 . .451 .474 .070 .007 .259 
PTS Nurses Correlation Coefficient .273 .185 -.363 -.089 -.198 -.051 -.157 .031 1.000 -.307 -.108 .289 .338 
Sig. (1-tailed) .136 .232 .070 .363 .215 .420 .267 .451 . .107 .335 .123 .085 
PTS Trust Correlation Coefficient .189 .200 -.114 .664
**
 .648
**
 .417
*
 .517
*
 .017 -.307 1.000 .474
*
 .224 .249 
Sig. (1-tailed) .227 .213 .326 .001 .002 .043 .014 .474 .107 . .023 .186 .159 
PTS R Correlation Coefficient .398 .117 -.401
*
 .454
*
 .612
**
 .404
*
 .728
**
 .362 -.108 .474
*
 1.000 .686
**
 .728
**
 
Sig. (1-tailed) .051 .321 .050 .029 .003 .048 .000 .070 .335 .023 . .001 .000 
PTS CA Correlation Coefficient .546
**
 -.120 -.533
*
 .195 .367 .381 .468
*
 .568
**
 .289 .224 .686
**
 1.000 .468
*
 
Sig. (1-tailed) .009 .318 .011 .219 .067 .059 .025 .007 .123 .186 .001 . .025 
PTS OE Correlation Coefficient .322 .236 -.454
*
 .478
*
 .396 .245 .500
*
 .163 .338 .249 .728
**
 .468
*
 1.000 
Sig. (1-tailed) .096 .173 .029 .023 .052 .164 .017 .259 .085 .159 .000 .025 . 
**. Correlation is significant at the 0.01 level (1-tailed).  *. Correlation is significant at the 0.05 level (1-tailed). 
 
 
Positive associations were found for RWB and HRQOL E.  Patients who felt 
close to ―God‖ and protected and loved by ―God‖ had a higher emotional QOL. Also 
found was an expected positive association between RC and HRQOL E pre MCS device 
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suggesting patients who felt comforted by their faith also had a higher emotional QOL 
pre MCS.  An unexpected negative association was found between RC2 and HRQOL E 
post MCS. Further investigation revealed some of the individual raw scores from the RC 
surveys post MCS had decreased, but not the overall score therefore the association is 
most likely due to chance. A negative association was found between RS and HRQOL P 
and HRQOL E pre MCS device and suggests that patients who were not distressed also 
had a higher physical QOL.   
An unexpected positive association was found between RWB and MCS RD and 
MCS RT and if the association is not from medical complications, it may be the result of 
patients being discharged too soon or readmitted too often.  Patients also may perceive a 
benefit from being an inpatient.  Otherwise the unexpected results may be due to chance.   
A negative association was found between RC and MCS DD and MCS ID post 
MCS and may suggest patients who find comfort and strength in their faith may have 
fewer inpatient days.  A negative association was also found between RS and MCS RD 
post MCS implant and may suggest patients with less strain will have fewer inpatient 
days while those who have more strain might be spiritually distressed resulting in more 
days.  Patients who are distressed may find other reasons to be readmitted to the hospital 
if no serious medical complications can be found. 
A positive association was found between RWB and PTS CC, PTS DM, and PTS 
CA and a negative association was found between RS and PTS CC, PTS R, PTS CA, and 
PTS OE post MCS. Patients who found comfort and strength in their faith and did not 
feel abandoned by ―God‖ were also satisfied that their treatment team was working 
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towards the same goal, felt they were included in the decision-making process, would 
choose the treatment team again, and were satisfied with the overall experience. 
 Statements on the religious comfort scale are ―I feel that God has forgiven me,‖ ―I 
trust that God will protect and take care of me,‖ ―I feel like God is close to me,‖ ―I feel 
loved by God,‖ ―I have good memories of past experiences with religion or religious 
people,‖  ―I feel like I am part of a religious or spiritual community‖ and ―I feel 
comforted by my faith.‖ Patients may need supportive presence to assist with connection 
to faith resources when they feel sad, nervous and/or worry about dying.  These emotions 
may conflict with feeling that God is close and protective.  One patient not able to speak 
would ―point to the Bible‖ as soon as a chaplain entered the room.  The conversation with 
this patient was minimal, but it appears the patient found comfort in hearing the Bible 
read. 
 Religious strain/distress statements were ―I feel like God is far away,‖  ―I feel like 
God has abandoned me,‖ ―I feel my faith is weak,‖  ―I have difficulty trusting God,‖ ―I 
have difficulty believing God exists,‖ ―I believe I‘ve committed a sin too big to be 
forgiven,‖ and ―I have fear of evil or the devil.‖  Patients reported experiencing times of 
despair before the MCS implant and acknowledged deep-seated beliefs about whether 
―God‖ was able to help them.  Although patients expressed statements like these, some 
were able show positive emotional health scores.  Patients reported feeling ―tethered to 
the machine,‖ anxiety about the device and stressed whether a normal life would ever be 
lived again.  Patients reported prayer and meditation helped, sometimes found it hard to 
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pray, and acknowledged they were comforted when others prayed for them during 
stressful times. 
 The questions on the PTS DM were ―did your doctor(s) discuss other treatments, 
for example, alternative medicine or new treatments,‖ ―were you encouraged to 
participate in decisions about your health care,‖ ―did you have enough time to make 
decisions about your healthcare,‖ ―did you have enough information to make decisions 
about your health care,‖ and ―did your doctor(s) seem to respect your opinions?‖ The 
PTS R question was ―would you recommend this hospital/clinic/office to others?‖ The 
question on the PTS OE was ―how do you rate the care you received?‖ 
Hypotheses 3 (See Appendix H for a detailed hypotheses grid) 
 
a. There will be a positive relationship between BCOPE EF and HRQOL for patients 
    with MCS.  
 
b. There will be a positive relationship between BCOPE PF and HRQOL for patients  
    with MCS. 
  
c. There will be a negative relationship between BCOPE DF and HRQOL for patients  
    with MCS. 
 
d. There will be a positive relationship between BRCope AD and HRQOL for patients  
    with MCS. 
  
e. There will be a negative relationship between BRCope M and HRQOL for patients  
    with MCS.  
 
f. There will be a positive relationship between LOC I and HRQOL for patients with  
    MCS.  
 
g. There will be a negative relationship between LOC E and HRQOL for patients with  
    MCS.  
 
h. There will be a positive relationship between LOC G and HRQOL for patients with  
    MCS.  
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i. There will be a positive relationship between SF and HRQOL for patients with MCS. 
 
 Hypothesis 3 was tested using a Spearman‘s Correlation Analysis to compute the 
correlation coefficients (rs) and (r
2
) for CSM and HRQOL.  The variables tested were 
BCOPE EF1, BCOPE PF1, BCOPE DF1, BRCope AD1, BRCOPE M1, LOC I1, LOC 
E1, LOC G1, SF1, HRQOL P1, HRQOL F1, HRQOL E1, BCOPE EF2, BCOPE PF2, 
BCope DF2, BRCope AD2, BRCope M1, LOC I2, LOC E2, LOC G2, SF2, HRQOL P2,  
HRQOL F2, HRQOL E2, PTS E, PTS I, PTS CC, PTS TQ, PTS DM, PTS Nurses, PTS 
Trust, PTS R, PTS CA, PTS OE, MCS DD, MCS RD, MCS ID, and MCS RT.  The 
correlation coefficients and variances are presented in Table 26, 27, 28, and 29.  
Table 26: Correlation Coefficients and Variances for CSM and HRQOL 
       rs p value  r
2 
 
LOC I1 and HRQOL F1   .418 .042*  .17 
LOC I2 and PTS E   .409 .046*  .17 
LOC E1 and HRQOL F1   -.513      .015*  .26 
LOC E2 and MCS ID   -.411 .045*  .17 
LOC E2 and PTS I   .547 .009*  .30 
LOC G2 and MCS DD   -.479 .022*  .23 
LOC G2 and MCS ID   -.535 .011*  .29 
BCOPE EF2 and PTS E   .636 .002**  .40 
BCOPE EF2 and PTS CC   .489 .020*  .24 
BCOPE EF2 and PTS TQ     .485 .021*  .24 
BCOPE EF2 and PTS R   .400 .050*  .16 
BCOPE PF2 and PTS E   .447 .032*  .20 
BCOPE PF2 and PTS CA   .445 .032*  .20 
BCOPE PF2 and PTS OE   .403 .049*  .16 
BCOPE DF2 and PTS CA   .513 .015*  .26 
BCOPE DF2 and PTS OE   .448 .031*  .20 
BRCope M2 and PTS R   -.419 .042*  .18 
SF2 and PTS E    .497 .018*  .25 
 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
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Table 27: Spearmans‘ Correlations: CSM1 and HRQOL1 
 BCOPE EF1 
BCOPE 
PF1 
BCOPE 
DF1 
BRCope 
AD1 
BRCope 
M1 LOC I1 
LOC 
E1 
LOC 
G1 SF1 
HRQOL 
P1 
HRQOL 
F1 
HRQOL 
E1 
 BCOPE EF1 Correlation Coefficient 1.000 .559
**
 .148 .413
*
 .353 .369 .073 .267 .012 .079 .030 .007 
Sig. (1-tailed) . .008 .279 .044 .075 .066 .386 .142 .482 .377 .453 .489 
BCOPE PF1 Correlation Coefficient .559
**
 1.000 .310 .165 .403
*
 .694
**
 -.204 -.046 -.099 .252 .177 .137 
Sig. (1-tailed) .008 . .105 .256 .048 .001 .208 .428 .348 .157 .241 .294 
BCOPE 
DF1 
Correlation Coefficient .148 .310 1.000 .319 .448
*
 .110 .110 .036 .041 .397 -.014 .314 
Sig. (1-tailed) .279 .105 . .098 .031 .332 .333 .443 .436 .051 .478 .102 
BRCope 
AD1 
Correlation Coefficient .413
*
 .165 .319 1.000 .556
**
 -.038 -.145 .072 .083 .157 .235 .350 
Sig. (1-tailed) .044 .256 .098 . .008 .440 .283 .388 .371 .267 .174 .077 
BRCope M1 Correlation Coefficient .353 .403
*
 .448
*
 .556
**
 1.000 .226 .133 -.020 -.164 .107 .231 .221 
Sig. (1-tailed) .075 .048 .031 .008 . .183 .299 .469 .258 .337 .178 .189 
LOC I1 Correlation Coefficient .369 .694
**
 .110 -.038 .226 1.000 -.143 .046 -.119 .309 .418
*
 .262 
Sig. (1-tailed) .066 .001 .332 .440 .183 . .285 .428 .318 .106 .042 .147 
LOC E1 Correlation Coefficient .073 -.204 .110 -.145 .133 -.143 1.000 .253 .300 -.136 -.513
*
 -.244 
Sig. (1-tailed) .386 .208 .333 .283 .299 .285 . .156 .113 .295 .015 .165 
LOC G1 Correlation Coefficient .267 -.046 .036 .072 -.020 .046 .253 1.000 .278 -.003 -.287 -.224 
Sig. (1-tailed) .142 .428 .443 .388 .469 .428 .156 . .132 .495 .124 .186 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
 
Table 28: Spearmans‘ Correlations: CSM2 and MCS 
 
 BCOPE EF2 
BCOPE 
PF2 
BCOPE 
DF2 
BRCope 
AD2 
BRCope 
M2 LOC I2 
LOC 
E2 
LOC 
G2 SF2 
MCS 
DD 
MCS 
RD 
MCS 
ID 
MCS 
RT 
 BCOPE EF2 Correlation Coefficient 1.000 .438
*
 -.093 .671
**
 -.267 .407
*
 .229 .492
*
 .441
*
 -.298 .031 -.316 -.145 
Sig. (1-tailed) . .035 .357 .001 .142 .047 .180 .019 .033 .115 .451 .101 .283 
BCOPE PF2 Correlation Coefficient .438
*
 1.000 .288 .381 -.007 .235 .163 .108 .269 -.283 .136 -.358 -.028 
Sig. (1-tailed) .035 . .123 .059 .489 .174 .259 .335 .140 .128 .295 .072 .455 
BCOPE DF2 Correlation Coefficient -.093 .288 1.000 -.135 .379 .052 -.111 -.073 .273 .037 -.115 -.022 .065 
Sig. (1-tailed) .357 .123 . .297 .060 .419 .330 .386 .136 .442 .324 .466 .399 
BRCope 
AD2 
Correlation Coefficient .671
**
 .381 -.135 1.000 .113 .206 .218 .154 .357 .094 .065 .094 -.181 
Sig. (1-tailed) .001 .059 .297 . .328 .206 .192 .270 .073 .355 .398 .356 .236 
BRCope M2 Correlation Coefficient -.267 -.007 .379 .113 1.000 .153 -.020 -.218 .080 .301 -.372 .227 -.333 
Sig. (1-tailed) .142 .489 .060 .328 . .272 .469 .192 .376 .113 .064 .183 .089 
LOC I2 Correlation Coefficient .407
*
 .235 .052 .206 .153 1.000 -.025 .076 .296 .013 .072 .082 -.096 
Sig. (1-tailed) .047 .174 .419 .206 .272 . .461 .382 .117 .479 .388 .373 .352 
LOC E2 Correlation Coefficient .229 .163 -.111 .218 -.020 -.025 1.000 .292 .202 -.345 -.046 -.411
*
 -.058 
Sig. (1-tailed) .180 .259 .330 .192 .469 .461 . .120 .210 .081 .429 .045 .409 
LOC G2 Correlation Coefficient .492
*
 .108 -.073 .154 -.218 .076 .292 1.000 .694
**
 -.479
*
 -.009 -.535
*
 -.110 
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Table 28: continued 
 
  
Sig. (1-tailed) .019 .335 .386 .270 .192 .382 .120 . .001 .022 .485 .011 .331 
SF2 Correlation Coefficient .441
*
 .269 .273 .357 .080 .296 .202 .694
**
 1.000 -.286 .072 -.298 -.057 
Sig. (1-tailed) .033 .140 .136 .073 .376 .117 .210 .001 . .125 .388 .115 .411 
MCS DD Correlation Coefficient -.298 -.283 .037 .094 .301 .013 -.345 -.479
*
 -.286 1.000 -.264 .966
**
 -.190 
Sig. (1-tailed) .115 .128 .442 .355 .113 .479 .081 .022 .125 . .145 .000 .225 
MCS RD Correlation Coefficient .031 .136 -.115 .065 -.372 .072 -.046 -.009 .072 -.264 1.000 -.116 .872
**
 
Sig. (1-tailed) .451 .295 .324 .398 .064 .388 .429 .485 .388 .145 . .323 .000 
MCS ID Correlation Coefficient -.316 -.358 -.022 .094 .227 .082 -.411
*
 -.535
*
 -.298 .966
**
 -.116 1.000 -.072 
 Sig. (1-tailed) .101 .072 .466 .356 .183 .373 .045 .011 .115 .000 .323 . .389 
MCS RT Correlation Coefficient -.145 -.028 .065 -.181 -.333 -.096 -.058 -.110 -.057 -.190 .872** -.072 1.000 
 Sig. (1-tailed) .283 .455 .399 .236 .089 .352 .409 .331 .411 .225 .000 .389 . 
*. Correlation is significant at the 0.05 level (1-tailed).   **. Correlation is significant at the 0.01 level (1-tailed). 
 
 
Table 29: Spearmans‘ Correlations: CSM2 and PTS 
 
 BCOPE 
EF2 
BCOPE 
PF2 
BCOPE 
DF2 
BRCope 
AD2 
BRCope 
M2 
LOC 
I2 
LOC 
E2 
LOC 
G2 SF2 
PTS 
E PTS I 
PTS 
CC 
PTS 
TQ 
PTS 
DM 
PTS 
Nurses 
PTS 
Trust 
PTS 
R 
PTS 
CA 
PTS 
OE 
  
Sig. (1-tailed) . .035 .357 .001 .142 .047 .180 .019 .033 .002 .154 .020 .021 .439 .305 .060 .050 .082 .074 
BCOPE PF2 Correlation Coefficient .438
*
 1.000 .288 .381 -.007 .235 .163 .108 .269 .447
*
 .014 .049 .290 .101 .096 .167 .399 .445
*
 .403
*
 
Sig. (1-tailed) .035 . .123 .059 .489 .174 .259 .335 .140 .032 .477 .423 .121 .346 .353 .253 .051 .032 .049 
BCOPE DF2 Correlation Coefficient -.093 .288 1.000 -.135 .379 .052 -.111 -.073 .273 .111 .242 -.107 .383 .138 .243 .136 .352 .513
*
 .448
*
 
Sig. (1-tailed) .357 .123 . .297 .060 .419 .330 .386 .136 .330 .166 .336 .058 .292 .165 .295 .076 .015 .031 
BRCope AD2 Correlation Coefficient .671
**
 .381 -.135 1.000 .113 .206 .218 .154 .357 .333 -.011 .119 .155 .115 -.069 .235 -.070 .239 -.151 
Sig. (1-tailed) .001 .059 .297 . .328 .206 .192 .270 .073 .089 .482 .319 .269 .324 .393 .174 .391 .169 .275 
BRCope M2 Correlation Coefficient -.267 -.007 .379 .113 1.000 .153 -.020 -.218 .080 -.238 -.347 -.302 -.207 -.198 -.064 -.276 -.419
*
 -.183 -.207 
Sig. (1-tailed) .142 .489 .060 .328 . .272 .469 .192 .376 .171 .079 .112 .205 .216 .401 .134 .042 .233 .205 
LOC I2 Correlation Coefficient .407
*
 .235 .052 .206 .153 1.000 -.025 .076 .296 .409
*
 -.108 .299 -.107 -.223 -.037 .157 .070 .017 .264 
Sig. (1-tailed) .047 .174 .419 .206 .272 . .461 .382 .117 .046 .334 .114 .336 .186 .442 .267 .391 .473 .145 
LOC E2 Correlation Coefficient .229 .163 -.111 .218 -.020 -.025 1.000 .292 .202 .163 .547
**
 .036 .368 .252 -.388 .232 .164 .103 -.019 
Sig. (1-tailed) .180 .259 .330 .192 .469 .461 . .120 .210 .258 .009 .443 .067 .157 .056 .177 .257 .343 .470 
LOC G2 Correlation Coefficient .492
*
 .108 -.073 .154 -.218 .076 .292 1.000 .694
**
 .343 .339 .192 .325 .293 .042 .147 .121 -.018 .374 
Sig. (1-tailed) .019 .335 .386 .270 .192 .382 .120 . .001 .081 .084 .223 .094 .119 .435 .280 .317 .472 .063 
SF2 Correlation Coefficient .441
*
 .269 .273 .357 .080 .296 .202 .694
**
 1.000 .497
*
 .240 .086 .376 .370 .066 .187 .213 .190 .425
*
 
Sig. (1-tailed) .033 .140 .136 .073 .376 .117 .210 .001 . .018 .169 .367 .062 .065 .397 .228 .198 .225 .040 
PTS E Correlation Coefficient .636
**
 .447
*
 .111 .333 -.238 .409
*
 .163 .343 .497
*
 1.000 .296 .433
*
 .478
*
 .028 -.089 .664
**
 .454
*
 .195 .478
*
 
Sig. (1-tailed) .002 .032 .330 .089 .171 .046 .258 .081 .018 . .116 .036 .023 .456 .363 .001 .029 .219 .023 
PTS I Correlation Coefficient .254 .014 .242 -.011 -.347 -.108 .547
**
 .339 .240 .296 1.000 .252 .791
**
 .274 -.198 .648
**
 .612
**
 .367 .396 
107 
 
 
 
Table 29: continued 
 
  
Sig. (1-tailed) .154 .477 .166 .482 .079 .334 .009 .084 .169 .116 . .157 .000 .135 .215 .002 .003 .067 .052 
PTS CC Correlation Coefficient .489
*
 .049 -.107 .119 -.302 .299 .036 .192 .086 .433
*
 .252 1.000 .245 .113 -.051 .417
*
 .404
*
 .381 .245 
Sig. (1-tailed) .020 .423 .336 .319 .112 .114 .443 .223 .367 .036 .157 . .164 .328 .420 .043 .048 .059 .164 
PTS TQ Correlation Coefficient .485
*
 .290 .383 .155 -.207 -.107 .368 .325 .376 .478
*
 .791
**
 .245 1.000 .163 -.157 .517
*
 .728
**
 .468
*
 .500
*
 
Sig. (1-tailed) .021 .121 .058 .269 .205 .336 .067 .094 .062 .023 .000 .164 . .259 .267 .014 .000 .025 .017 
PTS DM Correlation Coefficient .039 .101 .138 .115 -.198 -.223 .252 .293 .370 .028 .274 .113 .163 1.000 .031 .017 .362 .568
**
 .163 
Sig. (1-tailed) .439 .346 .292 .324 .216 .186 .157 .119 .065 .456 .135 .328 .259 . .451 .474 .070 .007 .259 
PTS Nurses Correlation Coefficient -.129 .096 .243 -.069 -.064 -.037 -.388 .042 .066 -.089 -.198 -.051 -.157 .031 1.000 -.307 -.108 .289 .338 
Sig. (1-tailed) .305 .353 .165 .393 .401 .442 .056 .435 .397 .363 .215 .420 .267 .451 . .107 .335 .123 .085 
PTS Trust Correlation Coefficient .380 .167 .136 .235 -.276 .157 .232 .147 .187 .664
**
 .648
**
 .417
*
 .517
*
 .017 -.307 1.000 .474
*
 .224 .249 
Sig. (1-tailed) .060 .253 .295 .174 .134 .267 .177 .280 .228 .001 .002 .043 .014 .474 .107 . .023 .186 .159 
PTS R Correlation Coefficient .400
*
 .399 .352 -.070 -.419
*
 .070 .164 .121 .213 .454
*
 .612
**
 .404
*
 .728
**
 .362 -.108 .474
*
 1.000 .686
**
 .728
**
 
Sig. (1-tailed) .050 .051 .076 .391 .042 .391 .257 .317 .198 .029 .003 .048 .000 .070 .335 .023 . .001 .000 
Sig. (1-tailed) .082 .032 .015 .169 .233 .473 .343 .472 .225 .219 .067 .059 .025 .007 .123 .186 .001 . .025 
*. Correlation is significant at the 0.05 level (1-tailed).   **. Correlation is significant at the 0.01 level (1-tailed). 
 
There was a positive relationship between LOC I and HRQOL F and a negative 
relationship between LOC E and HRQOL F pre MCS and suggests patients who felt 
personally responsible for their health condition had a higher functional QOL. There was 
a negative relationship between LOC E and MCS ID post MCS and may suggest that 
patients who were more dependent on external forces may also have more inpatient days.  
Negative relationships were found between LOC G and MCS DD and MCS ID post MCS  
and this may suggest that patients with a higher dependency on ―God‖ had fewer hospital 
inpatient days and a shorter hospital stays. If the patient did not experience other medical 
complications they may have been less anxious about discharge and may have had fewer 
inpatient days. 
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 LOC I  statements were ―if my (health; condition) worsens, it is my own behavior 
which determines how soon I will feel better again,‖ ―If I see my doctor regularly, I am 
less likely to have problems with my (health; condition),‖  ―whenever my (health; 
condition) worsens, I should consult a medically trained professional,‖ ―I am directly 
responsible for my (health; condition) getting worse,‖ ―whatever goes wrong with my 
(health; condition)  is my own fault,‖ and ―the main thing that affects my (health; 
condition) is what I myself might do.‖ 
 LOC E statements were ―as to my (health; condition), what will be, will be,‖ ― 
most things that affect my (health; condition) happen to me by chance,‖ ―other people 
play a big role in whether my (health; condition) improves, stays the same or gets worse,‖ 
luck plays a big part in determining how my (health; condition) improves,‖ ―in order for 
my (health; condition) to improve, it is up to other people to see that the right things 
happen,‖ whatever improvement occurs with my (health; condition)  is largely a matter of 
good fortune,‖ ―if my (health; condition) worsens it‘s a matter of fate,‖ ―if I‘m lucky my 
(health; condition) will get better,‖ and ―the type of help I get from other people 
determines how soon my (health; condition) improves.‖  
 LOC G statements were ―If my (health; condition) worsens, it is up to God to 
determine whether I will feel better again,‖ ―Most things that affect my (health;  
condition) happen because of God,‖ ―God is directly responsible for my (health; 
condition) getting better or worse,‖ ―Whatever happens to my (health; condition) is 
God‘s will,‖ ―Whether or not my (health; condition) improves is up to God‖ and ―God is 
in control of my (health; condition).‖ 
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 There was a positive relationship between BCOPE EF and PTS E, PTS CC, PTS 
TQ, and PTS R.  Patients who used a higher level of emotion-focused coping were 
satisfied with the explanations from their treatment team and felt they had access to their 
treatment team when needed.  Patients also felt their treatment team was experienced and  
worked together towards the same goals. Patients also reported they would recommend 
the hospital/clinic/office again.  
BCOPE EF statements were ―I‘ve been getting emotional support from others,‖ 
I‘ve been getting help and advice from other people,‖ ―I‘ve been trying to see it in a 
different light, to make it seem more positive,‖ ―I‘ve been getting comfort and 
understanding from someone,‖ ―I‘ve been looking for something good in what is 
happening,‖ ―I‘ve been accepting the reality of the fact that this has happened,‖ I‘ve been 
expressing my negative feelings,‖ ―I‘ve been learning to live with this,‖ ―I‘ve been trying 
to find comfort in my religion or spiritual beliefs,‖ and ―I‘ve been praying or meditating.‖   
 There was a positive relationship between BCOPE PF and PTS E, PTS CA, and 
PTS OE post MCS. The BCOPE PF statements were ―I‘ve been concentrating my efforts 
on doing something about the situation,‖ I‘ve been taking action to try to make the 
situation better,‖ ―I‘ve been trying to come up with a strategy about what to do,‖ and 
―I‘ve been thinking hard about what steps to take.‖  Patients who used problem solving 
coping also had higher patient satisfaction scores when they were able to be in dialogue 
with the treatment team about their healthcare.  These patients also had higher ratings on 
their overall experience and would choose the treatment team again. 
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 There was an unexpected positive relationship between BCOPE DF and PTS CA, 
and PTS OE post MCS. The BCOPE DF questions were ―I‘ve been saying to myself this 
isn‘t real,‖ I‘ve been using alcohol or other drugs to make myself feel better,‖ ―I‘ve been 
giving up trying to deal with it,‖ ―I‘ve been refusing to believe that it has happened,‖ 
―I‘ve been saying things to let my unpleasant feelings escape,‖ ―I‘ve been using alcohol 
or other drugs to help me get through it,‖ ―I‘ve been criticizing myself,‖ ―I‘ve been 
giving up the attempt to cope,‖ ―I‘ve been  making jokes about it,‖ ―I‘ve been doing 
something to think about it less, such as going to movies watching TV, reading, 
daydreaming, sleeping, or shopping,‖ ―I‘ve been blaming myself for things that 
happened,‖ and ― I‘ve been making fun of the situation.‖  An unexpected positive 
relationship may be due to chance or it may suggest patients receive some benefit from 
their dysfunctional behavior.  
 There was a negative relationship between BRCope M and PTS R and may 
suggest that patients who were not feeling abandoned or punished would recommend the 
treatment team again. The BRCope M statements were ―wondered whether God had 
abandoned me,‖ ―felt punished by God for my lack of devotion,‖ ―wondered what I did 
for God to punish me,‖ ―questioned God‘s love for me,‖ ―wondered whether my church 
had abandoned me,‖ ―decided the devil made this happen,‖ and ―questioned the power of 
God.‖   
 There was a positive relationship between LOC I and PTS E, LOC E and PTS I, 
and SF2 and PTS E post MCS. Patients with a higher internal locus of control were able 
to personally utilize the explanations from the treatment team.  Patients with a higher 
111 
 
 
 
external locus of control felt satisfied with their interpersonal relations with the treatment 
team.  Patients may also have felt the treatment team had genuine concern for them.  
 Patients who felt they were satisfied with their support from their family were 
also satisfied with the advice and support they were receiving from their treatment team.   
 The PTS E questions were ―did the doctor give explanations that I could 
understand,‖ ―did the doctor explain the possible benefits of my treatment,‖ ―did the 
doctor explain the side effects or risks of my treatment‖ and ―did the doctor give me an 
opportunity to ask questions.‖ The PTS TQ questions were ―did I feel the doctors had 
experience treating my illness,‖ ―did I feel my doctors knew about the latest medical 
developments for my illness,‖ and ―did I feel the treatment staff was thorough in 
examining and treating me.‖ The PTS I questions were ―did I get to say the things to my 
doctors that were most important to me,‖ ―did my doctors seem to understand what was 
important to me‖ and ―did my doctors show genuine concern for me.‖ 
 SF survey questions are ―I feel close to my friends,‖ ―I get emotional support 
from my family, ―I get support from my friends,‖ ―my family has accepted my illness,‖ ―I 
am satisfied with family communication about my illness,‖ I feel close to my partner or 
main support person‖ and ―I am satisfied with my sex life.‖ 
Hypotheses 4 (See Appendix I for a detailed hypotheses grid) 
 
a. There will be a positive relationship between an emotion focused BCOPE-EF and  
    SWB for patients with MCS.  
 
b. There will be a positive relationship between a problem focused BCOPE-PF and SWB  
    for patients with MCS. 
  
c. There will be a negative relationship between a dysfunctional focused BCOPE-DF and  
    SWB for patients with MCS. 
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d. There will be a positive relationship between an adaptive BRCope-AD and SWB for  
    patients with MCS. 
  
e. There will be a negative relationship between a maladaptive BRCope-M and SWB for  
    patients with MCS.  
 
f. There will be a positive relationship between an internal locus of control LOC-I and  
    SWB for patients with MCS.  
 
g. There will be a negative relationship between an external locus of control LOC-E and  
    SWB for patients with MCS.  
 
h. There will be a positive relationship between a ―God‖ locus of control LOC-G and  
    SWB for patients with MCS.  
 
i. There will be a positive relationship between a social and family SF and SWB for  
   patients with MCS.  
 
 Hypothesis 4 was tested using a Spearman‘s Correlation Analysis to compute  
the correlation coefficient (rs) and (r
2
) for CSM and SWB.  The variables tested were 
BCOPE EF1, BCOPE-PF1, BCOPE-DF1, BRCope AD1 and BRCope M1, LOC I1, LOC 
E1, LOC G1 and SF1 and SWB1, MP1, ROF1, RLC1 and  BCOPE EF2, BCOPE-PF2, 
BCOPE-DF2, BRCope AD2 and BRCope M2, LOC I2, LOC E2, LOC G2 and SF2 and 
SWB2, MP2, ROF2, RLC2.  The correlation coefficients and variances are presented in 
Table 30 and 31.    
Table 30: Correlations and Variances for CSM and SWB 
      
     rs           p value    r
2 
 
BCOPE PF2 and MP2   -.402  .049*  .16 
LOC-E2 and ROF2   .453  .029*  .21 
LOC-G2 and RLC2   -.454  .029*  .21 
SF2 and RLC2    -.523  .013*  .27 
 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
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Table 31: Spearmans‘ Correlations: CSM and SWB 
 BCOPE EF2 
BCOPE 
PF2 
BCOPE 
DF2 
BRCope 
AD2 
BRCope 
M2 LOC I2 
LOC 
E2 
LOC 
G2 SF2 SWB2 MP2 ROF2 RLC2 
 BCOPE EF2 Correlation Coefficient 1.000 .438
*
 -.093 .671
**
 -.267 .407
*
 .229 .492
*
 .441
*
 -.053 -.060 .098 -.064 
Sig. (1-tailed) . .035 .357 .001 .142 .047 .180 .019 .033 .417 .406 .350 .401 
BCOPE PF2 Correlation Coefficient .438
*
 1.000 .288 .381 -.007 .235 .163 .108 .269 -.299 -.402
*
 .012 -.297 
Sig. (1-tailed) .035 . .123 .059 .489 .174 .259 .335 .140 .114 .049 .482 .115 
BCOPE DF2 Correlation Coefficient -.093 .288 1.000 -.135 .379 .052 -.111 -.073 .273 -.105 -.079 .106 -.275 
Sig. (1-tailed) .357 .123 . .297 .060 .419 .330 .386 .136 .340 .378 .337 .134 
BRCope AD2 Correlation Coefficient .671
**
 .381 -.135 1.000 .113 .206 .218 .154 .357 -.011 .095 .037 -.163 
Sig. (1-tailed) .001 .059 .297 . .328 .206 .192 .270 .073 .482 .354 .442 .259 
BRCope M2 Correlation Coefficient -.267 -.007 .379 .113 1.000 .153 -.020 -.218 .080 -.120 .119 -.096 -.305 
Sig. (1-tailed) .142 .489 .060 .328 . .272 .469 .192 .376 .318 .319 .352 .109 
LOC I2 Correlation Coefficient .407
*
 .235 .052 .206 .153 1.000 -.025 .076 .296 -.001 .279 .136 -.046 
Sig. (1-tailed) .047 .174 .419 .206 .272 . .461 .382 .117 .499 .131 .296 .428 
LOC E2 Correlation Coefficient .229 .163 -.111 .218 -.020 -.025 1.000 .292 .202 .175 -.129 .453
*
 -.013 
Sig. (1-tailed) .180 .259 .330 .192 .469 .461 . .120 .210 .244 .306 .029 .480 
LOC G2 Correlation Coefficient .492
*
 .108 -.073 .154 -.218 .076 .292 1.000 .694
**
 -.285 -.268 -.083 -.454
*
 
Sig. (1-tailed) .019 .335 .386 .270 .192 .382 .120 . .001 .126 .142 .371 .029 
SF2 Correlation Coefficient .441
*
 .269 .273 .357 .080 .296 .202 .694
**
 1.000 -.298 .026 -.097 -.523
*
 
Sig. (1-tailed) .033 .140 .136 .073 .376 .117 .210 .001 . .115 .459 .350 .013 
SWB2 Correlation Coefficient -.053 -.299 -.105 -.011 -.120 -.001 .175 -.285 -.298 1.000 .594
**
 .845
**
 .778
**
 
Sig. (1-tailed) .417 .114 .340 .482 .318 .499 .244 .126 .115 . .005 .000 .000 
MP2 Correlation Coefficient -.060 -.402
*
 -.079 .095 .119 .279 -.129 -.268 .026 .594
**
 1.000 .310 .379 
Sig. (1-tailed) .406 .049 .378 .354 .319 .131 .306 .142 .459 .005 . .106 .061 
ROF2 Correlation Coefficient .098 .012 .106 .037 -.096 .136 .453
*
 -.083 -.097 .845
**
 .310 1.000 .545
**
 
Sig. (1-tailed) .350 .482 .337 .442 .352 .296 .029 .371 .350 .000 .106 . .010 
RLC2 Correlation Coefficient -.064 -.297 -.275 -.163 -.305 -.046 -.013 -.454
*
 -.523
*
 .778
**
 .379 .545
**
 1.000 
Sig. (1-tailed) .401 .115 .134 .259 .109 .428 .480 .029 .013 .000 .061 .010 . 
*. Correlation is significant at the 0.05 level (1-tailed).  **. Correlation is significant at the 0.01 level (1-tailed). 
 
There was an unexpected negative relationship between BCOPE PF and MP post 
MCS.  It appears that patients who used a higher problem-focused coping did not find 
meaning and peace in their illness experience. This may be related to the uncontrollable 
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aspects of the living with the MCS as some patients stated they felt ―tethered‖ to the 
machine.   
 There was a positive relationship between LOC E and ROF and suggests that 
patients with a higher external locus of control also found comfort and strength through 
the use of their faith.  These patients also felt ―whatever happens with their illness, things 
would be okay.‖ 
There was an unexpected negative relationship between LOC G and RLC and an 
unexpected negative relationship between SF and RLC post MCS.   This unexpected 
relationship might suggest the patients‘ relationships with ―God‖ or ―family‖ may be 
strained, otherwise these results may be due to chance. 
Hypotheses 5:  (See Appendix I for a detailed hypotheses grid) 
 
a. There will be a positive relationship between BCOPE-EF and RWB for patients with 
    MCS.  
 
b. There will be a positive relationship between BCOPE-PF and RWB for patients with  
    MCS. 
  
c. There will be a negative relationship between BCOPE-DF and RWB for patients with  
    MCS. 
  
d. There will be a positive relationship between BRCope-AD and RWB for patients with  
    MCS. 
  
e. There will be a negative relationship between BRCope-M and RWB for patients with  
    MCS.  
 
f. There will be a positive relationship between LOC-I and RWB for patients with MCS.  
 
g. There will be a negative relationship between LOC-E and RWB for patients with    
     MCS. 
 
h. There will be a positive relationship between LOC-G and RWB for patients with MCS.  
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i. There will be a positive relationship between SF and RWB for patients with MCS.    
 
Hypothesis 5 was tested using a Spearman‘s Correlation Analysis to compute the 
correlation coefficient (rs) for (r
2
) CSM and RWB.  The variables tested were BCOPE 
EF1, BCOPE PF1, BCOPE DF1, BRCope AD1, BRCope M1, LOC I1, LOC E1, LOC 
G1, SF1 and RWB1, RC1 and RS1 and BCOPE EF2, BCOPE PF2, BCOPE DF2, 
BRCope AD2, BRCope M2, LOC I2, LOC E2, LOC G2, SF2 and RWB2, RC2 and RS2.   
The correlation coefficient and variance is presented in Table 32 and the correlations 
tables are in Table 32 and 33. 
A negative association was found for BRCope M and RC.  Patients who felt that 
―God‖ would protect them and would not abandon them also found strength and comfort 
from their faith.  Some patients acknowledged feeling abandoned by ―God.‖  One patient 
related this struggle to a decreased level of support from the community of faith. 
 
Table 32: Correlation Coefficient and Variance for CSM and RWB   
 
 
       r s p  r 
2
 
 
BRCope M2 and RC2   -.600 .004*  .36 
 
**. Correlation is significant at the 0.01 level (1-tailed).   *. Correlation is significant at the 0.05 level (1-tailed). 
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Table 33: Spearmans‘ Correlations: CSM2 and RWB2 
 BCOPE EF2 
BCOPE 
PF2 
BCOPE 
DF2 
BRCope 
AD2 
BRCope 
M2 LOC I2 
LOC 
E2 
LOC 
G2 SF2 RWB2 RC2 RS2 
 BCOPE EF2 Correlation Coefficient 1.000 .438
*
 -.093 .671
**
 -.267 .407
*
 .229 .492
*
 .441
*
 .241 .132 -.142 
Sig. (1-tailed) . .035 .357 .001 .142 .047 .180 .019 .033 .168 .301 .287 
BCOPE PF2 Correlation Coefficient .438
*
 1.000 .288 .381 -.007 .235 .163 .108 .269 -.020 .107 -.108 
Sig. (1-tailed) .035 . .123 .059 .489 .174 .259 .335 .140 .468 .337 .335 
BCOPE DF2 Correlation Coefficient -.093 .288 1.000 -.135 .379 .052 -.111 -.073 .273 -.103 -.231 -.122 
Sig. (1-tailed) .357 .123 . .297 .060 .419 .330 .386 .136 .342 .178 .314 
BRCope AD2 Correlation Coefficient .671
**
 .381 -.135 1.000 .113 .206 .218 .154 .357 .253 -.165 -.183 
Sig. (1-tailed) .001 .059 .297 . .328 .206 .192 .270 .073 .156 .256 .234 
BRCope M2 Correlation Coefficient -.267 -.007 .379 .113 1.000 .153 -.020 -.218 .080 -.361 -.600
**
 -.021 
Sig. (1-tailed) .142 .489 .060 .328 . .272 .469 .192 .376 .070 .004 .468 
LOC I2 Correlation Coefficient .407
*
 .235 .052 .206 .153 1.000 -.025 .076 .296 .126 -.038 -.170 
Sig. (1-tailed) .047 .174 .419 .206 .272 . .461 .382 .117 .309 .440 .250 
LOC E2 Correlation Coefficient .229 .163 -.111 .218 -.020 -.025 1.000 .292 .202 -.085 -.062 .251 
Sig. (1-tailed) .180 .259 .330 .192 .469 .461 . .120 .210 .369 .403 .157 
LOC G2 Correlation Coefficient .492
*
 .108 -.073 .154 -.218 .076 .292 1.000 .694
**
 .027 .239 .117 
Sig. (1-tailed) .019 .335 .386 .270 .192 .382 .120 . .001 .458 .170 .323 
SF2 Correlation Coefficient .441
*
 .269 .273 .357 .080 .296 .202 .694
**
 1.000 .057 .092 -.164 
Sig. (1-tailed) .033 .140 .136 .073 .376 .117 .210 .001 . .411 .359 .258 
RWB2 Correlation Coefficient .241 -.020 -.103 .253 -.361 .126 -.085 .027 .057 1.000 -.047 -.761
**
 
Sig. (1-tailed) .168 .468 .342 .156 .070 .309 .369 .458 .411 . .426 .000 
RC2 Correlation Coefficient .132 .107 -.231 -.165 -.600
**
 -.038 -.062 .239 .092 -.047 1.000 -.024 
Sig. (1-tailed) .301 .337 .178 .256 .004 .440 .403 .170 .359 .426 . .463 
RS2 Correlation Coefficient -.142 -.108 -.122 -.183 -.021 -.170 .251 .117 -.164 -.761
**
 -.024 1.000 
Sig. (1-tailed) .287 .335 .314 .234 .468 .250 .157 .323 .258 .000 .463 . 
*. Correlation is significant at the 0.05 level (1-tailed).  **. Correlation is significant at the 0.01 level (1-tailed).  
 
Comparison Analyses 
Hypotheses 6 (See Appendix J for a detailed hypotheses grid) 
 
a. The SWB for patients with MCS will significantly change over time (SWB1 and  
    SWB2)  
 
b. The MP for patients with MCS will significantly change over time (MP1 and MP2). 
 
 
117 
 
 
 
c. The ROF for patients with MCS will significantly change over time (ROF1 and  
    ROF2). 
 
d. The RLC for patients with MCS will significantly change over time (RLC1 and 
 Hypothesis 6 was tested using the Wilcoxons‘ Signed Rank Test in IBM SPSS 19 
to compute the W
+ 
(Z) Statistic.  The variables compared were SWB1 and SWB2, MP1 
and MP2, ROF1 to ROF2 and RLC1 and RLC2.     
 Table 34, 35, and 36 display the means for the SWB variables.  The SWB2, MP2, 
ROF2 and RLC2 means were higher than SWB1, MP1, ROF1 and RLC1 for all devices 
combined.  MP2 was significantly higher than MP1.  The SWB2, MP2, ROF2 AND 
RLC2 means were higher than SWB1, MP1, ROF1 and RLC1 for the HMII.    
SWB2 was significantly higher than SWB1 and MP2 was significantly higher than MP1.  
The SWB2, ROF2 and RLC2 mean s were lower than SWB1, ROF1 and RLC1 for 
the TAH.  MP2 and MP1 means were tied. There was no change in the mean scores for 
the patient who received both devices. 
 
Table 34: Significant SWB Mean and W
+ 
  
 
   Mean  Z score/Ws p value (* .05; **.01) 
All devices 
MP2> MP1  26.28/24.28 -1.769  .040 exact 1 tailed 
 
HMII 
SWB2 > SWB1  76.71/65 -2.207  .016 exact 1 tailed 
        
MP2>MP1  25/19.86 -1.992  .031 exact 1 tailed 
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Table 35:  SWB means and standard deviations:  Full Sample 
Descriptives 
 
(All Devices) 
 
Mean 
Std. 
Deviation Minimum Maximum 
Percentiles 
25
th
 
50th 
(Median) 75th 
SWB1 73.33 14.071 37 92 66.00 72.50 86.75 
SWB2 77.56 9.319 66 92 69.75 75.00 89.25 
MP1* 24.28 6.378 7 32 19.75 24.00 30.00 
MP2* 26.28 4.254 17 32 23.75 25.50 31.25 
ROF1 12.83 3.034 7 16 10.00 13.00 16.00 
ROF2 13.06 3.621 6 16 10.75 15.00 16.00 
RLC1 36.22 7.059 17 44 33.00 37.00 42.50 
RLC2 38.22 4.138 31 44 34.75 38.00 42.25 
All Devices  *Ws = -1.769,  exact sig (1 tailed ) p=.040 
 
 
Table 36:  SWB means and standard deviations: By Device Type 
 
 
 
 
Descriptive Statistics (By MCS  Device) 
 Mean 
Std. 
Deviation Minimum Maximum 
Percentiles 
25th 
50th 
(Median) 75th 
Heart Mate 2 SWB1* 65.00 16.482 37 89 56.00 67.00 75.00 
SWB2* 76.71 6.945 71 92 73.00 75.00 76.00 
MP1** 19.86 6.962 7 30 18.00 20.00 24.00 
MP2** 25.00 4.619 17 32 23.00 25.00 28.00 
ROF1 12.86 2.545 8 16 12.00 13.00 15.00 
ROF2 14.14 2.968 8 16 13.00 16.00 16.00 
RLC1 32.29 8.789 17 44 27.00 35.00 38.00 
RLC2 37.57 4.036 31 44 35.00 38.00 40.00 
Total Artificial 
Heart 
SWB1 77.30 9.093 63 90 71.25 75.00 86.75 
SWB2 76.70 10.361 66 92 68.75 71.00 89.25 
MP1 26.60 4.088 19 32 23.75 27.00 30.25 
MP2 26.60 3.864 21 32 23.75 25.50 31.25 
ROF1 12.50 3.440 7 16 9.75 13.00 16.00 
ROF2 12.00 3.972 6 16 9.00 11.50 16.00 
RLC1 38.20 4.417 33 44 33.75 39.00 42.50 
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Table 36: continued 
 
 
 
Hypotheses 7 (See Appendix J for a detailed hypotheses grid) 
 
a. The RWB for patients with MCS will significantly change over time (RWB1 and     
    RWB2). 
 
b. The RC for patients with MCS will significantly change over time (RC1 and RC2). 
 
c. The RS for patients with MCS will significantly change over time (RS1 and RS2). 
 
 Hypothesis 7 was tested using the Wilcoxons‘ Signed Rank Test in IBM SPSS 19 
to compute the W
+ 
(Z) Statistic.  The variables compared were RWB1, RC1 and RS1 to 
RWB2, RC2 and RS2.    
 Tables 37 and 38 display the means for the RWB variables.  No significant 
differences were found from pre to post MCS implant, but RWB2, RC2 and RS2 were 
higher than RWB1, RC1 and RS1 for all devices combined and the HMII.  The TAH 
mean were lower for RWB2 and RC2 and higher for RS1.  The means for the patient who 
received both devices increased from RWB1 to RWB2, but decreased  
 
 
 
RLC2 38.10 4.175 33 44 33.75 37.50 42.25 
Both SWB1 92.00 . 92 92 . . . 
SWB2 92.00 . 92 92 . . . 
MP1 32.00 . 32 32 . . . 
MP2 32.00 . 32 32 . . . 
ROF1 16.00 . 16 16 . . . 
ROF2 16.00 . 16 16 . . . 
RLC1 44.00 . 44 44 . . . 
RLC2 44.00 . 44 44 . . . 
*Ws= -2.207, exact sig (1 tailed) p = .016. **Ws =-1.992, exact sig (1 tailed) p=.03. 
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Table 37: RWB means and standard deviations:  Full Sample  
 
 
Table 38:  RWB means and standard deviations:  By Device Type 
Descriptive Statistics (By MCS Device) 
 Mean 
Std. 
 Deviation Minimum Maximum 
Percentiles 
25th 
50th  
(Median) 75th 
Heart Mate 2 RWB1 65.14 13.862 36 78 62.00 68.00 75.00 
RWB2 68.29 8.826 56 79 59.00 68.00 76.00 
RC1 20.71 5.707 10 28 19.00 20.00 25.00 
RC2 23.57 5.473 12 28 23.00 25.00 27.00 
RS1 7.00 7.188 2 22 2.00 4.00 10.00 
RS2 7.14 6.203 1 14 1.00 4.00 14.00 
Total Artificial 
Heart 
RWB1 67.60 8.086 49 75 62.50 69.50 74.00 
RWB2 67.00 9.226 44 75 63.25 69.50 74.00 
RC1 21.30 5.889 10 28 16.75 22.00 27.00 
RC2 21.10 5.152 11 28 18.00 20.00 26.00 
RS1 5.10 3.213 0 10 2.50 5.00 8.00 
RS2 5.80 6.973 0 24 2.25 3.50 7.50 
Both RWB1 75.00 . 75 75 . . . 
RWB2 79.00 . 79 79 . . . 
RC1 25.00 . 25 25 . . . 
RC2 20.00 . 20 20 . . . 
RS1 2.00 . 2 2 . . . 
RS2 1.00 . 1 1 . . . 
Descriptive Statistics (All Devices) 
  
Mean Std. Deviation Minimum Maximum 
Percentiles 
25th 
50th 
(Median) 75th 
RWB1 67.06 10.384 36 78 62.75 68.50 74.25 
RWB2 68.17 8.959 44 79 63.25 69.50 75.00 
RC1 21.28 5.550 10 28 18.50 21.50 25.50 
RC2 22.00 5.134 11 28 18.75 23.00 26.25 
RS1 5.67 5.041 0 22 2.00 4.50 8.00 
RS2 6.06 6.430 0 24 1.00 3.50 10.00 
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from RC1 to RC2 and RS1 to RS2.  
Hypotheses 8 (See Appendix K for a detailed hypotheses grid) 
 
a. The BCOPE-EF for patients with MCS will significantly change over time (BCOPE- 
    EF1 and BCOPE-EF2).   
 
b. The BCOPE-PF for patients with MCS will significantly change over time (BCOPE- 
    PF1 and BCOPE-PF2).  
  
c. The BCOPE-DF for patients with MCS will significantly change over time (BCOPE-    
    DF1 and BCOPE-DF2).  
 
d. The BRCope-AD for patients with MCS will significantly change over time (BRCope- 
    AD1 and BRCope-AD2).  
 
e. The BRCope-M for patients with MCS will significantly change over time (BRCope- 
    M1 and BRCope-M2). 
 
f. The LOC-I for patients with MCS will significantly change over time (LOC-I1 and  
    LOC-I2). 
g. The LOC-E for patients with MCS will significantly change over time (LOC-E1 and  
    LOC-E2). 
 
h. The LOC-G for patients with MCS will significantly change over time (LOC-G1 and  
    LOC-G2).  
 
i. The SF for patients with MCS will significantly change over time (SF1 and SF2). 
 
Hypothesis 8 was tested using the Wilcoxons‘ Signed Rank Test in IBM SPSS 19 
to compute the W
+ 
(Z) Statistic.  The variables compared were BCOPE E1, BCOPE P1, 
BCOPE DF1, BRCope AD1, BRCope M1, LOC I1, LOC E1, LOC G1 and SF1 to 
BCOPE E2, BCOPE P2, BCOPE DF2, BRCope AD2, BRCope M2, LOC I2, LOC E2, 
LOC G2 and SF2.   
 Table 39, 40, and 41 display the means for the CSM variables.  All means for the 
CSM2 variables for all devices were higher than the CSM1 variables except for and TAH  
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Table 39: CSM Means and W
+ 
 
Mean  Z score/Ws p value (* .05; **.01) 
 
All devices  
BRCope AD2>  18.33/16.55 -1.937  .028 exact 1 tailed 
BRCope AD1   
 
SF2>   22.44/20.33 -1.887  .031 exact 1 tailed 
SF1   
 
HMII 
BRCope AD2> 19.29/16.57 -2.032  .031 exact 1 tailed  
BRCope AD1 
 
LOC G2>  23.57/20.71 -2.023  .031 exact 1 tailed 
LOC G1 
 
TAH 
LOC I2>  37.80/37.40 -1.947  .031 exact 1 tailed 
LOC I1 
 
Table 40: CSM means and standard deviations: Full Sample 
 
 
Descriptive Statistics (Full Sample) 
 
Mean Std. Deviation Minimum Maximum 
Percentiles 
25th 50th (Median) 75th 
BCOPE EF1 27.06 5.693 16 35 23.75 27.50 31.25 
BCOPE EF2 27.00 6.306 12 33 24.00 29.00 32.00 
BCOPE PF1 14.28 4.800 4 23 10.75 13.50 18.25 
BCOPE PF2 12.61 5.710 3 24 8.75 12.00 16.75 
BCOPE DF1 11.28 6.569 0 20 7.50 12.00 17.25 
BCOPE DF2 9.61 6.679 0 21 2.75 10.50 14.00 
BRCope AD1* 16.50 7.073 3 28 11.50 17.00 22.50 
BRCope AD2* 18.33 7.088 7 28 12.50 19.50 24.50 
BRCope M1 2.83 5.469 0 22 .00 .00 4.00 
BRCope M2 1.17 2.121 0 8 .00 .00 2.00 
LOC I1 36.56 7.935 20 49 32.50 37.00 43.00 
LOC I2 38.11 7.576 22 49 32.75 38.50 44.00 
LOC E1 40.22 5.766 30 49 35.00 42.00 45.00 
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Table 40: continued 
 
LOC E2 41.61 5.101 31 49 38.75 42.00 45.50 
LOC G1 21.83 2.854 17 28 20.00 21.00 23.50 
LOC G2 22.89 3.563 18 32 21.00 21.00 25.25 
SF1** 20.33 5.292 9 28 17.00 22.50 24.00 
SF2** 22.44 4.062 14 28 20.00 23.50 24.50 
All devices *Ws = -1.937, exact sig (1 tailed) p = . 028; ** Ws = -1.887, exact sig (1 tailed) p = .031   
 
Table 41: CSM means and standard deviations: By Device Type 
 
Descriptive Statistics (By MCS Device) 
MCS DEVICE Mean 
Std. 
Deviation Minimum Maximum 
Percentiles 
25th 
50th 
(Median) 75th 
HMII BCOPE EF1 30.14 3.436 24 35 28.00 31.00 32.00 
BCOPE EF2 30.43 2.070 28 33 28.00 30.00 33.00 
BCOPE PF1 16.43 4.541 10 23 11.00 17.00 19.00 
BCOPE PF2 13.29 5.187 7 19 8.00 15.00 19.00 
BCOPE DF1 12.43 6.754 0 20 9.00 14.00 17.00 
BCOPE DF2 10.43 5.798 0 19 9.00 10.00 14.00 
BRCope 
AD1* 
16.57 9.016 3 28 10.00 14.00 24.00 
BRCope 
AD2* 
19.29 8.321 7 28 13.00 19.00 28.00 
BRCope M1 4.71 8.139 0 22 .00 1.00 8.00 
BRCope M2 1.14 3.024 0 8 .00 .00 .00 
LOC I1 38.00 9.345 22 49 33.00 38.00 47.00 
LOC I2 38.29 9.962 22 49 32.00 39.00 49.00 
LOC E1 40.71 6.102 30 49 38.00 42.00 45.00 
LOC E2 42.14 4.140 35 49 41.00 42.00 44.00 
LOC G1** 20.71 2.430 17 25 19.00 21.00 21.00 
LOC G2** 23.57 2.820 21 28 21.00 23.00 26.00 
SF1 21.14 4.914 13 28 18.00 22.00 24.00 
 
SF2 22.57 4.685 14 28 20.00 23.00 27.00 
TAH BCOPE EF1 26.00 5.578 16 34 22.25 26.50 29.50 
BCOPE EF2 25.20 7.451 12 32 18.50 27.50 32.00 
BCOPE PF1 12.90 4.886 4 21 10.00 12.00 16.75 
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Table 41: continued 
 
 
BCOPE PF2 12.20 6.563 3 24 8.50 11.50 16.50 
BCOPE DF1 11.00 6.848 0 18 6.00 12.00 18.00 
BCOPE DF2 9.50 7.678 0 21 1.50 12.00 15.00 
BRCope AD1 17.70 4.620 10 25 14.25 19.00 20.50 
BRCope AD2 18.60 6.186 8 28 14.00 20.50 22.50 
BRCope M1 1.80 2.741 0 8 .00 .00 4.00 
BRCope M2 1.30 1.494 0 4 .00 1.00 2.25 
LOC I1*** 34.80 7.036 20 43 30.75 34.50 42.00 
LOC I2*** 37.40 6.150 27 47 33.25 38.00 42.00 
LOC E1 40.50 5.778 30 48 35.00 42.00 45.25 
LOC E2 42.10 5.384 31 48 38.75 42.50 47.25 
LOC G1 22.80 3.011 19 28 20.00 22.50 26.00 
LOC G2 22.70 4.165 18 32 20.75 21.00 24.25 
SF1 20.90 4.654 12 26 17.75 23.00 24.00 
SF2 22.70 3.889 14 28 20.00 24.00 24.50 
Both BCOPE EF1 16.00 . 16 16 . . . 
BCOPE EF2 21.00 . 21 21 . . . 
BCOPE PF1 13.00 . 13 13 . . . 
BCOPE PF2 12.00 . 12 12 . . . 
BCOPE DF1 6.00 . 6 6 . . . 
BCOPE DF2 5.00 . 5 5 . . . 
BRCope AD1 4.00 . 4 4 . . . 
BRCope AD2 9.00 . 9 9 . . . 
BRCope M1 .00 . 0 0 . . . 
BRCope M2 .00 . 0 0 . . . 
LOC I1 44.00 . 44 44 . . . 
LOC I2 44.00 . 44 44 . . . 
LOC E1 34.00 . 34 34 . . . 
LOC E2 33.00 . 33 33 . . . 
LOC G1 20.00 . 20 20 . . . 
LOC G2 20.00 . 20 20 . . . 
SF1 9.00 . 9 9 . . . 
 
SF2 19.00 . 19 19 . . . 
*Ws =  exact sig (1 tailed) p = .03; **Ws =  exact sig (1 tailed) p = .03; ***Ws = -1.947, exact sig (1 tailed) p = .03 
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patients increased their LOC.  BCOPE PF decreased for HMII patients and the patient 
with both devices.   
The statements on the BRCope AD were ―looked for a stronger connection with 
God,‖ ―sought God‘s love and care,‖ ―sought help from God in letting go of my anger,‖ 
―tried to put my plans into action together with God,‖ ―tried to see how God might be 
trying to strengthen me in this situation,‖  ―asked forgiveness of my sins‖ and ―focused 
on religion to stop worrying about my problems.‖ 
Hypotheses 9 (See Appendix L for a detailed hypotheses grid) 
 
a. The HRQOL-Physical (P) health status for patients with MCS will significantly change  
    over time (HRQOL-P1 and HRQOL-P2). 
 
b. The HRQOL-Functional (F) health status for patients with MCS will significantly  
    change over time (HRQOL-F1 and HRQOL-F2). 
 
c. The HRQOL-Emotional (E) health status for patients with MCS will significantly  
    change over time (HRQOL-E1 and HRQOL-E2). 
 
 Hypothesis 9 was tested using the Wilcoxons‘ Signed Rank Test in IBM SPSS 19 
to compute the W
+ 
(Z) Statistic.  The variables compared were HRQOL P1, HRQOL F1 
and HRQOL E1 to HRQOL P2, HRQOL F2 and HRQOL E2.  
 Table 42, 43, and 44 display the means for HRQOL.  The HRQOL P2, HRQOL 
F2 and HRQOL E2 means were higher than the HRQOL P1, HRQOL F1 and HRQOL 
E1 scores for all devices, HMII and the TAH.  Significance was found for HRQOL F2 
and HRQOL F1 all devices combined. 
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Table 42: HRQOL Means and W
+ 
 
   Mean  Z score/Ws p value (* .05; **.01) 
 
All devices  
HRQOL F2>   17.22/15 -1.823  .035 exact 1 tailed 
HRQOL F1   
 
Table 43: HRQOL means and standard deviations: Full Sample 
Descriptive Statistics (Full Sample) 
 
Mean Std. Deviation Minimum Maximum 
Percentiles 
25th 50th (Median) 75th 
HRQOL P1 16.78 7.026 3 26 13.00 18.00 21.50 
HRQOL P2 18.22 8.264 2 28 13.75 21.50 23.25 
HRQOL F1* 15.00 7.608 0 26 8.75 14.50 22.00 
HRQOL F2* 17.22 7.232 0 25 11.00 19.50 22.25 
HRQOL E1 17.28 6.027 5 24 13.25 18.50 23.00 
HRQOL E2 19.28 5.085 5 24 16.75 20.50 23.00 
 All devices *Ws = -1.823 , exact sig(I tailed) p = .035 
 
Table 44: HRQOL means and standard deviations: By Device Type 
 
Descriptive Statistics (By MCS Device) 
MCS DEVICE Mean Std. Deviation Minimum Maximum 
Percentiles 
25th 50th (Median) 75th 
Heart Mate 2 HRQOL P1 15.14 8.255 3 26 6.00 18.00 20.00 
HRQOL P2 16.57 10.261 2 26 2.00 21.00 24.00 
HRQOL F1 15.14 6.914 8 26 9.00 14.00 23.00 
HRQOL F2 18.00 5.745 11 25 11.00 19.00 23.00 
HRQOL E1 17.00 7.071 6 24 11.00 17.00 24.00 
HRQOL E2 19.14 4.776 10 24 16.00 20.00 23.00 
Total Artificial 
Heart 
HRQOL P1 17.30 6.413 3 25 13.75 18.00 22.00 
HRQOL P2 19.00 7.379 3 28 13.75 21.00 23.25 
HRQOL F1 14.20 8.443 0 25 7.00 15.50 22.00 
HRQOL F2 16.20 8.522 0 24 8.50 19.50 22.50 
HRQOL E1 16.90 5.607 5 23 14.00 18.50 22.00 
HRQOL E2 18.90 5.567 5 24 16.75 20.00 23.00 
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Table 44: continued 
 
Both HRQOL P1 23.00 . 23 23 . . . 
HRQOL P2 22.00 . 22 22 . . . 
HRQOL F1 22.00 . 22 22 . . . 
HRQOL F2 22.00 . 22 22 . . . 
HRQOL E1 23.00 . 23 23 . . . 
HRQOL E2 24.00 . 24 24 . . . 
 
The patient with both devices had lower means for HRQOL P2, higher means for 
HRQOL E2, and  no change between HRQOL F2 and HRQOL F1.  
Chapter Summary 
 This chapter presented a description of the patient sample and the statistical 
results from the correlation and comparative analyses.  This chapter also summarized the 
results from the patient interviews and hospital information system.  
 The religious and spiritual practices of patients increased from pre to post MCS 
implant and patients who used their faith in previous times of distress reported they 
would also use their faith after receiving MCS.  The patients reported satisfaction with 
support from their family and friends, faith community members, hospital staff including 
hospital chaplains.  
 HMII patients appeared to have an increase in their SWB while the patients with 
TAHs experienced more spiritual struggle than the patients with HMIIs. The means 
scores post MCS for SWB, MP, ROF and RLC increased for the patients with HMIIs and 
were satisfied with how they were coping with their illness.  Although there were no 
significant differences found for the RWB, RC and RS mean scores from pre to post 
MCS, patients‘ RWB, RC and RS increased for the HMII.  The TAH mean scores 
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decreased for RWB and RC and increased for RS. The mean scores for the patient who 
received both devices increased for overall RWB, but decreased for RC and RS. The 
increase in the RS mean score and decrease in RC might be an indication of ―religious 
and/or spiritual struggle.‖   
 RWB and MCS DD and MCS RT were positively associated and may suggest 
patients with a higher RWB may also find comfort and support in the hospital inpatient 
setting. This may be the result of patients feeling less anxiety in the hospital setting and 
an increased anxiety in returning home. There was also a positive association between 
RWB and PTS DM and PTS CA and also a negative association between RS and PTS 
CA.  This may suggest that comfort from religious faith is related to finding satisfaction 
with the amount of decision-making participation by the patient. A lower level of 
religious and spiritual distress from feeling supported by the treatment team may have 
increased the level of trust and also influenced the patients‘ decision to choose the 
treatment team again.  
 LOC I was positively related to functional QOL and LOC E and LOC G were 
related to fewer hospital inpatient days.  An expected negative association was found 
between LOC E and HRQOL E and suggests that patients with an external LOC had a 
decreased emotional QOL.  LOG G and MCS DD and MCS ID were negatively 
associated and suggest patients with a ―God‖ locus of control may have fewer inpatient 
days.  Comparing LOC E to LOC I and LOC G might shed more light on exactly how 
LOG G correlates with MCS DD and MCS ID.  Taking more personal control in the 
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healing process, in addition to using faith as a resource may have influenced patients‘ 
discharge and inpatient days barring any serious medical illness. 
 BCOPE EF was correlated with the patients‘ satisfaction with the doctors‘ advice 
about their illness and the treatment team comprehensiveness and experience.  Patients 
also stated they would recommend the treatment team again.   There was a significant 
negative correlation between SF and RLC suggesting these patients may have been 
distressed in their relationship with God, themselves and/or others.  
 Some patients reported a desire to work on becoming better persons after their 
discharge from the hospital.  A few patients also struggled with their illness experience 
and in some cases said they found it hard to use any religious or faith practices.  One 
patient said he felt ―abandoned‖ by ―God‖ and community of faith. Prayer, meditation, 
and visits with community of faith and/or hospital chaplains were used most often as 
spiritual and religious coping methods. 
 SF and PTS E were positively associated and may have reflected the patients 
comfort from being able to openly engage with the treatment team.  These same patients 
also felt supported by their family and friends. 
 All of the mean scores for the CSM increased for the patients with the HMIIs 
except for BCOPE PF.  Significance was found for an increased BRCope AD and LOC 
G.  TAH mean scores were higher for all CSM variables except BCOPE EF, BCOPE PF 
and LOC G.  Significance was found for a higher LOC I and may suggest these patients 
became more independent as a way to control their illness. The patient who received both 
devices had a decreased BCOPE PF.  
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 The BRCope M and RC were negatively associated. Patients who felt loved by 
―God‖ and did not feel abandoned felt comforted that ―God‖ was not far away. These 
patients also reported a strong faith.   
 Not surprising was the increase in the means scores for HRQOL P and HRQOL E 
for the HMIIs and TAHs.  Significance was found for HRQOL F for both devices. The 
patient with both devices had lower means scores for HRQOL P, higher scores for 
HRQOL E and no change for HRQOL F. 
 Chapter Five follows and will discuss the results as they relate to the study 
concepts. Statistical and practical implications, limitations and recommendations for 
future research will also be discussed and will conclude the chapter.  
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CHAPTER FIVE:  DISCUSSION 
 
 
 
This study examined the impact of spiritual well-being (SWB), religious well-
being (RWB), coping styles and methods (CSM) and their impact on the health-related 
quality of life (HRQOL) for patients with mechanical circulatory support (MCS).  This 
study also evaluated changes in SWB, RWB, CSM and HRQOL after the MCS implant 
to further clarify the relationships. This preliminary study included many variables for 
possible use in a future study capable of building a predictive model. Therefore, results 
were interpreted conservatively while keeping in mind the large family-wise error rate. 
 This study cautiously supports the growing body of knowledge that reports 
positive relationships between spiritual and religious coping and well-being and health-
related quality of life and discusses the results as they relate to the conceptual model and 
compares these results to the existing literature.  Lastly, study implications, limitations, 
conclusions and areas for future research will end this discussion.   
Faith Practices and Spiritual Outcomes 
 Patients reported an increase in the use of faith practices from pre to post MCS 
device implantation which possibly reveals some type of spiritual growth.  Patients were 
visited by members of their community of faith and hospital chaplains and found comfort 
in being able to express their concerns about their illness. Some patients reported 
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expressing their fears enabled them to cope with their illness. Other patients stated it did 
not help to talk about their concerns, but all of the patients reported spiritual visits were 
helpful to them.  Admittedly, these patients were most likely visited more often due to the 
nature of their illness and the increased number of visits may also have impacted the 
increase in their use of faith practices.    
 Patient interviews also revealed an increase in spiritual outcomes.  Patients 
reported spiritual visits helped them cope better, increased their faith and courage, helped 
their belief system, helped them connect with their relationships, helped them understand 
themselves better, helped them find meaning in life, gave them a sense of purpose and 
helped them to reinterpret their medical condition.   
Spiritual Well-Being and Health-Related Quality of Life 
 Positive significant relationships were found between spiritual well-being 
(meaning and peace, role of faith in illness, relational connectedness) and health-related 
quality of life (physical, functional, emotional) for all devices.  The correlation 
coefficients and variance scores were consistently medium to large and possibly 
represented predictive relationships. Analysis by device type found a decrease in the 
spiritual well-being means scores for the TAH patients.  Further investigation is needed 
to discriminate the reasons for this decrease in spiritual well-being with TAH patients.   
 A significantly higher meaning and peace mean score was found for the HMII 
patients after MCS implant, but did not change for the TAH patients post MCS. Meaning 
and peace were consistently correlated before and after MCS for all patients combined 
(both HMII and TAH).  Patients who consistently found a reason for living felt 
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productive, felt peaceful, and felt a sense of purpose and harmony.  They were also able 
to not feel sadness, find satisfaction in the way they coped with their illness, not lose 
hope, and not worry about dying or getting worse. The results do not indicate that 
patients never felt sad, lost hope or worried, but they do suggest they were able to balance 
those feelings with meaning and purpose.  
  Interviews with some patients revealed they were able to come to terms with how 
their illness had impacted their life.  A TAH patient commented ―I now understand the 
importance of submission and surrender and the importance of my relationship with God 
and other people.‖  A HM II patient stated ―I just want to go home.  I think I can heal 
better there with my family, because I feel better when I am with them.‖   
 Patients cope by using spiritual resources to bring meaning to their illness and the 
possible benefits are improved physical, mental and spiritual health (Koenig, 2001; 
Pargament, 1997; Parks, 2008).  The illness experience often leads patients on spiritual 
quests to find meaning. Hospital chaplains who are knowledgeable about the patients‘ 
particular illness may provide directed benefits to these patients by being present at each 
critical stage of the illness.  Hospital chaplains may also assist with the use of existing 
spiritual resources as well as introduce new ones to encourage or facilitate spiritual 
growth. 
Not surprising was the significant correlation between meaning and peace, role of 
faith and functional quality of life. The correlation coefficient and variance were medium 
to high and possibly represents a predictive relationship. Previous MCS studies report a 
higher functional quality for patients after MCS (Franzen, Saveman, & Blomqvist, 2007; 
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Friedrich & Bohm, 2007; Rose et al., 2001).  This study showed that patients who felt 
they had a reason for living, felt productive, felt peaceful, felt a sense of purpose, and felt 
a sense of harmony within themselves were also able to work (including work at home), 
find work (including work at home) fulfilling, enjoy life, accept their illness, sleep well, 
enjoy the things they usually did for fun and find contentment with the quality of their 
life. These same patients also found comfort and strength in their faith or spiritual beliefs, 
found their illness had strengthened their faith or spiritual beliefs and believed that they 
would be okay, no matter what happened with their illness.  After the MCS implant, 
patients reported ―feeling better‖ and ―able to move around‖ without getting tired. One 
patient stated ―I feel fine and if it wasn‘t for the noise this device makes I wouldn‘t know 
I was sick.‖  One other patient remarked ―I feel better now since I have the device.‖ 
Patients reported enjoying life and being content in spite of the MCS.  
According to the biopsychosocial model Engel (1977) psychosocial factors 
influence health outcomes directly or indirectly.  The direct influence may be due to the 
patients‘ beliefs or values about their illness or treatment and indirect influence is when 
physical factors influence psychological or emotional factors that ultimately impact 
health outcomes.  Psychological and emotional factors such as positive spiritual and 
religious well-being and coping strategies produce better health outcomes (Daaleman, 
Perera, & Sudenski, 2004; Koenig, 2001; Stewart, Ross, & Hartley, 2004).  Higher 
functional quality of life outcomes may have benefited partly from the patients‘ belief 
that their function would improve.  The peace from finding comfort and strength from 
their faith may have also influenced their improved functional quality.  
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 The role of faith was also positively related to treatment satisfaction.  Patients 
who were satisfied in the way they were able to communicate with their team and also 
felt the team understood their needs stated they would choose their team again.  These 
patients felt the treatment staff worked together towards the same goals.  The correlation 
coefficients and variances were medium to large indicating possible predictive tendencies 
from the role of faith (patients finding strengthened in their faith, and believing they 
would be okay with whatever happened to them).  Future studies may examine 
attachment relationship theories to examine how previous relationships might impact the 
current relationships with the healthcare team.  The results from this future examination 
may shed light on patient and treatment team dynamics and help with interventions that 
use collaboration for healthy patient outcomes.    
Surprisingly meaning and peace and the number of inpatient days were positively 
related.  Tepper, Rogers, Coleman, and Maloney (2001) found certain religious beliefs 
and faith activities reduced stress, symptom severity, and number of hospitalizations.  
The expected results for this study were a negative association between meaning and 
peace and number of inpatient days.  After examining the relationship between the 
patients‘ satisfaction with the treatment team and meaning and peace, it might be 
suggested that patients also found some comfort from being in the hospital.  A HMII and 
TAH freedom driver patient commented ―I think I moved too fast before (this patient 
initially had a short length of hospital stay) and now I want to stay here (in the hospital) 
slow down and take the time to heal. I want to get better first so I don‘t have to come 
back.  I know God is with me.  I just keep praying.‖  A TAH freedom driver patient 
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stated ―This sucks.  I‘m hoping for the best, but I‘m afraid if I go home I won‘t get a 
heart.‖  If there are no other serious medical complications and no other known reasons 
for the patient remaining in the hospital, an increased number of inpatient days may need 
further exploration.  Otherwise the positive correlation for meaning and peace and 
number of inpatient days may be due to chance or sampling error. The nature of this 
patient population is too varied to make a determination as to why there is a positive 
relationship between meaning and peace and the number of inpatient days.  
 The meaning and peace variable was consistent for both the correlation and 
comparative analyses.  Important to note is the increase in mean scores for the HMII 
patients and the decrease in the mean scores for the TAH patients.  The meaning and 
peace mean score for the TAH patients remained the same.  These results warrant further 
study to unveil how meaning and peace affect HRQOL. Finding ways to spiritually and 
emotionally increase or at the least maintain meaning and peace for patients may 
consistently improve HRQOL.   
 Spirituality influences the attitudes and behaviors of individuals experiencing 
illness and assists in the adjustment process (Dull & Skokan, 1995; Rokeach, 1960; Gall 
& Grant, 2005).  One patient commented that faith had been used to cope in the past and 
would be used again to cope with the MCS device and future HT surgery. One other 
patient said ―my life is out there (meaning outside of the hospital).  If I have two days or 
two years, I‘m going to live it to the best of my ability.‖ It appears that those patients 
whose faith had been tested prior to the MCS device possessed a higher resilience (Tusaie 
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& Dyer, 2004; Tusaie, Puskar & Sereika, 2007; Werner & Smith, 1992) to stress and 
were able re-use positive coping strategies.  
Religious Well-Being and Health-Related Quality of Life 
 
  Positive associations were found for overall religious well-being, religious 
comfort and emotional quality of life pre MCS device. Negative associations were found 
between religious strain and physical and emotional quality of life pre MCS device.  An 
unexpected negative association was found between religious comfort and emotional 
quality of life.  The correlation coefficients and variances represented high medium to 
large effects indicating potential predictive ability. 
 The patients who reported they felt close to ―God‖ and felt protected and loved by 
―God‖ also had a positive emotional quality of life.  The correlation between religious 
well-being and religious comfort and emotional quality of life reflected patients felt 
forgiven by ―God‖ and also felt ―God‖ would protect and take of them. These patients 
also reported they felt close to ―God,‖ felt loved by ―God,‖ had good memories of past 
experiences with religion or religious people, felt like they were a part of a religious or 
spiritual community and felt comforted by their faith.  These patients were also able to 
not feel sadness, find satisfaction in the way they coped with their illness, not lose hope 
and not worry about dying or getting worse.  
 Patients may need a supportive presence to assist with faith resources for coping 
when they feel sad, nervous and worry about dying or when they have emotional conflict 
about feeling that God is close and protective.  One patient who was not able to speak 
would ―point to the Bible‖ as soon as a chaplain entered the room.  Very little 
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conversation transpired with this patient other than the reading of scripture.  The patient 
appeared to relax and seemed to find comfort during the reading.  
 These results are supported by Hamrick & Diefenback (2006) and Koenig (1998), 
who report that patients desire a deeper faith and closer relationship to ―God‖ following 
stressful and traumatic events.  The use of religion and religious practice may influence 
how patients feel about their illness experience by providing comfort and strength. 
Negative associations were found for religious strain and physical and emotional 
quality of life pre MCS.  A low level of distress correlates with a higher emotional and 
physical quality of life. Patients who felt ―God‖ was close, did not have difficulty trusting 
―God‖, believed they would be forgiven and did not fear evil, and found satisfaction in 
the way they coped with their illness. They did not lose hope and did not worry about 
dying or getting worse.  These patients also felt better physically. 
 An unexpected negative association was found between religious comfort and 
emotional quality of life post MCS. Further investigation revealed some of the individual 
raw scores from the religious comfort surveys post MCS had decreased, but not the 
overall score.  One possible explanation for this unexpected association may have been 
the mixed emotions expressed by patients living with MCS.  Patients reported feeling 
―tethered to the machine‖ and expressed anxiety about living with the MCS.  Patients 
reported prayer and meditation helped, but sometimes found it hard to pray and 
acknowledged they felt comforted when others prayed for them. The negative association 
may have been due to chance or sampling error.   
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 Religion and spirituality can have both positive and negative effects (Koenig, 
McCullough, & Larson, 2001) and both can be important when considering provision of 
support to patients.  Positive images of ―God,‖ sacred texts, hymns and prayer may 
provide comfort peace and joy and may lead to lower levels of distress during the illness 
experience; negative images of ―God‖ may induce distress according to Gall, 
Kristjansson, & Charbonneau (2009), Koenig (2001) and Levin (2001).  Appropriate 
spiritual interventions may potentially enhance patients‘ recovery from illness (Mueller, 
Plevak & Rummans, 2001).  As previously mentioned, attachment theory may support a 
better understanding of relationships with others and in this case ―the other‖ is ―God.‖  
 Unexpected positive associations were found between religious well-being and 
number of readmission days and readmission times post MCS.  An earlier discussion of 
spiritual well-being and number of inpatient days post MCS may support these 
correlations as well.  Patients may have associated being in the hospital and in close 
proximity to the treatment team as one of the ways that ―God‖ protected them.  Good 
memories of past experiences with religion or religious people may also have translated 
being in a community as a hospital inpatient.     
 A positive association was found between religious well-being and treatment 
satisfaction (comprehensive care, decision-making, and choose again) and may reflect 
that patients not feeling abandoned by ―God‖ correlated with patients also finding 
satisfaction with the comprehensiveness of care from their treatment team.  An open 
patient and healthcare provider relationship is important in order to accurately assess 
patient needs (Fisch, Titzer, and Kristeller, 2003).  Patients who felt close to and not 
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abandoned by ―God‖ also found satisfaction when their doctor(s) discussed treatment 
options with them and also encouraged them to participate in making decisions about 
their own health care. These patients perceived their opinions were respected by the 
doctor(s).  As previously stated, positive coping strategies include allowing patients to 
engage in the decision-making process for setting their treatment goals. 
 Negative associations were found between religious comfort and number of 
discharge days and inpatient days post MCS. This correlation supports the earlier 
mentioned findings from Tepper, Rogers, Coleman & Maloney (2001), who found certain 
religious beliefs and activities reduced stress, symptom severity and the number of 
hospitalizations.  Negative associations also were found between religious strain and 
number of readmission days and treatment satisfaction (comprehensive care, recommend, 
choose again, and overall experience).  Patients with a low level of religious strain had 
fewer readmission days and were also satisfied with their overall treatment experience.  
Fewer readmissions may be related to better compliance by properly caring for the MCS 
device, taking medications, and keeping outpatient follow-up visits.  Sometimes patients 
experience an increase in religious strain from the anxiety felt with the MCS device.  
Religious strain could negatively impact the patients‘ relationship with the treatment 
team.   
 A comparison analysis of the pre and post MCS mean scores did not show 
significance for religious well-being, religious comfort or religious strain.  Although 
significance was not found, all HMII mean scores increased and TAH mean scores 
decreased for religious well-being and religious comfort and increased for religious 
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strain.  These results are similar to the comparison tests for spiritual well-being.  Another 
fact to consider is that patients with HMIIs were discharged from the hospital sooner, 
whereas patients with the TAH remained in the hospital until they are switched over to 
the freedom driver or received a heart transplant. Is the increased religious strain and 
decreased spiritual well-being and religious well-being related to TAH patients not 
having their native heart?  A future study may be able to reveal a better understanding of 
―personhood‖ and how mechanical devices replacing organs potentially isolates patients 
from society.  
 Patients reported experiencing times of despair before and after the MCS implant 
and revealed deep-seated beliefs about ―God‘s‖ ability to fix their health.  Spiritual 
struggle and religious discontent may lead to psychological distress and lower life 
satisfaction (Gall, Charbonneau, & Clark, et al., 2005).  According to Brown (2008) and 
Harrison, Koenig, & Hays (2001) patients may view their illness as an opportunity for 
growth or as punishment from ―God.‖ Supportive networks and alliances may prevent 
social isolation and provide a sense of belonging while providing opportunities to work 
through the distress (Holland, Kash & Passik, et al., 1998; Koenig, 1997; Koenig, 
McCullough & Larson, 2001). 
Coping Style and Method and Health-Related Quality of Life 
 
 A positive relationship was found between internal locus of control and functional 
quality of life and a negative relationship between external locus of control and 
functional quality of life pre MCS.   The correlation coefficients and variances were 
medium to large. Patients who reported feeling responsible for their own health condition 
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getting better had a higher functional quality of life; in contrast, with patients who relied 
on forces outside of themselves had a lower functional quality of life.  
 Patients with a higher external locus of control had a positive association with 
their treatment satisfaction as it related to the interpersonal relationship with the doctors.   
The correlation coefficient and variance was large.  It appears the doctors or the treatment 
team played a critical role in the patients‘ health improvement.  Patients with a higher 
external locus of control may need support through exercises that support independence.  
 Patients with a higher internal locus of control had a positive association with 
treatment satisfaction as it related to the doctors‘ explanation.  These patients appeared to 
engage their healthcare team in order to find the information needed to improve their 
health and then take the responsibility for using that information.  
 A negative relationship was found between external locus of control and number 
of inpatient days post MCS.  Patients who had lower external locus of control may 
depend more on themselves for health improvement and less on the treatment team.    
  Negative relationships were found between a ―God‖ focused locus of control and 
number of days discharged after MCS and total number of inpatient days.   For these 
patients the external force was ―God‖ and might suggest their faith and beliefs about 
protection and care would also translate into protection and care at home.  An 
intervention might incorporate spiritual exercises that induce comfort whenever needed. 
 A comparison analysis of locus of control revealed HMII patients showed a 
significant increase in their ―God‖ locus of control and a significant increase for the 
internal locus of control for TAH patients.  TAH patients had more inpatient days than 
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the HMII patients and spent more time alone due to limited mobility when attached to the 
pump.  Many TAH families lived over an hour away from the hospital, contributing to 
the time spent alone.  TAH patients that were changed over to the freedom driver may 
have isolated themselves, possibly due to the risk of getting sick, the stigma associated 
with wearing the device in public, and the noise that the mechanical device makes.  
 Various coping models show that differences in personality (coping strategies, 
locus of control and personal meaning of condition) influence how patients cognitively 
appraise and adapt to illness.  The adaptation process is dynamic and multidimensional. 
Cognitive appraisal, influenced by the social and physical context of the relationships 
between the individuals and the disease, family members and caregivers, social network 
and other forms of support helps, patients assess what is needed to cope with their health 
condition. Hospital chaplains may help to mediate this dynamic process through presence 
and directed interventions that provide comfort and reassurance.   
 There were positive correlations between emotion-focused coping and treatment 
satisfaction (doctors‘ explanations, comprehensive care, technical quality, and 
recommend again).  The correlation coefficients and variances were high medium to 
large.  These patients reached out to others for support and for different perspectives. 
They were able to express their negative feelings and tried to find comfort in their 
religion or beliefs through prayer and meditation. These patients also were satisfied with 
the care received from their treatment team and would recommend their team to others.  
 There were positive relationships between problem-focused coping and treatment 
satisfaction.  These patients concentrated their efforts on doing something about their 
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situation, took action by trying to make their situation better, and tried to come up with 
strategies to change their situation.  These same patients also found satisfaction when 
they were able to be in dialogue with their treatment team about their healthcare and were 
satisfied with their overall treatment experience.  
 There was an unexpected positive relationship between dysfunctional coping and 
treatment satisfaction (overall experience).  Dysfunctional coping was reflected by denial, 
substance use or abuse, and avoidance behaviors.  One possible explanation may be that 
some patients find comfort in negative experiences.  An assessment of maladaptive 
coping behaviors may signal that the patient may need more assistance from the team 
psychologist.  Dysfunctional coping may also be due to chance or sampling error.   
 Comparison analyses for the CSM variables (all devices) revealed an increase in 
mean scores except for emotion-focused coping, problem-focused coping, dysfunctional 
coping and maladaptive coping, which decreased.  Significance was found for an 
increased adaptive coping (looked for a stronger connection with ―God‖, sought ―Gods‖ 
love and care, sought help from ―God‖ in letting go of anger, tried to put plans into action 
together with ―God‖, tried to see how ―God‖ might be trying to strengthen in this 
situation, asked for forgiveness of sins, and focused on religion to stop worrying about 
problems). 
 HMII mean scores increased for all coping style and method variables except 
problem-focused coping. Significance was found for an increased adaptive coping and 
―God‖ locus of control.  TAH mean scores increased for all coping style and method 
variables except emotion-focused, problem-focused, ―God" locus of control.  
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Significance was found for an increased internal locus of control for the TAH.  The one 
patient who received both devices had a decreased problem-focused coping.  Internal and 
―God‖ focused control were tied.  HMII patients coped by looking for ―God‘s‖ comfort 
and care and TAH patients increased their internal locus of control.  Problem-focused 
control decreased for HMII patients and the patient with both devices.  Adaptive coping  
and God locus of control were significant for HMII patients and TAH patient showed 
significance for internal locus of control.  Further study by device type is needed as 
discussed earlier. 
 Interviews with the study patients revealed goal setting decreased their level of 
anxiety by providing a structure for tasks.  The multi-disciplinary staff provided MCS 
education and set goals for discharge in collaboration with the patients and their families. 
Patients were able to discuss with close family members how to take care of the MCS 
device as well as plan for discharge and follow-up with the treatment staff.  Spiritual and 
emotional support was also provided to patients and their families.  Patients may find 
some benefit from directed spiritual tasks alongside the multi-disciplinary goal planning.   
 Negative significance was found for maladaptive coping and treatment 
satisfaction. The correlation and variance was medium and represented a possible 
predictive influence.  Patients who ―questioned ―God‘s‖ love wondered what they did for 
―God‖ to punish them, and questioned ―God‘s‖ love, were less likely to recommend the 
treatment team again.  Again, patients relate their feelings about ―God‘s‖ care for them 
with the treatment team. 
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 Significance was found for social family support and treatment satisfaction. A 
large correlation coefficient and variance demonstrated a strong predictive influence.  
Social and family support (I feel close to my friends, I get emotional support from my 
family, I get support from my family and friends, my family has accepted my illness, I 
am satisfied with family communication about my illness, I feel close to my partner or 
main support person, and, I am satisfied with my sex life) significantly increased post 
MCS.  Patients may see their opportunities with the doctors to dialogue about their illness 
and social and family support as the same.  
 The MCS program requires good social support before acceptance into the 
program.  The process is stressful for the patients and their families and conversation 
with the doctors and others on the treatment is ongoing throughout the assessment 
process. Patients are encouraged to engage their family members and support network 
early in the process.  A TAH patient commented ―I didn‘t realize how much other people 
love me.  My spouse is a saint.‖ Therefore offering emotional and spiritual support to the 
family is imperative.  Spiritual care providers can help to facilitate bonding and reflection 
opportunities through familiar rituals and practices (Gall, Charbonneau, & Clarke, 2005) 
with patients and their families.  
Coping Styles and Methods and Spiritual Well-Being 
 There was an unexpected negative relationship between problem-focused control 
and meaning and peace. This may be related to the uncontrollable aspects of living with 
the MCS as some patients stated they felt ―tethered‖ to the machine.  A TAH patient 
commented ―I was struggling because I didn‘t understand why God would let this happen 
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to me. I believe God had me arrested for a season so I‘m listening to his voice for my 
next assignment.‖  This patient suggested he found peace by listening for the voice of 
―God.‖ 
 There was a positive relationship between external locus of control and the role of 
faith.  One of the statements on the role of faith questionnaire was ―whatever happens 
with my illness, things will be okay.‖  Patients may benefit from support through the use 
of faith rituals and practices and in being in community with others. 
 There was a negative relationship between a ―God‖ locus of control, social family 
support and relational connectedness post MCS.  This unexpected negative relationship 
might suggest the patients‘ relationships with ―God‖ or ―family‖ may be strained.  
Patients may be disappointed if their recovery from the MCS surgery was not as fast as 
they desired.  Complications and the unpredictable nature of recovery may also frustrate 
the patients‘ family members.  Support to the patient and the family while the patient is in 
the hospital in collaboration with the multidisciplinary team may decrease anxiety and 
lessen strain.   A spiritual assessment may discover misinterpretations about ―God‖ or 
maladaptive uses of ―God‖ as a coping resource.    
Coping Styles and Methods and Religious Well-Being 
 There was a negative relationship between maladaptive coping and religious 
comfort. Although most patients reported a low score on the maladaptive coping scale 
and higher on the religious comfort, some reported trouble trusting ―God‖ to help them 
get well.  One patient related this struggle to a decreased level of support from the 
community of faith.  It appears patients‘ disappointment in the church congregation also 
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affected beliefs about ―God‘s‖ help.  One patient stated the sickness was punishment 
from ―God‖ because of past behaviors (non health and health-related) and expressed a 
need to talk about the past to seek reassurance of  forgiveness.  Supportive conversations 
that allow patients to express current and past loss and grief as well as other expectations 
may prove helpful to prevent maladaptive religious coping.  Reinforcement of positive 
coping strategies may build the needed resilience for living with the MCS device and 
future surgeries.   
 It is important to note that patients who have positive images of ―God‖ or ―a 
transcendent other‖ might find relief in seeking forgiveness for past behaviors.  If the 
patients‘ image of ―God‖ is negative, acceptance of comfort and forgiveness may be hard 
to receive.  Spiritual care interventions might assist with acknowledging the patients‘ 
concerns, identifying any maladaptive beliefs and providing a spiritual framework for 
working through feelings of loss.   
Change in HRQOL 
 A significant increase in mean scores was found for functional quality of life and 
is probably the most obvious benefit from an MCS device implant (Grady, et al., 2003).  
Interestingly, both HM and TAH patients show an increase in functional quality of life 
post device implant.  Also interesting is the means scores of TAH patients decreased on 
all of the other variables, but increased in functional quality of life. As mentioned earlier 
functional quality of life reflects patients being able to enjoy life, sleep well, work (home 
or work) and being content with their current functional quality of life during the illness 
experience.  
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Practical Implications 
 The practical implications for this study are the potential benefits for the 
patients and their families when they are able to receive support that helps them cope.  
Challenges in the recovery process include long hospital stays that potentially create 
opportunities for the display of maladaptive or dysfunctional behavior.  Patients who are 
able to cope in situations outside of the hospital may not have or be able to use the same 
kinds of coping strategies to relieve stress.  Sometimes family dynamics and other 
stressors play out at the bedside; leaving little room for escape.  Patients can engage with 
the treatment team to gather information that empowers them to learn new ways to 
spiritually and emotionally cope with the MCS.   
Tix and Frazier (1998) suggest religious and spiritual coping works through three 
general pathways: a framework of beliefs that facilitate cognitive restructuring of the 
meaning of the event, the social support of the religious community, and a sense of 
control over the stressful episode.  Sulmasys‘ modified biopsychosocial model of care 
(See Figure 6) provides the framework for a comprehensive assessment (Sulmasy, 2002) 
along with the Guidelines for HF and HF Therapy Spiritual Care (Appendix F)  
The spiritual provider can design patient-centered and patient directed support 
models that strengthen and build resilience. Evidence-based spiritual care plans can be 
incorporated into the overall treatment plan in a collaborative effort that improves MCS 
health outcomes.  The healthcare system  also may benefit from improved  administrative 
goals such as reducing the length of hospital stay days and readmission rates. 
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A spiritual assessment taken early in the MCS process may benefit patients and 
their families through the appropriate allocation of healthcare resources, in particular 
spiritual care services with hospital chaplains as well as generate referrals to other 
healthcare team members when necessary.  Other members of the multidisciplinary team 
simultaneously make their assessments according to their specific disciplines. 
The initial spiritual assessment can provide baseline data to measure 
improvement.  Assessments allow for the design of spiritual and emotional interventions. 
Interventions might include educative counseling (creative education and dynamic 
counseling).  The goal of educative counseling is to  (1) identify the concepts, values, 
beliefs, skills guidance or advice needed by the patient, (2) communicate these to the 
patient, (3) help the patient utilize the information to understand their situation, make 
wise decisions, or handle problems in a constructive manner (Clinebell, 1984).  Rituals 
and faith practices can also be supportive if patients have used them in the past. 
Reframing (seeing the situation in a different light) and meaning-making activities 
(journaling, writing and other creative activities) are often used to help patients process 
their illness experience. Collaborative goal setting is one way of constructively engaging 
the patient, family and treatment team for a successful MCS outcome.   
Limitations 
Internal Validity 
 Internal validity is dependent on the research design, the sample, the variables 
used, and the statistical method.  The study was a purposive study and not randomized.   
The nature of the repeated measures design produced exposure and testing effects since 
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patients were able to answer the survey questions more than once. Repeated measures 
designs are also threatened by the patient‘s mortality or through attrition.  One patient 
died after consent and one other patient died before being approached for consent. 
Patients may not be able to complete the self-administered surveys because they become 
―too sick‖ or ―too tired‖ to complete the self-administered surveys or they may die 
reducing the sample size. Low sample sizes and nonparametric statistical analysis may 
decrease the power of the study.  Missing from this study is the descriptive information 
about the patients who did not participate.  The patients who were able to participate were 
male, with a higher level of education and married (Table 12). 
 Selection bias could be a potential threat.  Patients electing to receive MCS may 
infer different assumptions about the definition of quality of life with MCS from patients 
who decline the offer of MCS to wait for a heart transplant (HT) or choose palliative care 
and eventually hospice.  Not included in this study are patients in the end-stage of heart 
failure (HF) who are not eligible for HT or MCS. A future study might compare the MCS 
patient group with those patients who decide not to receive the device. 
   Data collection was through the use of self-report data and semi-structured 
interviews.  Self-report data was subject to response bias.  Participants completed two 
surveys at two different points in time and may have experienced poor recall, poor 
comprehension of the questions being asked and may have been influenced by social 
desirability.  Hospital chaplains potentially invoke positive responses because of the 
profession. 
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 Other variables may have affected participant response. Competing events 
(history threats) in the patients‘ life and interventions by multiple hospital chaplains, 
outside clergy and spiritual support and other healthcare team members may have 
influenced the quality of life outcomes.     
 Another limitation to this study involved construct validity.  Latent variables such 
as well-being and quality of life are abstract and not directly measured, but inferred from 
other observed variables. Previously defined constructs were used but were subject to 
response bias.  Another threat to internal validity is measurement.  Latent variables must 
be inferred by using a priori knowledge and clear definitions.  Spiritual well-being and 
religious well-being are subjective in nature and definition.   
 Placebo effects from spiritual and religious care visits are confounders that may 
influence bias into the self-administered survey results. Patients who use spirituality or 
religion might exhibit some spiritual growth as they struggle with emotions during the 
MCS process.  Survey data captured the associations, but more information is needed to 
fully understand the process of coping with this patient population. 
External Validity 
 Threats to external validity might be the generalizability of this study in non-
urban, non-teaching and non-government hospitals.  This study used two sites with 
different referral systems for MCS.  Site one is an urban teaching hospital and receives 
referrals from the inpatient population and from community physicians.  Site two is a 
veterans‘ hospital and receives referrals from all over the United States.  The cardiac 
surgeons perform surgery at both sites and could potentially cross-contaminate the 
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results. One hospital has a special unit for this patient population, the other does not.  One  
performs all of the TAHs surgery.  All of the patients in this study were implanted at the 
same site,  although two patients were from the Veterans facility. Future studies with a 
larger sample size may provide additional information by comparing these two sites and 
then expanding to other sites with a diverse age, gender, racial and ethnic population, and 
socioeconomic population.  
Statistical Validity. 
 Small samples sizes with repeated measures on multiple and similar variables 
increase the risk of producing Type I errors.  Family wise error rates are displayed in the 
Appendices G, H, I, J, K and L.  The Bonferroni procedure would decrease the risk of 
Type I errors by reducing the ―p‖ value, but would also increase the Type II error rate.    
The Bonferroni procedure was not used in this preliminary study and instead the analysis 
relied on a priori knowledge and nonparametric testing with ―exact tests.‖ Although the 
significant results  were presented as revealed, conservative interpretations will lead 
towards cautious future application.  Future studies will benefit from a larger sample size 
and cross-validation techniques.  After splitting the sample, into two parts, cross-
validation runs statistical techniques on each part to determine if both parts report 
significance.  If so, the significance  may not be due to chance (Warner, 2008).  
 Providing support to the MCS patient population dictates a need for evidence-
based support therefore the ―p – level‖ will remain at .05 and the study results will be 
interpreted recognizing the potential for Type I and Type II errors.  Post hoc analyses will 
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be used to determine the future use of current study variables or other variables of interest 
for this patient population.    
 Nonparametric tests are prone to Type II errors.  A priori knowledge and using 
the most robust statistical tests were used to calculate the test statistics and ―p-values.‖    
IBM SPSS 19 with the module for ―exact tests‖ was used to calculate the statistics and 
‗p-values.  
Conclusions 
 The results of this study, which support the existing literature that shows spiritual 
and religious well-being and coping impact health-related quality of life,  and may inform 
the future development of interdisciplinary plans of spiritual and emotional care for this 
patient population and for other chronic illness populations. Patients on mechanical 
circulatory support used meaning and peace, role of faith and connection to others, 
―God,‖ and themselves as a way to cope with their illness.  Patients who looked for a 
connection with ―God,‖ sought ―God‘s‖ love and care, sought ―God‘s‖ help, and put their 
plans into action together with ―God‖ had an improved emotional, physical and 
functional quality of life.  Patients cope in many ways and there was a balance between 
emotion-focused and problem focused coping and treatment satisfaction through 
engagement with the doctors and the treatment team.  The patients may have 
interchanged their understanding of social and family support with treatment team 
support and ―Gods‖ protection and care. 
 The TAH patients mean scores decreased for spiritual well-being and religious 
well-being while religious strain increased indicating some spiritual distress. The internal 
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locus of control for TAH patients increased significantly from pre to post MCS; further 
study with this patient population may provide a deeper understanding of coping, more 
specifically locus of control.  HMII patients had significant increases in adaptive coping 
and ―God‖ locus of control.  Early spiritual assessment with MCS patients can screen for 
maladaptive and dysfunctional coping and provide an opportunity to support them 
through the MCS process.  Spiritual care providers who are knowledgeable about the 
MCS assessment, implantation, and the recovery process can provide interventions to 
patients that encourage interdependence between themselves, others, and ―God.‖ These 
interventions could build resilience and mediate improved outcomes through supportive 
and directed counseling. 
 The results of this study inform the future development of interdisciplinary plans 
of spiritual and emotional care for this patient population and for other chronic illness 
populations. Further examination may reveal how SWB, RWB and CSM improve 
HRQOL as well as highlight the unique support needs of HMII and TAH patients.   
Areas for Future Research 
 This study provided an initial framework for studying the influences of spiritual 
and religious well-being and coping on health-related quality of life. The study results 
had medium to high correlations and variances.  However, the results were not able to 
conclusively explain all of the variance in each correlation due to the small sample size 
and high risk for Type I errors.  Future studies with an increased sample size and a more 
robust multivariate statistical test may provide more reliable results.  Future studies with 
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clinical, physical, and neurological variables may provide additional quantitative 
evidence for a mixed method study.  
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Appendix A 
 
Conceptual Definitions 
 
In order to support an understanding of the current research and the conceptual literature 
that focuses on spiritual, religious coping and well-being, a list of the key terms with 
definitions follow. 
 
Heart Failure Patient: Heart failure is diagnosed when the heart can no longer pump 
sufficient amounts of blood needed to carry oxygen throughout the body. 
 
Health-Related Quality of Life: Quality of life (QOL) is the degree of well-being (WB) 
felt by an individual or group of people. The World Health Organization (WHO) defines 
health as being ―a complete state of physical and mental WB and not merely the absence 
of disease or infirmity.‖ QOL is the individuals‘ perception in the context of culture; the 
value system lived in and in relation to their goals, expectations, standards, and concerns. 
Health-related quality-of-life (HRQOL) is QOL as it pertains to health status and is 
determined by the patients‘ perception of their health status. 
 
Heart Transplant Candidate: A patient who has been placed on a heart transplant (HT) 
waiting list. 
 
Heart Transplant Patient: A patient who has received a donor heart. 
 
Mechanical Circulatory Support Candidate: A patient with end-stage heart failure 
(ESHF) who may not survive until a donor heart becomes available for a HT. This patient 
may or may not be a HT candidate. The patient is evaluated by a multidisciplinary health 
care team using medical, psychosocial and financial criteria. 
 
Mechanical Circulatory Support Patient: A patient who has a mechanical circulatory 
support (MCS) device (left ventricular support device LVAD or total artificial 
heart/TAH).  
 
Religious Well-Being (RWB):  Religion or  religiosity is the search for significance as 
found in ways related to the sacred and may be exhibited as membership in organized 
religion, practice of sacraments and rituals, and obedience to creeds and doctrines. 
Positive images of ―God‖ may contribute to WB and negative images may induce stress 
and strain. 
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Spiritual Well-Being (SWB): Spirituality pertains to the inner resources of an individual. 
It includes the ultimate concern and basic values around which all other values are 
focused. These values guide how individuals think, feel, act, or interrelate with and 
transform the sacred in their lives. Spirituality is an awareness of the inner resources and 
strengths that facilitate peace and meaning. Components of SWB are overall positive 
affect and low negative affect with life, and work satisfaction, alienation from the world, 
self, and others. Spirituality consists of cognitive, emotional, and behavioral components 
that contribute to defining the way a patient experiences life. 
 
Well-being (WB): is rooted in moral philosophy, utilitarianism, and ethics and is the state 
of being happy, healthy or prosperous. Some components of WB are physiological, 
psychological, mental/cognitive functional, emotional, spiritual, religious, cultural, social 
and economic. 
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Appendix B  
 
Descriptive Variable Definitions and Measurement Instruments 
 
 
 
Advanced directive/living will completed: The patients‘ living will status. 
 
Age: The patients‘ self-identified age. 
 
Distance lived from hospital: The number of miles lived from the VCU Health System 
 
Education level: The patients‘ level of education 
 
Gender: The patients‘ self-identified gender 
 
Heart Failure Etiology: The cause of the patients‘ HF 
 
Heart Transplant (Y/N): Has the patient received a heart transplant? 
 
Hospital admission previous 60 days/6 months: The number of hospital admissions in  
the previous 6 months before the MCS implant. 
 
Hospital inpatient days previous 60 days/6 months: The number of hospital inpatient  
days in the previous 6 months before MCS implant. 
  
Length of illness prior to MCS implant: The number of months since the patients‘ initial 
HF diagnosis  
 
Marital Status: The patients‘ self-identified marital status 
 
MCS device type: Heartmate II or TAH.  
 
Palliative Care (Y/N): Is  the patient receiving palliative care?  
 
Race/ethnicity: The patients self-identified race or ethnicity. 
 
Socioeconomic level (Income): The patients‘ income level. 
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Well-Being Variable Definitions and Measurement Instruments 
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Appendix C 
 
Well-Being Variable Definitions and Measurement Instruments 
 
Religious well-being ( Religious Well-being overall/ RWB, Religious comfort/RC,strain 
or distress/RS) – See Appendix P): A twenty item self-administered survey that measures 
religious comfort (source of comfort, solace and guidance) and strain (alienation from 
God, fear and guilt, religious rifts).. The survey  takes approximately 5-7 minutes to 
complete. The total score and subscales scores have good internal consistency reliability 
(Cronbachs‘ alphas from .83 to 87) for religious comfort and religious strain (Cronbach 
alphas from .67- 71) (Exline,Yali and Sanderson, 2000) Computing overall RWB score 
requires reverse scoring the religious strain items.   
 
Spiritual well-being (Facit-sp Ex- SWB overall/ SWB, meaning peace/MP, role of faith in 
illness/ROF, relational connectedness/RLC - See Appendix O ): A 23 item self-
administered survey that  measures the sense of meaning and peace  with the  illness 
experience, the role that faith plays in coping with the illness and how connected the 
patient is to others and ―God.‖ The survey takes approximately 5-10 minutes to complete. 
This instrument has been well validated (Brady et al., 1999). The total score and 
subscales scores have good internal consistency reliability (Cronbachs‘ alphas from .72 to 
85) (Brady, Peterman and Fitchett, et al., 1999; Cella, Tulsky and Gray, et al., 
1993;Facit.org).  Items # 4 and 8 are reverse scored.  
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Appendix D 
 
Coping Variable Definitions and Measurement Instruments 
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Appendix D 
 
Coping Variable Definitions and Measurement Instruments 
 
Coping Style/Method (Brief Cope – emotion focused/BCOPE EF, problem 
focused/BCOPE EF dysfunctional coping/BCOPE /DF – See Appendix Q ):  A 28 item 
self-administered survey  with three subscales (EM, PF and DF) that measures  the 
coping style or method used by patients  when dealing with stress.  The  survey takes 
approximately 10-15 minutes to complete. This instrument has been well validated. 
Internal consistencies reliability for EF, PF and DF are .72, .84 and 75.  Test-retest 
reliability for over a year has been demonstrated at r=.58, r=.72 and r=.68 (Cooper, 
Katona and Livingston, 2008). 
 
Brief Cope Emotion focus 
Use of emotional support, items 5 and 15        emotion 
Use of religion, items 22 and 27     emotion 
Use of instrumental support, items 10 and 23  emotion 
Positive reframing, items 12 and 17                 emotion 
Acceptance, items 20 and 24      emotion 
 
Brief Cope Problem focus 
Active coping, items 2 and 7                           problem  
Planning, items 14 and 25                       problem 
 
Dysfunctional focus 
Self-distraction, items 1 and 19                        dysfunctional 
Denial, items 3 and 8                                        dysfunctional 
Substance use, items 4 and 11       dysfunctional 
Behavioral disengagement, items 6 and 16     dysfunctional 
Venting, items 9 and 21                                    dysfunctional 
Humor, items 18 and 28      dysfunctional 
Self-blame, items 13 and 26      dysfunctional 
 
Coping Style Religious: 
Religious well-being (Brief RCope – adaptive/BRCope AD, maladaptive/BRCope M See 
Appendix R):  A fourteen item self-administered survey with two subscales (AD, M) that 
measures the positive and negative effects of religion and spiritual coping with life 
stressors.  The survey takes approximately 3-5 minutes to complete.  The longer version of 
this form (RCope) has good internal consistency reliability (Cronbachs‘ alpha for maladaptive 
coping .78-.92 and for adaptive coping .61-.93).  Although the Brief RCope (items that loaded 
the highest on the RCope) has not been tested as extensively as the longer version, it has 
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shown evidence of internal consistency, criterion-related validity and incremental validity in 2 
diverse samples. (Pargament, Fetzer Institute/National Institute on Aging Workgroup, 
1999, 2003; Pargament, Koenig and Perez, 2000).  
Locus of Control Scale-Form C with God Locus of Control (LOC – Internal/ LOC I, 
External/LOC E, God/LOC G – See Appendix S):  A 24 item self-administered survey 
with three subscales (I, E, G) that measures beliefs about who has control over the 
patients‘ health status. The survey takes approximately 8-10 minutes to complete. The 
development of the LOC is based on the social learning theory of general expectancy 
(Rotter, 1954) and is used to predict health behavior.  
 
Faith tradition(initial intake form/interview): Self-report by patient for religion or faith 
denomination 
 
Faith community membership (initial intake form/interview): Self-report by patient for 
membership in a faith community. 
  
Faith rituals and practices(initial intake form/interview): Self-report by patient for 
regular faith rituals and practices usually within a community of faith, but may  also be 
practiced at alone.. 
 
Faith visitations (chaplains, outside clergy/faith leaders, community of  
faith)(initial intake form/interview: Self-report by patient and extracted from the  
hospital information system for visits from the faith community or hospital chaplains. 
  
Social/Family Support (Fact-G- social family/SF See Appendix T ):  A seven item self-
administered survey that measures patient satisfaction with family support.  The survey 
takes approximately 2minutes to complete. The subscale score has good internal 
consistency reliability (Cronbachs‘ alphas from .68 to .78) (Cella, Hahn and Dineen, 
2001; Cella, Tulsky and Gray, et al., 1993; Facit.org). 
 
Having a confidante (initial intake form/interview): Self-report by the patient that there is 
a person to confide in. 
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Appendix E 
 
Health-Related Quality of Life Variable Definitions and Measurement Instruments 
 
Physical well-being/QOL (Fac t G- HRQOL P - See Appendix T): A seven item self-
administered survey that measures the patient‘s perception of their physical ability during 
illness experience and response to treatment.  The urvey takes approximately 2 minutes to 
complete. This instrument has been well validated. The subscale score has good internal 
consistency reliability (Cronbachs‘ alphas from .68 to .78) (Cella, Hahn and Dineen, 
2001; Cella, Tulsky and Gray, et al., 1993; Facit.org). The scale has to be reverse scored.  
 
Functional well-being/QOL (Fact G –HRQOL  F See Appendix T):A seven item self-
administered survey that measures the patient‘s ability to function at work or home, enjoy 
life and accept their illness.  The survey takes approximately 2 minutes to complete. This 
instrument has been well validated. The subscale score has good internal consistency 
reliability (Cronbachs‘ alphas from .80 to .84) (Cella, Hahn and Dineen, 2001; Cella, 
Tulsky and Gray, et al., 1993; Facit.org). 
 
Emotional well-being/QOL (Fact G – HRQOL E – See Appendix T): A six item self- 
administered survey that measures the patient‘s emotional state during illness and 
treatment.   with a 6 items self-administered survey that takes approximately 2 minutes to 
complete. This instrument has been well validated.  The subscale score has good internal 
consistency reliability (Cronbachs‘ alphas from .74 to .82) (Cella, Hahn and Dineen, 
2001; Cella, Tulsky and Gray, et al., 1993; Facit.org).  The scale must be reverse scored. 
 
SO Spiritual Outcomes (Cerner Appendix N and final interview Appendix U):  Self-report 
by the patient on the initial intake and final interview form. (enhanced coping, 
faith/courage, hope, belief system, connection with higher power, connection with 
relationships, sense of self, sense of meaning, sense of vocation, reconciliation with self, 
situational reinterpretation, advance directives completed, patient spiritual and emotional 
condition unchanged after spiritual encounter. 
 
 Survival days Post MCS implant-MCS- SD : The number of days lived post 
MCS implant. 
 
Number of days to Discharge Home post MCS implant MCS-DD: The number of days 
from MCS implant to discharge home. 
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Number of readmission days after discharge post MCS imlant MCS-RD: 
The number of inpatient days after the patient is readmitted to the hospital. 
Inpatient days post MCS implant MCS-ID: The number of inpatient days overall post 
MCS implant (including readmission days). 
 
Number of readmission times post MCS implant MCS-RT: The number of times the 
patient is readmitted after discharge post MCS implant.  
 
PTS Patient treatment satisfaction (Fact-PTS –  Explanation from the doctors/ 
PTS-E, Interpersonal Relationship with the doctors/PTS-I, Comprehensive care from the 
treatment team/ PTS-CC, Technical Quality of the treatment team/ PTS-TQ, Patient  
satisfaction with the level of involvement in the  decision making process/PTS-DM, 
Nurses Care/ PTS-N, Trust in the treatment team/PTS-T, Recommend the treatment team 
to others/PTS-R,  Would choose treatment team again/PTS-CA, Overall experience with 
the healthcare provided/PTS-OE - See Appendix V): a 33 item self-administered survey 
that measures the patient‘s perceptions about the quality of the healthcare services 
received.  The survey takes approximately 15-20 minutes to complete. The scale has 
good internal consistency reliability (total score and subscale scores Cronbachs‘ alphas 
from .71 to .90) (Facit.org). 
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Appendix F 
 
Spiritual Pathway/Guideline for Advanced Heart Failure 
Chaplain Angela Duncan for VCU Pauley Center 
Adapted from Cerner Spiritual Assessment Inventory 
 
 
 
Definition for Spiritual Pathway: ―A descriptive set of indicators of what may be 
happening to a person spiritually in the midst of a particular life predicament and some 
suggested ways of optimally assisting that person‖ (Hilsman) 
 
A spiritual pathway includes naming the event, identified with a set of indicators, an 
assessment, actions/interventions that include a plan of care and outcomes and a rationale 
 
Advanced heart failure and MCS patients experience: unpredictability due to the illness 
to death trajectory—multiple exacerbations with positive outcomes, longer hospital 
admissions, multiple readmissions, long term admissions awaiting heart transplant, with 
mechanical circulatory assist devices (Artificial Hearts, LVAD‘s), infections, tiredness, 
fluid overload, home on drips, negative self image, Firing of ICD‘s, Guilt from negative 
lifestyle, Anxiety and Guilt waiting for donor heart, gratitude and desire to contact donor 
family. 
 
Why the need for a Spiritual Pathway? (Hilsman, 1998; Wintz, 2004) 
 
• Articulates the work of pastoral care 
• Provides a designated place in the plan of care 
• Provides concentrated focused efforts for care which increase effectiveness and 
efficacy 
• Acknowledges the importance of spirituality and treatment plans for the ―whole 
person‖ using a patient centered model of care 
• Can be used as a teaching tool for staff about spiritual issues and contribution of 
pastoral care staff to Heart Center patients 
• Can be used as a teaching tool to other pastoral care providers who provide 
support to Heart Center patients 
• Helps to demonstrate outcomes  
• To other members of the interdisciplinary team 
• Provides rationale for inclusion of professional spiritual care 
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This process is dynamic and unique for each case and is used only to provide direction in 
spiritual and emotional care.  Assessment should be done often due to patient‘s values 
changing over time affected by quality of life and course of disease 
Elements of a patient centered model of care for advanced heart failure  - (Albert, Davis 
and Young, 2002) 
 
Effective Symptom Management 
 Bedside presence by physicians and other essential healthcare providers 
 Clear communication about the current condition 
 Autonomy preservation; control 
 Avoidance of prolonged suffering/dying or bridge to transplant and heart 
transplant 
 Minimization of family burden 
 Strengthening of relationships with significant others 
 Addressing spirituality issues 
 Discussion of the site of death 
 Terminal sedation, if necessary 
 
Some Basic Spiritual and Emotional Needs 
• Search for meaning and purpose 
• Value and Dignity 
• Relationship 
• Reconciliation 
• Hope 
• Alleviation of loneliness 
• Transcendence 
• Desire to maintain religious/spiritual practices 
• Feel presence of God/higher power 
• Autonomy and Control 
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Possible Triggers or Critical Events 
• New/Readmission Team C/Advanced Heart failure inpatient admission (Main  
10E, Main 10W, CICU, CSICU) 
• Team C Patient Service( Pre and Post Procedures, Surgeries) 
• New diagnosis, multiple diagnosis, additional problems encountered 
• Critical Conversations 
• Change in plan of care  
• Evaluations for (LVAD, Artificial Heart, Heart Transplant) 
• Home on a dobutamine drip or other drips 
• Lengthy hospital stay, multiple readmissions  
• Negative outcomes for intervention and treatment (heart transplant rejection, 
MCS rejection - LVAD, artificial heart, ICD)  
• New/additional procedures/interventions (BiV, ICD, Pacemaker)  
• Grave prognosis  
• LVAD, Artificial Heart, Heart Transplant are not options 
• Transition from life sustaining procedures to comfort care 
• Deactivation of ICD 
• End of Life Planning 
• Class III or Class IV Heart Failure 
• Loss/Grief Issues (especially within the previous year) 
• Family Issues 
 
INDICATORS 
How has illness affected the following? Look for signs of spiritual pain/spiritual distress. 
What are issues? 
 
Indicators   Description 
Shock/Denial: 
 Initial diagnoses – this can‘t be happening to me. 
 God will fix this, cure/heal this 
 Multiple exacerbations with recovery and then imminent death – we‘ve beaten this 
before 
 No association of past/current negative lifestyle choices with health outcomes 
 I don‘t know what I am going to do 
 Little or no communication 
 Uncertainty about future-What happens to me now and to my family, job, finances, 
role social life, leisure activities, abilities       
 Concern about death/afterlife. Will I die? 
 What do I believe about death, afterlife?  
 Unresolved issues in life 
Grief/Loss:   
 Unresolved, Anticipatory, Complicated function, abilities - inability to do the things 
that they used to do before 
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 Don‘t feel well 
 Role loss 
 Job, lack of finances 
 Responsibilities 
 Insurance 
 Friends/family/other family members with same illness 
 Leisure/pleasure activities 
Burden to Others:  
 Need for assistance from others 
 Help with taking meds, infusion pumps 
Self Image:   
 Sick role, puffiness, bloatedness, weight gain, other losses 
 Infusion pump, LVAD, Artificial Heart, Heart Transplant 
 Sex and Intimacy issues 
Helplessness/Powerlessness:   
 Activities of Daily Living 
 Driving 
 Too tired, don‘t‘ feel good 
Hopelessness:  
 Family members have died with this? 
 It‘s gone too far 
Loss of Motivation:  
• Nothing seems to help 
• I can‘t beat this   
• Lethargy 
Fear/Panic/Anxiety:  
 ICD Firing 
 Sudden Death 
 Upcoming Surgeries and procedures 
Hope:    
 Cure/Healing ―I will beat this‖ 
 Redefining healing 
 I‘ve beaten this before 
 When illness is prolonged or death is imminent what other things can the 
patient/family hope for? 
Feelings of Abandonment:   
 Family 
 Friends 
 God – disconnection from higher power, where is God? 
Isolation/Loneliness:  
 Family works or lives far away and can‘t visit 
 Other family needs distract away from the patient 
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Guilt:   
 Referenced/Undifferentiated 
 Past health abuses 
 Not taking care of self – diet, exercise 
 Drugs, alcohol 
 Punishment for sins 
Resignation:   
 God‘s will be done 
Anger:   
 God allowed this 
 System didn‘t give me what I need  (transplant list,  
 more surgery, all my life nothing has worked for me) 
 
Need for Comfort/Pain control/Support: 
 Feeling ―heard‖ 
 Patient involved in the plan of care 
Conflict:   
 Healthcare Team – over plan of care 
 Family  
 Other Support 
 Religious Beliefs  
Ethical dilemma:  
 Treatment or Withdrawal Issues 
 Advanced stages of heart disease – LVAD, Artificial  
 Heart, Heart Transplant 
 Futility of Care  
Cultural Challenges:  
 Lack of family support due to distance/loneliness and isolation 
 Language Barriers 
 Different meaning of illness to patient than healthcare team 
 Different expectations 
 Different manifestation of spiritual and emotional distress 
 Inability to practice rituals common to culture 
 Non traditional configurations of family 
Gender Issues: 
 Sexuality 
 Role reversal/role conflict 
Loss of Meaning/Purpose:  
 Lack of vocation due to illness   
 What/Why am I here? 
 How can I be a productive citizen? 
Values Clarification:  
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 What‘s important to me? 
 How does my value relate to my productivity, independence, appearance? 
Bereavement:  
 Death in family 
 Imminent death 
Unable to assess:   
 Patient intubated, sleepy, not present at this time   
Other Spiritual needs:  Distress, pain is dynamic as it relates to: 
 Finances/Employment 
 Housing 
 Care after return home 
 Relationships 
 Skilled Nursing Facility 
 Home Health Care 
 Palliative Care 
 Hospice 
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Appendix G 
 
Hypotheses Grid for SWB RWB and HRQOL 
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Appendix G 
 
Hypotheses Grid for SWB RWB and HRQOL 
 
 
Correlation Analyses for SWB and HRQOL and  RWB and HRQOL 
Research Question # 1 and  # 2 
 SWB 
 
SWB 
MP 
 
SWB 
ROF 
 
SWB 
RLC 
 
RWB 
 
RWB 
RC 
 
RWB 
RS 
 
HRQOL  
P 
1-a1 1-b1 1-c1 1-d1 2-a1 2-b1 2-c1 
HRQOL 
F 
1-a2 1-b2 1-c2 1-d2 2-a2 2-b2 2-c2 
HRQOL 
E 
1-a3 1-b3 1-c3 1-d3 2-a3 2-b3 2-c3 
MCS 
DD 
1-a4 1-b4 1-c4 1-d4 2-a4 2-b4 2-c4 
MCS 
 RD 
1-a5 1-b5 1-c5 1-d5 2-a5 2-b5 2-c5 
MCS  
ID  
1-a6 1-b6 1-c6 1-d6 2-a6 2-b6 2-c6 
PTS  
E 
1-a7 1-b7 1-c7 1-d7 2-a7 2-b7 2-c7 
PTS  
I 
1-a8 1-b8 1-c8 1-d8 2-a8 2-b8 2-c8 
PTS  
CC 
1-a9 1-b9 1-c9 1-d9 2-a9 2-b9 2-c9 
PTS  
TQ 
1-a10 1-b10 1-c10 1-d10 2-a10 2-b10 2-c10 
PTS  
DM 
1-a11 1-b11 1-c11 1-d11 2-a11 2-b11 2-c11 
PTS 
Nurses 
1-a12 1-b12 1-c12 1-d12 2-a12 2-b12 2-c12 
PTS 
Trust 
1-a13 1-b13 1-c13 1-d13 2-a13 2-b13 2-c13 
PTS  
R 
1-a14 1-b14 1-c14 1-d14 2-a14 2-b14 2-c14 
PTS  
CA 
1-a15 1-b15 1-c15 1-d15 2-a15 2-b15 2-c15 
PTS  
OE 
1-a16 1-b16 1-c16 1-d16 2-a16 2-b16 2-c16 
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Appendix H 
 
Hypotheses Grid for Coping Style and Method with HRQOL 
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Appendix H 
 
Hypotheses Grid for Coping Style and Method with HRQOL 
 
 
Correlation Analyses for CSM and HRQOL 
Research Question # 3 
 BCOPE 
EF 
BCOPE 
PF 
BCOPE 
DF 
BRCope 
AD 
BRCope 
M 
LOC 
I 
LOC 
E 
LOC 
G 
SF 
HRQOL 
P 
3-a1 3-b1 3-c1 3-d1 3-e1 3-f1 3-g1 3-h1 3-i1 
HRQOL 
F 
3-a2 3-b2 3-c2 3-d2 3-e2 3-f2 3-g2 3-h2 3-i2 
HRQOL 
E 
3-a3 3-b3 3-c3 3-d3 3-e3 3-f3 3-g3 3-h3 3-i3 
MCS 
DD 
3-a4 3-b4 3-c4 3-d4 3-e4 3-f4 3-g4 3-h4 3-i14 
MCS 
RD 
3-a5 3-b5 3-c5 3-d5 3-e5 3-f5 3-g5 3-h5 3-i5 
MCS 
ID 
3-a6 3-b6 3-c6 3-d6 3-e6 3-f6 3-g6 3-h6 3-i6 
PTS 
E 
3-a7 3-b7 3-c7 3-d7 3-e7 3-f7 3-g7 3-h7 3-i7 
PTS 
I 
3-a8 3-b8 3-c8 3-d8 3-e8 3-f8 3-g8 3-h8 3-i8 
PTS 
CC 
3-a9 3-b9 3-c9 3-d9 3-e9 3-f9 3-g9 3-h9 3-i9 
PTS 
TQ 
3-a10 3-b10 3-c10 3-d10 3-e10 3-f10 3-g10 3-h10 3-i10 
PTS 
DM 
3-a11 3-b11 3-c11 3-d11 3-e11 3-f11 3-g11 3-h11 3-i11 
PTS 
Nurses 
3-a12 3-b12 3-c12 3-d12 3-e12 3-f12 3-g12 3-h12 3-i12 
PTS 
Trust 
3-a13 3-b13 3-c13 3-d13 3-e13 3-f13 3-g13 3-h13 3-i13 
PTS 
R 
3-a14 3-b14 3-c14 3-d14 3-e14 3-f14 3-g14 3-h14 3-i14 
PTS 
CA 
3-a15 3-b15 3-c15 3-d15 3-e15 3-f15 3-g15 3-h15 3-i15 
PTS 
OE 
3-a16 3-b16 3-c16 3-d16 3-e16 3-f16 3-g16 3-h16 3-i16 
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Appendix I 
 
Hypothesis Grid for Coping Style and Method with SWB and RWB 
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Appendix I 
 
Hypothesis Grid for Coping Style and Method with SWB and RWB 
 
 
Correlation Analyses for CSM and Method and SWB and RWB 
Research 
Question # 4 
and # 5 
BCOPE 
EF 
BCOPE 
PF 
BCOPE 
DF 
BRCope 
AD 
BRCope 
M 
LOC 
 I 
LOC  
E 
LOC  
G 
SF 
SWB 
SWB-MP 
SWB-ROF 
SWB-RLC 
RWB 
RWB-RC 
RWB-RS 
4-a1 4-b1 4 –c1 4-d1 4-e1 4-f1 4-g1 4-h1 4-i1 
4-a2 4-b2 4-c2 4-d2 4-e2 4-f2 4-g2 4-h2 4-i2 
4-a3 4-b3 4-c3 4-d3 4-e3 4-f3 4-g3 4-h3 4-i3 
4-a4 4-b4 4-c4 4-d4 4-d4 4-f4 4-g4 4-h4 4-i4 
5-a1 5-b1 5-c1 5-d1 5-e1 5-f1 5-g1 5-h1 5-i1 
5-a2 5-b2 5-c2 5-d2 5-e2 5-f2 5-g2 5-h2 5-i2 
5-a3 5-b3 5-c3 5-d3 5-e3 5-f3 5-g3 5-h3 5-i3 
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Appendix J 
 
Hypotheses Grid for SWB1 and 2 and RWB 1 and 2 
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Appendix J 
 
Hypotheses Grid for SWB1 and 2 and RWB 1 and 2 
 
 
Comparative Analyses for SWB RWB and HRQOL 
(Pre and Post MCS Device Implant) 
 
Research Question # 6, # 7 
Pre MCS Post MCS Hypotheses 
SWB SWB 6a 
SWB-MP1 SWB-MP2 6b 
SWB-ROF1  SWB-ROF2 6c 
SWB-RLC1 SWB-RLC2 6d 
RWB-O1  RWB-O2 7a 
RWB-RC1 RWB-RC2 7b 
RWB-RS1  RWB-RS2 7c 
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Appendix K 
 
Hypotheses Grid for Coping Style and Method 1 and 2 
 
  
220 
 
 
 
Appendix K 
 
Hypotheses Grid for Coping Style and Method 1 and 2 
 
 
Comparative Analyses for CSM  
(Pre and Post MCS Device Implant) 
 
Research Question # 8 
Pre MCS Post MCS Hypotheses 
BCOPE –O1 BCOPE-O 8a 
BCOPE-EF1 BCOPE-EF2 8b 
BCOPE-PF1 BCOPE—PF2 8c 
BCOPE-DF1 BCOPE-DF2 8d 
BRCOPE-AD1 BRCOPE-AD2 8e 
BRCOPE-M1 BRCOPE-M2 8f 
LOC-O1 LOC-O2 8g 
LOC-I1 LOC-I2 8h 
LOC-E1 LOC-E2 8i 
LOC-G1 LOC-G2 8j 
SF1 SF2 8k 
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Appendix L 
 
Hypotheses Grid for HRQOL 1 and 2 
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Appendix L 
 
Hypotheses Grid for HRQOL 1 and 2 
 
Comparative Analyses for CSM 
 (Pre and Post MCS Device Implant) 
 
Research Question # 9 
HRQOL-P1 HRQOL-P2 9a 
HRQOL-F1 HRQOL-F2 9b 
HRQOL-E1 HRQOL-E2 9c 
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Initial Interview 
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Appendix M 
 
Initial Interview 
 
Joint Commission – basic spiritual assessment 
Q: Does the Joint Commission specify what needs to be included in a spiritual 
assessment? 
  
A: Spiritual assessment should, at a minimum, determine the patient’s 
denomination, beliefs, and what spiritual practices are important to the patient. 
This information would assist in determining the impact of spirituality, if any, on the 
care/services being provided and will identify if any further assessment is needed.  The 
standards require organization‘s to define the content and scope of spiritual and other 
assessments and the included qualifications of the individual(s) performing the 
assessment. 
  
Examples of elements that could be but are not required, in a spiritual assessment 
include the following questions directed to the patient or his/her family: 
 Who or what provides the patient with strength and hope?  
 Does the patient use prayer in their life?  
 How does the patient express their spirituality?  
 How would the patient describe their philosophy of life?  
 What type of spiritual/religious support does the patient desire?  
 What is the name of the patient‘s clergy, ministers, chaplains, pastor, rabbi?  
 What does suffering mean to the patient?  
 What does dying mean to the patient?  
 What are the patient‘s spiritual goals?  
 Is there a role of church/synagogue in the patient‘s life?  
 How does your faith help the patient cope with illness?  
 How does the patient keep going day after day?  
 What helps the patient get through this health care experience?  
 How has illness affected the patient and his/her family? 
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Appendix N 
 
 
Intake Form 
 
ID Number _____________     Date 
 
1. Gender    _____Male       ____Female                  
 
2. Race/Ethnicity    ____African American   ____Asian American   ___Euro American                   
 
____Latino/Latina    ____Native American   ____Other (please specify)_____________ 
                            
 
3. Marital Status 
 
___Single   ___Married   ___Separated   ___Divorced   ____Widowed   ___In a significant relationship  
 
 ___Not in a significant relationship 
 
4. Educational Level 
 
____less than high school graduate (highest grade completed) _____  
 
____High School Graduate  _____GED  ____Vocational/Technical 
 
____Some College  ____College Graduate  ____Graduate/Professional Degree 
  
 
5. Income Level 
 
____ 0-25,000   ____26,000-50,000   ____ 51,000-75,000   ____76,000-100,000    
 
____ over 100,000  
 
 
6. City   __________________________  7. State _______________ 
 
 
8. How many miles do you live from the hospital? __________ 
 
 
9. How long have you had this illness?  ____years  ____months 
 
 
10. How many times have you been in the hospital within the past 6 months?  ________ 
 
11. How many days were you in the hospital in the past 6 months? ________ 
 
12. Do you have someone to confide in?   ____Yes   ____No 
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13. What is your faith tradition (Type or Denomination)?   ________________________ 
 
14. Do you belong to a faith community?  _____Yes    _____No 
 
 
15. Faith Rituals and Practices (check all that apply)   ____communion   ____prayer 
 
 
____meditation  ____sacred text reading   ____community worship   _____fasting 
 
 
____anointing   ____other (please specify) _____________________________ 
 
 
16. Do you receive visitations from chaplain/clergy/community of faith? ____Y  ____N 
 
 
17. How often? _______   18. Would you prefer more visits? _____Y  ____N 
 
 
19. How does a visit from a chaplain/clergy/community of faith help (check all that  
     apply)? 
 
____helps me cope   ____increases faith and courage  ____give me hope   
 
____helps my belief system  ____ helps me connect with higher my power 
 
____helps me connect with my relationships  ____ helps me understand myself   
 
____helps me find meaning  ____gives me sense of purpose/calling/ vocation 
 
____helps me find peace and forgiveness with myself  
 
 ____helps me reinterpret my situation  _____completed my advance directives 
 
____ does not help me 
 
20. Do you have a living will?  ____Y  ____N 
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Appendix O 
 
FACIT-Sp-Ex (Version 4) 
 
Below is a list of statements that other people have said are important. Please indicate how true each statement has been 
for you during the past 7 days by circling (1) number per line.  
 
0= Not at all    1= A little bit    2= Somewhat     3= Quite a bit     4= Very much 
Sp1 I feel peaceful.…………………………………… 0 1 2 3 4 
Sp2 I have a reason for living…………………………... 0 1 2 3 4 
Sp3 My life has been productive………………………. 0 1 2 3 4 
Sp4 I have trouble feeling peace of mind……………… 0 1 2 3 4 
Sp5 I feel a sense of purpose in my life……………….. 0 1 2 3 4 
Sp6 I am able to reach down deep into myself for  comfort 
 
0 1 2 3 4 
Sp7 I feel a sense of harmony within myself…………. 0 1 2 3 4 
Sp8 My life lacks meaning and purpose………………. 0 1 2 3 4 
Sp9 I find comfort in my faith or spiritual beliefs…….. 0 1 2 3 4 
Sp10 I find strength in my faith or spiritual beliefs…….. 0 1 2 3 4 
Sp11 My illness has strengthened my faith or spiritual beliefs. 
 
0 1 2 3 4 
Sp12 I know that whatever happens with my illness, things will be 
okay……………………………….. 
 
0 
 
1 
 
2 
 
3 
 
4 
Sp13 I feel connected to a higher power (or God)……………… 0 1 2 3 4 
Sp14 I feel connected to other people……………………………. 0 1 2 3 4 
Sp15 I feel loved………………...………………………………... 0 1 2 3 4 
Sp16 I feel love for others………………………………………... 0 1 2 3 4 
Sp17 I am able to forgive others for any harm they have ever caused 
me…………………………………………………... 
 
0 
 
1 
 
2 
 
3 
 
4 
Sp18 I feel forgiven for any harm I may have ever caused………. 0 1 2 3 4 
Sp19 Throughout the course of my day, I feel a sense of thankfulness 
for my life……………………………………. 
 
0 
 
1 
 
2 
 
3 
 
4 
Sp20 Throughout the course of my day, I feel a sense of thankfulness 
for what others bring to my life……………… 
 
0 
 
1 
 
2 
 
3 
 
4 
Sp21 I feel hopeful……………………………………………... 0 1 2 3 4 
Sp22 I feel a sense of appreciation for the beauty of nature……... 0 1 2 3 4 
Sp23 I feel compassion for others in the difficulties they are 
facing……………………………………………………….. 
 
0 
 
1 
 
2 
 
3 
 
4 
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Appendix P 
 
Spiritual Comfort/Strain (Exline, Yali and Sanderson, 2000) 
 
Below is a list of statements that other people with your illness have said are important. Please indicate how true each 
statement has been for you during the past 7 days by circling one (1) number per line. 
0                   1                 2                   3                          4 
Not at all      A little bit     Somewhat      Quite a bit      A great deal 
1) Feeling like God has forgiven your sins.                                                     0     1     2     3     4 
2) Trusting God to protect and take care of you.                                              0     1     2     3     4 
3) Feeling like God is close to you.                                                                  0     1     2     3     4 
4) Feeling loved by God.                                                                                  0     1     2     3     4 
5) Good memories of past experiences with religion or religious people.        0     1     2     3     4 
6) Feeling like a part of a religious or spiritual community.                               0     1     2     3     4 
7) Feeling comforted by your faith.                                                                   0     1     2     3     4 
8) Feeling that God is far away.                                                                        0     1     2     3     4    
9) Feeling abandoned by God.                                                                         0     1     2     3     4 
10)Feeling that your faith is weak.                                                                    0     1     2     3     4 
11) Difficulty trusting God.                                                                                 0     1     2     3     4 
12) Difficulty believing God exists.                                                                     0     1     2     3     4 
13) Belief that you have committed a sin too big to be forgiven.                       0     1     2     3     4 
14) Fear of evil or of the devil.                                                                            0     1     2     3     4 
15) Belief that sin has caused your problems.                                                   0     1     2     3     4 
16) Fear of Gods‘ punishment.                                                                           0     1     2     3     4 
17) Bad memories of religion or religious people.                                              0     1     2     3     4 
18) Disagreement with a family member or friend about religious issues.         0     1     2     3     4 
19) Disagreement with something that your religion or church teaches.            0     1     2     3     4 
20) Feeling lonely or different from others because of your beliefs.                   0     1     2     3     4 
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Appendix Q 
 
Brief COPE 
 
 
 
These items deal with ways you have been coping with the stress in your life since you found out your heart failure 
would lead to receiving a mechanical circulatory assist device.  People deal with things in different ways and we are 
interested in how you have tried to deal with getting a mechanical circulatory assist device.  Each item says something 
about a particular way of coping.  We want to know to what extent you have been doing what the item says.  Below is a 
list of statements that other people with your illness have said are important. Please indicate how much you have been 
using each strategy by circling one (1) number per line. 
 
0                   1                 2                   3                          4 
Not at all      A little bit     Somewhat      Quite a bit      A great deal 
1.   I‘ve been turning to work or other activities to take my mind off things 0      1      2      3      4 
2.  I‘ve been concentrating my efforts on doing something about the situation. 0      1      2      3      4 
3.  I‘ve been saying to myself ―this isn‘t real.‖ 0      1      2      3      4 
4.  I‘ve been using alcohol or other drugs to make myself feel better. 0      1      2      3      4 
5.  I‘ve been getting emotional support from others. 0      1      2      3      4 
6.  I‘ve been giving up trying to deal with it. 0      1      2      3      4 
7.  I‘ve been taking action to try to make the situation better. 0      1      2      3      4 
8.  I‘ve been refusing to believe that it has happened. 0      1      2      3      4    
9.  I‘ve been saying things to let my unpleasant feelings escape. 0      1      2      3      4 
10. I‘ve been getting help and advice from other people. 0      1      2      3      4 
11. I‘ve been using alcohol or other drugs to help me get through it. 0      1      2      3      4 
12. I‘ve been trying to see it in a different light, to make it seem more positive. 0      1      2      3      4 
13. I‘ve been criticizing myself. 0      1      2      3      4 
14. I‘ve been trying to come up with a strategy about what to do. 0      1      2      3      4 
15. I‘ve been getting comfort and understanding from someone. 0      1      2      3      4 
16. I‘ve been giving up the attempt to cope. 0      1      2      3      4 
17. I‘ve been looking for something good in what is happening. 0      1      2      3      4 
18. I‘ve been making jokes about it. 0      1      2      3      4 
19. I‘ve been doing something to think about it less, such as going to movies watching TV,  
      reading, daydreaming, sleeping, or shopping. 
0      1      2      3      4 
20. I‘ve been accepting the reality of the fact that is has happened. 0      1      2      3      4 
21. I‘ve been expressing my negative feelings. 0      1      2      3      4 
22. I‘ve been trying to find comfort in my religion or spiritual beliefs. 0      1      2      3      4 
23. I‘ve been trying to get advice or help from other people about what to do. 0      1      2      3      4 
24. I‘ve been learning to live with it. 0      1      2      3      4 
25. I‘ve been thinking hard about what steps to take. 0      1      2      3      4 
26. I‘ve been blaming myself for things that happened. 0      1      2      3      4 
27. I‘ve been praying or meditating. 0      1      2      3      4 
28. I‘ve been making fun of the situation. 0      1      2      3      4 
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Appendix R 
 
Brief RCOPE – Pargament 
 
Below is a list of statements that other people with your illness have said are important. Please indicate how true each 
statement has been for you during the past 7 days by circling one (1) number per line. 
 
How have I coped with my illness? 
                                                                      0) not at all     1) a little bit   2) somewhat   3) quite a bit   4) a great deal 
 
 
1. Looked for a stronger connection with God.       0    1    2    3    4  
2. Sought God‘s love and care.        0    1    2    3    4 
3. Sought help from God in letting go of my anger.      0    1    2    3    4  
4. Tried to put my plans into action together with God.      0    1    2    3     4 
5. Tried to see how God might be trying to strengthen me in this situation.          0   1    2     3    4  
6. Asked forgiveness of my sins.         0  1    2     3    4 
7. Focused on religion to stop worrying about my problems.       0  1    2     3    4  
8. Wondered whether God had abandoned me. .        0  1   2     3    4  
9. Felt punished by God for my lack of devotion.       0   1   2     3    4 
10. Wondered what I did for God to punish me.        0   1   2     3    4 
11. Questioned God‘s love for me.         0   1   2     3   4 
12. Wondered whether my church had abandoned me.       0   1   2     3   4 
13. Decided the devil made this happen.        0   1   2     3   4 
14. Questioned the power of God.         0   1   2    3    4 
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Appendix S 
 
Multidimensional Health Locus of Control Form C with GLOC 
 
Below is a list of statements that other people with your illness have said are important. Please indicate how true each 
statement has been for you during the past 7 days by circling one (1) number per line. 
1=STRONGLY DISAGREE (SD) 
2=MODERATELY DISAGREE (MD) 
3=SLIGHTLY DISAGREE (D) 
4=SLIGHTLY AGREE (A) 
5=MODERATELY AGREE (MA) 
6=STRONGLY AGREE (SA) 
 
  SD MD D A MA SA 
1 
If my (health; condition) worsens, it is my own behavior which determines how soon 
I will feel better again. 
1 2 3 4 5 6 
2 
If my (health; condition) worsens, it is up to God to determine whether I will feel 
better again.* 
1 2 3 4 5 6 
3 As to my (health; condition), what will be will be. 1 2 3 4 5 6 
4 
If I see my doctor regularly, I am less likely to have problems with my (health; 
condition). 
1 2 3 4 5 6 
5 Most things that affect my (health; condition) happen to me by chance. 1 2 3 4 5 6 
6 Most things that affect my (health; condition) happen because of God.* 1 2 3 4 5 6 
7 
Whenever my (health; condition) worsens, I should consult a medically trained 
professional. 
1 2 3 4 5 6 
8 I am directly responsible for my (health; condition) getting better or worse. 1 2 3 4 5 6 
9 God is directly responsible for my (health; condition) getting better or worse.* 1 2 3 4 5 6 
10 
Other people play a big role in whether my (health; condition) improves, stays the 
same, or gets worse. 
1 2 3 4 5 6 
11 Whatever goes wrong with my (health; condition) is my own fault. 1 2 3 4 5 6 
12 Luck plays a big part in determining how my (health; condition) improves. 1 2 3 4 5 6 
13 Whatever happens to my (health; condition) is God‘s will.* 1 2 3 4 5 6 
14 
In order for my (health; condition) to improve, it is up to other people to see that the 
right things happen. 
1 2 3 4 5 6 
15 
Whatever improvement occurs with my (health; condition) is largely a matter of good 
fortune. 
1 2 3 4 5 6 
16 The main thing which affects my (health; condition) is what I myself do. 1 2 3 4 5 6 
17 Whether or not my (health; condition) improves is up to God.* 1 2 3 4 5 6 
18 
I deserve the credit when my (health; condition) improves and the blame when it gets 
worse. 
1 2 3 4 5 6 
19 
Following doctor's orders to the letter is the best way to keep my (health; condition) 
from getting any worse. 
1 2 3 4 5 6 
20 If my (health; condition) worsens, it's a matter of fate. 1 2 3 4 5 6 
21 God is in control of my (health; condition).* 1 2 3 4 5 6 
22 If I am lucky, my (health; condition) will get better. 1 2 3 4 5 6 
23 
If my (health; condition) takes a turn for the worse, it is because I have not been 
taking proper care of myself. 
1 2 3 4 5 6 
24 
The type of help I receive from other people determines how soon my (health; 
condition) improves. 
1 2 3 4 5 6 
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Appendix T 
 
          FACT-G (Version 4) 
 
Below is a list of statements that other people with your illness have said are important. Please indicate how true each 
statement has been for you during the past 7 days by circling one (1) number per line. 
 
 
                                                                                                       
 
PHYSICAL WELL-BEING 
 
Not at all A little 
bit 
Somew
hat 
Quite 
a bit 
Very 
much 
 
GP1 I have a lack of energy 0 1 2 3 4 
GP2 I have nausea 0 1 2 3 4 
GP3 Because of my physical condition, I have trouble meeting the 
needs of my family 
 
0 
 
1 
 
2 
 
3 
 
4 
GP4 I have pain 0 1 2 3 4 
GP5 I am bothered by side effects of treatment ......................................................................  0 1 2 3 4 
GP6 I feel ill 0 1 2 3 4 
GP7 I am forced to spend time in bed 0 1 2 3 4 
 SOCIAL/FAMILY WELL-BEING 
 
Not at all A little 
bit 
Somew
hat 
Quite a 
bit 
Very 
much 
 
GS1 I feel close to my friends 0 1 2 3 4 
GS2 I get emotional support from my family 0 1 2 3 4 
GS3 I get support from my friends 0 1 2 3 4 
GS4 My family has accepted my illness 0 1 2 3 4 
GS5 I am satisfied with family communication about my illness  
0 
 
1 
 
2 
 
3 
 
4 
GS6 I feel close to my partner (or the person who is my main 
support) 
 
0 
 
1 
 
2 
 
3 
 
4 
Q1 Regardless of your current level of sexual activity, please 
answer the following question. If you prefer not to answer it, 
please mark this box           and go to the next section. 
     
GS7 I am satisfied with my sex life 0 1 2 3 4 
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 EMOTIONAL WELL-BEING Not at 
all 
A little 
bit 
Some
what 
Quite a 
bit 
Very 
much 
 
GE1 I feel sad 0 1 2 3 4 
GE2 I am satisfied with how I am coping with my illness 0 1 2 3 4 
GE3 I am losing hope in the fight against my illness 0 1 2 3 4 
GE4 I feel nervous 0 1 2 3 4 
GE5 I worry about dying 0 1 2 3 4 
GE6 I worry that my condition will get worse 0 1 2 3 4 
 FUNCTIONAL WELL-BEING 
 
Not at 
all 
A little 
bit 
Some
what 
Quite 
a bit 
Very 
much 
 
GF1 I am able to work (include work at home) 0 1 2 3 4 
GF2 My work (include work at home) is fulfilling 0 1 2 3 4 
GF3 I am able to enjoy life 0 1 2 3 4 
GF4 I have accepted my illness 0 1 2 3 4 
GF5 I am sleeping well 0 1 2 3 4 
GF6 I am enjoying the things I usually do for fun 0 1 2 3 4 
GF7 I am content with the quality of my life right now 0 1 2 3 4 
 
 
 
 
 
 
 
 
 
 
 
English (Universal)   16 November 2007 
Copyright  1987, 1997    
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Appendix U 
 
Final Spiritual Interview 
 
 
(Adapted from Cerner Spiritual Encounter Assessment) 
 
Below is a list of comments that other people with your illness have given concerning their experience with 
the MCS.  Please check all statements that apply.  
 
My experience with the MCS has:  
 
(check all that apply)? 
 
____ helped me learn how to cope better. 
 
____ increased my faith and courage.   
 
____ given me hope.   
 
____ helped my belief system.  
 
____ helped me connect with my higher power. 
 
____ helped me connect with my relationships.   
 
____ helped me to understand myself better.   
 
____ helped me find meaning in my life. 
 
____ given me a sense of purpose/calling/ vocation. 
 
____ helped me find peace and forgiveness with myself.  
 
____ helped me reinterpret my life situation. 
 
____ made my life worse. 
 
Comments _____________________________________________________________________ 
______________________________________________________________________________ 
______________________________________________________________________________ 
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Appendix V 
 
Patient Satisfaction Survey 
 
Facit –TS – PS  
 
These questions are about the quality of the health care services you are currently receiving. All of your responses will 
be kept confidential. Your opinions may refer to your last visit or to several visits.  
 
Please mark one box to choose the visit(s) you would like to rate: 
 
 
1 
My most recent visit 0 
 
 
  
 1 
 
 
Several of my most recent visits 0 
 
  
 2 
 
 
My experience in general 0 
 
  
 3 
 
Please mark one answer for each of the following questions. 
 
 
Explanations 
No, not at all Yes, but 
not as 
much as I 
wanted 
Yes, 
almost as 
much as I 
wanted 
Yes, and 
as much 
as I 
wanted 
TS9 Did your doctor(s) give explanations that you could 
understand? 
 
0 
 
1 
 
2 
 
3 
TS10 Did your doctor(s) explain the possible benefits of your 
treatment? 
 
0 
 
1 
 
2 
 
3 
TS11 Did your doctor(s) explain the possible side effects or 
risks of your treatment? 
 
0 
 
1 
 
2 
 
3 
TS12 Did you have an opportunity to ask questions? 0 1 2 3 
 
Interpersonal 
    
TS13 Did you get to say the things that were important to 
you? 
 
0 
 
1 
 
2 
 
3 
TS14 Did your doctor(s) seem to understand what was 
important to you? 
 
0 
 
1 
 
2 
 
3 
TS15 Did your doctor(s) show genuine concern for you? 0 1 2 3 
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Comprehensive Care 
No, not at all Yes, but 
not as 
much as I 
wanted 
Yes, 
almost as 
much as I 
wanted 
Yes,  
and as 
much as 
I wanted 
 
TS16 Did your doctor(s) seem to understand your needs? 0 1 2 3 
TS17 Did you feel that the treatment staff worked together 
towards the same goal? 
 
0 
 
1 
 
2 
 
3 
TS18 Were you able to talk to your doctor(s) when you 
needed to? 
 
0 
 
1 
 
2 
 
3 
TS19 Did the treatment staff discuss how your health and 
treatment may affect your normal work (including 
housework)? 
 
 
0 
 
 
1 
 
 
2 
 
 
3 
TS20 Did the treatment staff discuss how your health and 
treatment may affect your normal daily activities? 
 
0 
 
1 
 
2 
 
3 
TS21 Did the treatment staff discuss how your health and 
treatment may affect your personal relationships? 
 
0 
 
1 
 
2 
 
3 
TS22 Did the treatment staff discuss how your health and 
treatment may affect you emotionally? 
 
0 
 
1 
 
2 
 
3 
 
Technical Quality     
TS23 Did you feel your doctor(s) had experience treating 
your illness? 
 
0 
 
1 
 
2 
 
3 
TS24 Did you feel your doctor(s) knew about the latest 
medical developments for your illness? 
 
0 
 
1 
 
2 
 
3 
TS25 Was the treatment staff thorough in examining and 
treating you? 
 
0 
 
1 
 
2 
 
3 
 
Decision-making 
No, not at 
all 
Yes, but 
not as 
much as I 
wanted 
Yes, almost 
as much as 
I wanted 
Yes, and as 
much as I 
wanted 
TS2
6 
Did your doctor(s) discuss other treatments, for 
example, alternative medicine or new treatments? 
 
0 
 
1 
 
2 
 
3 
TS2
7 
Were you encouraged to participate in decisions 
about your health care? 
 
0 
 
1 
 
2 
 
3 
TS2
8 
Did you have enough time to make decisions about 
your healthcare? 
 
0 
 
1 
 
2 
 
3 
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TS2
9 
Did you have enough information to make decisions 
about your health care? 
 
0 
 
1 
 
2 
 
3 
TS3
0 
Did your doctor(s) seem to respect your opinions? 0 1 2 3 
 
Nurses 
 
    
TS3
1 
Did your nurse(s) give explanations that you could 
understand? 
 
0 
 
1 
 
2 
 
3 
TS3
2 
Did your nurse(s) show genuine concern for you? 0 1 2 3 
TS3
3 
Did your nurse(s) seem to understand your needs? 0 1 2 3 
 
Trust 
No, not at 
all 
Yes, to 
some 
extent 
Yes, for the 
most part 
Yes, 
completely 
TS3
4 
Did you feel that the treatment staff answered your 
questions honestly? 
............................................... 
 
0 
 
1 
 
2 
 
3 
TS3
5 
Did the treatment staff respect your privacy? 
 
0 1 2 3 
TS3
6 
Did you have confidence in your doctor(s)? 0 1 2 3 
TS3
7 
Did you trust your doctor(s)' suggestions for 
treatment? 
 
0 
 
1 
 
2 
 
3 
 
 
 
Overall 
No Maybe Yes 
TS38 Would you recommend this hospital/clinic/office to 
others? 
 
0 
 
1 
 
2 
TS39 Would you choose this hospital/clinic/office again? 0 1 2 
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Overall 
Poor Fair Good Very 
Good 
Excellent 
TS40 How do you rate the care you received? 0 1 2 3 4 
 
Thank you! Do you have any comments? 
 
________________________________________________________________________________________________ 
 
________________________________________________________________________________________________ 
 
________________________________________________________________________________________________ 
 
________________________________________________________________________________________________ 
 
________________________________________________________________________________________________ 
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Appendix W 
 
Cerner Pastoral Care Tool 
 
VCU Medical System Department of Pastoral Care – Each encounter 
 
(Check all that apply from each column) 
Referral 
 
Spiritual Concerns  Intervention Outcomes Plan 
Patient request Fear/anxiety Spiritual/Emotional 
Support 
Resolution of 
concern 
 
Ongoing 
support 
Family request Hopelessness Crisis intervention Enhanced coping 
 
Continue 
noted 
interventions 
Screening 
assessment 
Uncertainty about the 
future 
Support present Coping Enhanced 
faith/courage 
 
Referral to 
unit/service 
chaplain 
Staff referral Concern about 
death/afterlife 
Reassess present coping Enhanced hope 
 
Referral to 
bereavement 
program 
Self referral Anger/resentment Prayer Enhanced  belief 
system 
 
Bereavement 
packet 
Pre-operative Guilt – referenced Ritual Enhanced 
connection with 
higher power 
 
Team consult 
Code Guilt- 
undifferentiated 
Sacred writings/readings Enhanced 
connection with 
relationships 
 
Referral to 
other service 
TTA  Self image Confession/forgiveness Enhanced 
connection with 
higher power 
 
Referral to 
other 
community 
resources 
Death Bereavement 
incident 
Bereavement care Enhanced sense of 
self 
 
Other 
FCC  Unresolved grief Reconciliation Reconciliation 
with self 
 
 
Advance 
directives 
Anticipatory grief Situational Reassessment Enhanced sense of 
meaning 
 
 
Follow up 
visit 
Disconnection from 
higher power 
Values clarification Enhanced sense of 
vocation 
 
 
Other Isolation/loneliness Life review Situational 
reinterpretation 
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 Alienation from 
religious community 
Family intervention/care Advance 
directives 
completed 
 
 
 Burden to other Other Unchanged 
 
 
 Helplessness  None 
 
 
 Loss of meaning or 
purpose 
   
 Loss of motivation     
 Values clarification    
 None at this time    
 Unable to assess    
 Other    
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Appendix X 
 
Confidential Name Numeric Identifier 
(To be kept separate from survey data) 
 
Name/Site ID# Contact  
Information 
(phone/email) 
Primary 
Caregiver Name 
and Contact Info 
Informed 
Consent Date 
Intake Date 
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Appendix Y 
 
Patient Demographics and Previous History Collection Sheet (Pre-MCS) 
 
Date  
Numeric Identifier  
Gender __ M   __ F 
 
Race/Ethnicity/Culture ____ African American 
____ Asian American 
____ Euro American 
____Latino/Latina 
____ Native American 
____Other (please specify) ___________ 
 
Marital Status __S __M __Sep __D __W __ISR __NISR 
 
Educational Level (Check One)  ____less than high school graduate (highest grade 
completed) _____ 
 
____High School Graduate   
_____GED   
____Vocational/Technical 
____Some College   
____College  
____Graduate  ____Graduate/Professional Degree 
 
Occupation  
Income Level ____ 0-25,000    
____ 26,000-50,000 
____ 51,000-75,000   
____ 76,000-100,000    
____ over 100,000 
  
City/State  
Do you have a confidante (Y/N)  
Faith Tradition (Type or Denomination)  
Faith Community Membership (Y/N)  
Faith Rituals and Practices (Check all that apply) __communion __prayer __meditation __sacred text reading  
__community worship __fasting __anointing   
__other (describe) ___________ 
 
Faith Visitation from Chaplain/Clergy/Community of 
Faith (Y/N, dates, # of times) 
Dates 
# of times 
Faith Outcomes (Check all that apply) __enhanced-coping  __faith/courage __hope  __belief 
system  
__connection with higher power __connection with 
relationships  
__sense of self  __sense of meaning __sense of vocation  
__reconciliation of self 
__situational reinterpretation 
__advance directives completion __unchanged/does not 
help 
Payor (Insurance or otherwise)  
Distance lived from hospital (miles)  
Length of time diagnosed or living with HF (years/mos)  
255 
 
 
 
HF Etiology (Check One) _Ischemic, _idiopathic, _hypertension, _valvular, 
_alcoholic, _postpartum, _other 
# readmissions days previous 6 mos.  
# hospital days previous 6 mos.  
MCS Plan _BTR, _BTT, _BTD, _DT  
Intervention 1) MCS Type _HMII, __Jarvik, _TAH, _Other 
Intervention 2) Other _HT, _Palliative, _Other 
Redevice; Retransplant _RD ________;  _RT________ 
Advance Directive Completed (Y/N) _Y, _N 
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Appendix Z 
 
Patient Survey and Post Treatment Data Collection Tool (Pre and Post MCS) 
 
ID# _________ 
 
Date__________ 
Pre MCS Post  MCS  Comments 
Initial Approach/Invitation    
Signed Informed Consent    
Initial Interview    
Intake Form    
SWB – 
Facit-Sp Ex 
Overall 
MP 
ROF 
RLC 
   
RWB 
Overall 
Comfort 
Strain 
   
CSM 
Brief Cope 
EF 
PF 
DF 
   
CSM 
Brief RCope 
Adaptive – AD 
Maladaptive – M 
   
CSM Locus of Control 
LOC-I 
LOC-E 
LOC-G 
   
CSM Fact G – SF    
HRQOL Fact G- P    
HRQOL Fact G-F    
HRQOL Fact G-E 
 
   
Facit – Patient Satisfaction PTS    
Final Interview    
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